| 1 |
Casas-Arozamena C, Moiola CP, Vilar A, Bouso M, Cueva J, Cabrera S, Sampayo V, Arias E, Abalo A, García Á, Lago-Lestón RM, Oltra S, Díaz E, Ruiz-Bañobre J, López-López R, Moreno-Bueno G, Gil-Moreno A, Colás E, Abal M, Muinelo-Romay L. Noninvasive detection of microsatellite instability in patients with endometrial cancer. Int J Cancer 2023;152:2206-17. [PMID: 36650670 DOI: 10.1002/ijc.34435] [Reference Citation Analysis]
|
| 2 |
Capasso I, Santoro A, Lucci Cordisco E, Perrone E, Tronconi F, Catena U, Zannoni GF, Scambia G, Fanfani F, Lorusso D, Duranti S. Lynch Syndrome and Gynecologic Tumors: Incidence, Prophylaxis, and Management of Patients with Cancer. Cancers (Basel) 2023;15. [PMID: 36900193 DOI: 10.3390/cancers15051400] [Reference Citation Analysis]
|
| 3 |
Dueñas N, Navarro M, Sanjuán X, Ruiz N, Iglesias S, Matias-Guiu X, Guardiola J, Kreisler E, Biondo S, González S, Legido R, Blanco A, Navarro S, Asiain L, Santos C, Capellá G, Pineda M, Brunet J. Lessons learnt from the implementation of a colorectal cancer screening programme for lynch syndrome in a tertiary public hospital. Cancer Epidemiol 2023;82:102291. [PMID: 36410089 DOI: 10.1016/j.canep.2022.102291] [Reference Citation Analysis]
|
| 4 |
Zammit AP, Brown I, Hooper JD, Clark DA, Riddell AD. Missing parameters in malignant polyp histology reports: can appropriate decisions be made? Pathology 2023;55:58-63. [PMID: 36109194 DOI: 10.1016/j.pathol.2022.06.007] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
|
| 5 |
Georgiou D, Monje-Garcia L, Miles T, Monahan K, Ryan NAJ. A Focused Clinical Review of Lynch Syndrome. Cancer Manag Res 2023;15:67-85. [PMID: 36699114 DOI: 10.2147/CMAR.S283668] [Reference Citation Analysis]
|
| 6 |
Ciombor KK, Eng C. Immunotherapy in Localized Microsatellite Instability-High/Mismatch Repair Deficient Solid Tumors: Are We Ready for a New Standard of Care? J Clin Oncol 2023;:JCO2202564. [PMID: 36623236 DOI: 10.1200/JCO.22.02564] [Reference Citation Analysis]
|
| 7 |
Hagemann AR, Nikam R, Mutch DG. Genes and cancer: Genetic counselling and clinical management. DiSaia and Creasman Clinical Gynecologic Oncology 2023. [DOI: 10.1016/b978-0-323-77684-4.00027-1] [Reference Citation Analysis]
|
| 8 |
Loong L, Huntley C, McRonald F, Santaniello F, Pethick J, Torr B, Allen S, Tulloch O, Goel S, Shand B, Rahman T, Luchtenborg M, Garrett A, Barber R, Bedenham T, Bourn D, Bradshaw K, Brooks C, Bruty J, Burghel GJ, Butler S, Buxton C, Callaway A, Callaway J, Drummond J, Durkie M, Field J, Jenkins L, McVeigh TP, Mountford R, Nyanhete R, Petrides E, Robinson R, Scott T, Stinton V, Tellez J, Wallace AJ, Yarram-Smith L, Sahan K, Hallowell N, Eccles DM, Pharoah P, Tischkowitz M, Antoniou AC, Evans DG, Lalloo F, Norbury G, Morris E, Burn J, Hardy S, Turnbull C. Germline mismatch repair (MMR) gene analyses from English NHS regional molecular genomics laboratories 1996-2020: development of a national resource of patient-level genomics laboratory records. J Med Genet 2022:jmg-2022-108800. [PMID: 36572524 DOI: 10.1136/jmg-2022-108800] [Reference Citation Analysis]
|
| 9 |
Hryhorowicz S, Kaczmarek-Ryś M, Lis-Tanaś E, Porowski J, Szuman M, Grot N, Kryszczyńska A, Paszkowski J, Banasiewicz T, Pławski A. Strong Hereditary Predispositions to Colorectal Cancer. Genes (Basel) 2022;13. [PMID: 36553592 DOI: 10.3390/genes13122326] [Reference Citation Analysis]
|
| 10 |
Hou W, Yi C, Zhu H. Predictive biomarkers of colon cancer immunotherapy: Present and future. Front Immunol 2022;13:1032314. [PMID: 36483562 DOI: 10.3389/fimmu.2022.1032314] [Reference Citation Analysis]
|
| 11 |
Dehghani Soufi M, Rezaei Hachesu P, Ferdousi R. Oncology Informatics for Lynch Syndrome Research and Care: A Literature Review. JCO Clinical Cancer Informatics 2022. [DOI: 10.1200/cci.22.00087] [Reference Citation Analysis]
|
| 12 |
Gambini D, Ferrero S, Kuhn E. Lynch Syndrome: From Carcinogenesis to Prevention Interventions. Cancers 2022;14:4102. [DOI: 10.3390/cancers14174102] [Reference Citation Analysis]
|
| 13 |
Lundqvist E, Kuchinskaya E, Landerholm K, Assarsson J, Benckert A, Myrelid P, Haapaniemi S. Hereditary evaluation and genetic counselling in young individuals with colorectal cancer in a population-based cohort. Surgical Oncology 2022;41:101741. [DOI: 10.1016/j.suronc.2022.101741] [Reference Citation Analysis]
|
| 14 |
Ozirmak Lermi N, Gray SB, Bowen CM, Reyes-uribe L, Dray BK, Deng N, Harris RA, Raveendran M, Benavides F, Hodo CL, Taggart MW, Colbert Maresso K, Sinha KM, Rogers J, Vilar E. Comparative molecular genomic analyses of a spontaneous rhesus macaque model of mismatch repair-deficient colorectal cancer. PLoS Genet 2022;18:e1010163. [DOI: 10.1371/journal.pgen.1010163] [Reference Citation Analysis]
|
| 15 |
Crain PR, Zepp JM, Gille S, Jenkins L, Kauffman TL, Shuster E, Goddard KAB, Wilfond BS, Hunter JE. Identifying patients with Lynch syndrome using a universal tumor screening program in an integrated healthcare system. Hered Cancer Clin Pract 2022;20:17. [PMID: 35436948 DOI: 10.1186/s13053-022-00217-1] [Reference Citation Analysis]
|
| 16 |
Aoun RJN, Kalady MF. The importance of genetics for timing and extent of surgery in inherited colorectal cancer syndromes. Surgical Oncology 2022. [DOI: 10.1016/j.suronc.2022.101765] [Reference Citation Analysis]
|
| 17 |
Contreras NA, Sabadell J, Verdaguer P, Julià C, Fernández-Montolí ME. Fertility-Sparing Approaches in Atypical Endometrial Hyperplasia and Endometrial Cancer Patients: Current Evidence and Future Directions. Int J Mol Sci 2022;23:2531. [PMID: 35269674 DOI: 10.3390/ijms23052531] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
|
| 18 |
O'Malley DM, Blair CK, Greenbaum A, Wiggins CL, Rajput A, Chiu VK, Kinney AY. Colorectal Cancer Survivors' Receptivity toward Genomic Testing and Targeted Use of Non-Steroidal Anti-Inflammatory Drugs to Prevent Cancer Recurrence. J Community Genet 2022. [PMID: 34997901 DOI: 10.1007/s12687-021-00574-9] [Reference Citation Analysis]
|
| 19 |
Pereira MA, de Oliveira Marinho FL, Leite LR, Alvim LB, Malta FSV, Marques FK, de Lima AB. Breast Cancer and Next-Generation Sequencing: Towards Clinical Relevance and Future. Breast Cancer: From Bench to Personalized Medicine 2022. [DOI: 10.1007/978-981-19-0197-3_20] [Reference Citation Analysis]
|
| 20 |
Vazquez-tunas ML. Hereditary nonpolyposis CRC. Foundations of Colorectal Cancer 2022. [DOI: 10.1016/b978-0-323-90055-3.00042-9] [Reference Citation Analysis]
|
| 21 |
Maratt JK, Stoffel E. Identification of Lynch Syndrome. Gastrointest Endosc Clin N Am 2022;32:45-58. [PMID: 34798986 DOI: 10.1016/j.giec.2021.09.002] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
|
| 22 |
Du F, Liu Y. Predictive molecular markers for the treatment with immune checkpoint inhibitors in colorectal cancer. J Clin Lab Anal 2021;:e24141. [PMID: 34817097 DOI: 10.1002/jcla.24141] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
|
| 23 |
Komlodi-Pasztor E, Blakeley JO. Brain Cancers in Genetic Syndromes. Curr Neurol Neurosci Rep 2021;21:64. [PMID: 34806136 DOI: 10.1007/s11910-021-01149-4] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
|
| 24 |
da Mata S, Franchi-Mendes T, Abreu S, Filipe B, Morgado S, Mesquita M, Albuquerque C, Fonseca R, Santo VE, Boghaert ER, Rosa I, Brito C. Patient-Derived Explants of Colorectal Cancer: Histopathological and Molecular Analysis of Long-Term Cultures. Cancers (Basel) 2021;13:4695. [PMID: 34572922 DOI: 10.3390/cancers13184695] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
|
| 25 |
Zhao S, Chen L, Zang Y, Liu W, Liu S, Teng F, Xue F, Wang Y. Endometrial cancer in Lynch syndrome. Int J Cancer 2021. [PMID: 34398969 DOI: 10.1002/ijc.33763] [Cited by in Crossref: 5] [Cited by in F6Publishing: 6] [Article Influence: 2.5] [Reference Citation Analysis]
|
| 26 |
Ramdzan AR, Manaf MRA, Aizuddin AN, Latiff ZA, Teik KW, Ch'ng GS, Ganasegeran K, Aljunid SM. Cost-Effectiveness of Colorectal Cancer Genetic Testing. Int J Environ Res Public Health 2021;18:8330. [PMID: 34444091 DOI: 10.3390/ijerph18168330] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
|
| 27 |
Khorram MR, Goshayeshi L, Maghool F, Bergquist R, Ghaffarzadegan K, Eslami S, Khooei A, Hoseini B. Prevalence of Mismatch Repair-Deficient Colorectal Adenoma/Polyp in Early-Onset, Advanced Cases: a Cross-Sectional Study Based on Iranian Hereditary Colorectal Cancer Registry. J Gastrointest Cancer 2021;52:263-8. [PMID: 32193764 DOI: 10.1007/s12029-020-00395-y] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 2.5] [Reference Citation Analysis]
|
| 28 |
Sajjadi E, Venetis K, Piciotti R, Invernizzi M, Guerini-Rocco E, Haricharan S, Fusco N. Mismatch repair-deficient hormone receptor-positive breast cancers: Biology and pathological characterization. Cancer Cell Int 2021;21:266. [PMID: 34001143 DOI: 10.1186/s12935-021-01976-y] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 4.0] [Reference Citation Analysis]
|
| 29 |
Gaiani F, Marchesi F, Negri F, Greco L, Malesci A, de'Angelis GL, Laghi L. Heterogeneity of Colorectal Cancer Progression: Molecular Gas and Brakes. Int J Mol Sci 2021;22. [PMID: 34063506 DOI: 10.3390/ijms22105246] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 2.5] [Reference Citation Analysis]
|
| 30 |
Dong L, Zou S, Jin X, Lu H, Zhang Y, Guo L, Cai J, Ying J. Cytoplasmic MSH2 Related to Genomic Deletions in the MSH2/EPCAM Genes in Colorectal Cancer Patients With Suspected Lynch Syndrome. Front Oncol 2021;11:627460. [PMID: 34055602 DOI: 10.3389/fonc.2021.627460] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
|
| 31 |
O'Shea R, Rankin NM, Kentwell M, Gleeson M, Tucker KM, Hampel H, Taylor N, Lewis S. Stakeholders' views of integrating universal tumour screening and genetic testing for colorectal and endometrial cancer into routine oncology. Eur J Hum Genet 2021. [PMID: 33811254 DOI: 10.1038/s41431-021-00871-4] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
|
| 32 |
Piciotti R, Venetis K, Sajjadi E, Fusco N. Mismatch Repair Status Characterization in Oncologic Pathology: Taking Stock of the Real-World Possibilities. JMP 2021;2:93-100. [DOI: 10.3390/jmp2020009] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
|
| 33 |
Ryan NA, McMahon RF, Ramchander NC, Seif MW, Evans DG, Crosbie EJ. Lynch syndrome for the gynaecologist. Obstet Gynaecol 2021;23:9-20. [PMID: 33679238 DOI: 10.1111/tog.12706] [Cited by in Crossref: 10] [Cited by in F6Publishing: 10] [Article Influence: 5.0] [Reference Citation Analysis]
|
| 34 |
Aretz S, Steinke-lange V, Vilz TO, Rädle J. Hereditäre Darmkrebssyndrome: Diagnostik und Management. Onkologe 2021;27:203-218. [DOI: 10.1007/s00761-020-00884-6] [Reference Citation Analysis]
|
| 35 |
Leelatian N, Hong CS, Bindra RS. The Role of Mismatch Repair in Glioblastoma Multiforme Treatment Response and Resistance. Neurosurg Clin N Am 2021;32:171-80. [PMID: 33781500 DOI: 10.1016/j.nec.2020.12.009] [Cited by in Crossref: 3] [Cited by in F6Publishing: 5] [Article Influence: 1.5] [Reference Citation Analysis]
|
| 36 |
Wolf AI, Buchanan AH, Farkas LM. Historical review of Lynch syndrome. Journal of Coloproctology 2021;33:095-110. [DOI: 10.1016/j.jcol.2013.04.004] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 3.5] [Reference Citation Analysis]
|
| 37 |
Gallon R, Gawthorpe P, Phelps RL, Hayes C, Borthwick GM, Santibanez-Koref M, Jackson MS, Burn J. How Should We Test for Lynch Syndrome? A Review of Current Guidelines and Future Strategies. Cancers (Basel) 2021;13:406. [PMID: 33499123 DOI: 10.3390/cancers13030406] [Cited by in Crossref: 13] [Cited by in F6Publishing: 13] [Article Influence: 6.5] [Reference Citation Analysis]
|
| 38 |
Evans DG, Lalloo F, Ryan NA, Bowers N, Green K, Woodward ER, Clancy T, Bolton J, McVey RJ, Wallace AJ, Newton K, Hill J, McMahon R, Crosbie EJ. Advances in genetic technologies result in improved diagnosis of mismatch repair deficiency in colorectal and endometrial cancers. J Med Genet 2021:jmedgenet-2020-107542. [PMID: 33452216 DOI: 10.1136/jmedgenet-2020-107542] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
|
| 39 |
Lindner AK, Schachtner G, Tulchiner G, Thurnher M, Untergasser G, Obrist P, Pipp I, Steinkohl F, Horninger W, Culig Z, Pichler R. Lynch Syndrome: Its Impact on Urothelial Carcinoma. Int J Mol Sci 2021;22:E531. [PMID: 33430305 DOI: 10.3390/ijms22020531] [Cited by in Crossref: 5] [Cited by in F6Publishing: 6] [Article Influence: 2.5] [Reference Citation Analysis]
|
| 40 |
Kirbiyik O, Özyilmaz B. Genetic Knowledge of Colorectal Cancer. Colon Polyps and Colorectal Cancer 2021. [DOI: 10.1007/978-3-030-57273-0_24] [Reference Citation Analysis]
|
| 41 |
Kahraman DS, Sayhan S. Colon Polyps and Their Pathologic Characteristics. Colon Polyps and Colorectal Cancer 2021. [DOI: 10.1007/978-3-030-57273-0_9] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
|
| 42 |
Augustin IG, Pirciu M, Stănculeanu DL, Marincaş MA, Mădălina R, Toma ŞA, Zob D. A rare case of associated renal, breast and colorectal cancer in a young patient. Oncolog-Hematolog ro 2021;4:33. [DOI: 10.26416/onhe.57.4.2021.5797] [Reference Citation Analysis]
|
| 43 |
Patel SG, Boland CR. Genetic Testing Use and Expectations in Early Onset Colorectal Cancer. Curr Treat Options Gastro 2020;18:589-603. [DOI: 10.1007/s11938-020-00308-9] [Cited by in Crossref: 4] [Article Influence: 1.3] [Reference Citation Analysis]
|
| 44 |
Heald B, Keel E, Marquard J, Burke CA, Kalady MF, Church JM, Liska D, Mankaney G, Hurley K, Eng C. Using chatbots to screen for heritable cancer syndromes in patients undergoing routine colonoscopy. J Med Genet 2021;58:807-14. [PMID: 33168571 DOI: 10.1136/jmedgenet-2020-107294] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 2.0] [Reference Citation Analysis]
|
| 45 |
Subramonian A, Smith D, Dicks E, Dawson L, Borgaonkar M, Etchegary H. Universal tumor screening for lynch syndrome: perspectives of patients regarding willingness and informed consent. Per Med 2020;17:373-87. [PMID: 32875945 DOI: 10.2217/pme-2020-0026] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
|
| 46 |
Baranova EE, Bodunova NA, Vorontsova МV, Zakharova GS, Makarova MV, Rumyantsev PO, Hat'kov IE. [Hereditary cancer syndromes: a modern paradigm]. Probl Endokrinol (Mosk) 2020;66:24-34. [PMID: 33351356 DOI: 10.14341/probl12366] [Reference Citation Analysis]
|
| 47 |
Aretz S, Steinke-lange V, Rädle J. Hereditäre Darmkrebssyndrome: Management und Surveillance-Strategien. Gastroenterologe 2020;15:259-272. [DOI: 10.1007/s11377-020-00449-4] [Cited by in Crossref: 2] [Article Influence: 0.7] [Reference Citation Analysis]
|
| 48 |
Pećina-Šlaus N, Kafka A, Salamon I, Bukovac A. Mismatch Repair Pathway, Genome Stability and Cancer. Front Mol Biosci 2020;7:122. [PMID: 32671096 DOI: 10.3389/fmolb.2020.00122] [Cited by in Crossref: 71] [Cited by in F6Publishing: 73] [Article Influence: 23.7] [Reference Citation Analysis]
|
| 49 |
Álvarez K, Orellana P, De la Fuente M, Canales T, Pinto E, Heine C, Solar B, Hurtado C, Møller P, Kronberg U, Zarate AJ, Dominguez-Valentin M, López-Köstner F. Spectrum and Frequency of Tumors, Cancer Risk and Survival in Chilean Families with Lynch Syndrome: Experience of the Implementation of a Registry. J Clin Med 2020;9:E1861. [PMID: 32549215 DOI: 10.3390/jcm9061861] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
|
| 50 |
Luchini C, Bibeau F, Ligtenberg MJL, Singh N, Nottegar A, Bosse T, Miller R, Riaz N, Douillard JY, Andre F, Scarpa A. ESMO recommendations on microsatellite instability testing for immunotherapy in cancer, and its relationship with PD-1/PD-L1 expression and tumour mutational burden: a systematic review-based approach. Ann Oncol 2019;30:1232-43. [PMID: 31056702 DOI: 10.1093/annonc/mdz116] [Cited by in Crossref: 322] [Cited by in F6Publishing: 351] [Article Influence: 107.3] [Reference Citation Analysis]
|
| 51 |
Bucksch K, Zachariae S, Aretz S, Büttner R, Holinski-Feder E, Holzapfel S, Hüneburg R, Kloor M, von Knebel Doeberitz M, Morak M, Möslein G, Nattermann J, Perne C, Rahner N, Schmiegel W, Schulmann K, Steinke-Lange V, Strassburg CP, Vangala DB, Weitz J, Loeffler M, Engel C; German Consortium for Familial Intestinal Cancer. Cancer risks in Lynch syndrome, Lynch-like syndrome, and familial colorectal cancer type X: a prospective cohort study. BMC Cancer 2020;20:460. [PMID: 32448342 DOI: 10.1186/s12885-020-06926-x] [Cited by in Crossref: 19] [Cited by in F6Publishing: 20] [Article Influence: 6.3] [Reference Citation Analysis]
|
| 52 |
Damilakis E, Mavroudis D, Sfakianaki M, Souglakos J. Immunotherapy in Metastatic Colorectal Cancer: Could the Latest Developments Hold the Key to Improving Patient Survival? Cancers (Basel) 2020;12:E889. [PMID: 32268531 DOI: 10.3390/cancers12040889] [Cited by in Crossref: 13] [Cited by in F6Publishing: 13] [Article Influence: 4.3] [Reference Citation Analysis]
|
| 53 |
Segev L, Kalady MF, Plesec T, Mor E, Schtrechman G, Nissan A, Church JM. The location of premalignant colorectal polyps under age 50: a further rationale for screening sigmoidoscopy. Int J Colorectal Dis 2020;35:529-35. [PMID: 31930456 DOI: 10.1007/s00384-020-03504-2] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 1.7] [Reference Citation Analysis]
|
| 54 |
Wu S, Liu X, Wang J, Zhou W, Guan M, Liu Y, Pang J, Lu T, Zhou L, Shi X, Wu H, Liang Z, Zeng X. DNA Mismatch Repair Deficiency Detection in Colorectal Cancer by a New Microsatellite Instability Analysis System. Interdiscip Sci 2020;12:145-54. [PMID: 31983041 DOI: 10.1007/s12539-020-00358-8] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 1.7] [Reference Citation Analysis]
|
| 55 |
Tamura K. Molecular Mechanism of Lynch Syndrome. Lynch Syndrome 2020. [DOI: 10.1007/978-981-15-6891-6_1] [Reference Citation Analysis]
|
| 56 |
Miyabe I, Tanaka K, Akagi K. Genetic Analysis for Lynch Syndrome. Lynch Syndrome 2020. [DOI: 10.1007/978-981-15-6891-6_5] [Reference Citation Analysis]
|
| 57 |
Yamaguchi T. Screening for Lynch Syndrome. Lynch Syndrome 2020. [DOI: 10.1007/978-981-15-6891-6_8] [Reference Citation Analysis]
|
| 58 |
Harada S, Morlote D. Molecular Pathology of Colorectal Cancer. Adv Anat Pathol 2020;27:20-6. [PMID: 31503031 DOI: 10.1097/PAP.0000000000000247] [Cited by in Crossref: 43] [Cited by in F6Publishing: 44] [Article Influence: 14.3] [Reference Citation Analysis]
|
| 59 |
Rädle J. Hereditäre Tumorerkrankungen – Diagnostik und Überwachungsstrategien. Prävention gastroenterologischer Tumorerkrankungen 2020. [DOI: 10.1007/978-3-662-58879-6_9] [Reference Citation Analysis]
|
| 60 |
Arora N. Hereditary Endometrial Cancers. Recent Advances in Endometrial Cancer 2020. [DOI: 10.1007/978-981-15-5317-2_4] [Reference Citation Analysis]
|
| 61 |
Walsh MF, Cadoo K, Salo-mullen EE, Dubard-gault M, Stadler ZK, Offit K. Genetic Factors. Abeloff's Clinical Oncology 2020. [DOI: 10.1016/b978-0-323-47674-4.00013-x] [Cited by in Crossref: 2] [Article Influence: 0.7] [Reference Citation Analysis]
|
| 62 |
Mittendorf KF, Hunter JE, Schneider JL, Shuster E, Rope AF, Zepp J, Gilmore MJ, Muessig KR, Davis JV, Kauffman TL, Bergen KM, Wiesner GL, Acheson LS, Peterson SK, Syngal S, Reiss JA, Goddard KAB. Recommended care and care adherence following a diagnosis of Lynch syndrome: a mixed-methods study. Hered Cancer Clin Pract 2019;17:31. [PMID: 31890059 DOI: 10.1186/s13053-019-0130-8] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 1.8] [Reference Citation Analysis]
|
| 63 |
Muller C, Matthews L, Kupfer SS, Weiss JM. Effective Identification of Lynch Syndrome in Gastroenterology Practice. Curr Treat Options Gastroenterol 2019;17:666-80. [PMID: 31677041 DOI: 10.1007/s11938-019-00261-2] [Cited by in Crossref: 5] [Cited by in F6Publishing: 6] [Article Influence: 1.3] [Reference Citation Analysis]
|
| 64 |
Santos MD, Silva C, Oliveira J, Brandão P, Sampaio M, Silva AC, Rocha A, Matos E, Marcos-pinto R. Extensive colectomy in colorectal cancer and hereditary nonpolyposis colorectal cancer – long-term results. Journal of Coloproctology 2019;39:223-230. [DOI: 10.1016/j.jcol.2019.04.005] [Reference Citation Analysis]
|
| 65 |
Alyabsi M, Alhumaid A, Allah-Bakhsh H, Alkelya M, Aziz MA. Colorectal cancer in Saudi Arabia as the proof-of-principle model for implementing strategies of predictive, preventive, and personalized medicine in healthcare. EPMA J 2020;11:119-31. [PMID: 32140189 DOI: 10.1007/s13167-019-00186-x] [Cited by in Crossref: 14] [Cited by in F6Publishing: 17] [Article Influence: 3.5] [Reference Citation Analysis]
|
| 66 |
Chao X, Li L, Wu M, Ma S, Tan X, Zhong S, Bi Y, Lang J. Comparison of screening strategies for Lynch syndrome in patients with newly diagnosed endometrial cancer: a prospective cohort study in China. Cancer Commun (Lond). 2019;39:42. [PMID: 31307542 DOI: 10.1186/s40880-019-0388-2] [Cited by in Crossref: 15] [Cited by in F6Publishing: 15] [Article Influence: 3.8] [Reference Citation Analysis]
|
| 67 |
Xavier A, Olsen MF, Lavik LA, Johansen J, Singh AK, Sjursen W, Scott RJ, Talseth-Palmer BA. Comprehensive mismatch repair gene panel identifies variants in patients with Lynch-like syndrome. Mol Genet Genomic Med 2019;7:e850. [PMID: 31297992 DOI: 10.1002/mgg3.850] [Cited by in Crossref: 17] [Cited by in F6Publishing: 19] [Article Influence: 4.3] [Reference Citation Analysis]
|
| 68 |
Tamura K, Kaneda M, Futagawa M, Takeshita M, Kim S, Nakama M, Kawashita N, Tatsumi-Miyajima J. Genetic and genomic basis of the mismatch repair system involved in Lynch syndrome. Int J Clin Oncol 2019;24:999-1011. [PMID: 31273487 DOI: 10.1007/s10147-019-01494-y] [Cited by in Crossref: 31] [Cited by in F6Publishing: 30] [Article Influence: 7.8] [Reference Citation Analysis]
|
| 69 |
Kamal Y, Schmit SL, Hoehn HJ, Amos CI, Frost HR. Transcriptomic Differences between Primary Colorectal Adenocarcinomas and Distant Metastases Reveal Metastatic Colorectal Cancer Subtypes. Cancer Res 2019;79:4227-41. [PMID: 31239274 DOI: 10.1158/0008-5472.CAN-18-3945] [Cited by in Crossref: 29] [Cited by in F6Publishing: 33] [Article Influence: 7.3] [Reference Citation Analysis]
|
| 70 |
Corti G, Bartolini A, Crisafulli G, Novara L, Rospo G, Montone M, Negrino C, Mussolin B, Buscarino M, Isella C, Barault L, Siravegna G, Siena S, Marsoni S, Di Nicolantonio F, Medico E, Bardelli A. A Genomic Analysis Workflow for Colorectal Cancer Precision Oncology. Clinical Colorectal Cancer 2019;18:91-101.e3. [DOI: 10.1016/j.clcc.2019.02.008] [Cited by in Crossref: 18] [Cited by in F6Publishing: 13] [Article Influence: 4.5] [Reference Citation Analysis]
|
| 71 |
Dicks E, Pullman D, Kao K, MacMillan A, Logan GS, Simmonds C, Etchegary H. Universal tumor screening for Lynch syndrome: Perceptions of Canadian pathologists and genetic counselors of barriers and facilitators. Cancer Med 2019;8:3614-22. [PMID: 31102338 DOI: 10.1002/cam4.2182] [Cited by in Crossref: 7] [Cited by in F6Publishing: 8] [Article Influence: 1.8] [Reference Citation Analysis]
|
| 72 |
Ramdzan AR, Abd Rahim MA, Mohamad Zaki A, Zaidun Z, Mohammed Nawi A. Diagnostic Accuracy of FOBT and Colorectal Cancer Genetic Testing: A Systematic Review & Meta-Analysis. Ann Glob Health 2019;85:70. [PMID: 31099505 DOI: 10.5334/aogh.2466] [Cited by in Crossref: 9] [Cited by in F6Publishing: 11] [Article Influence: 2.3] [Reference Citation Analysis]
|
| 73 |
Kamarádová K, Vošmiková H, Rozkošová K, Ryška A, Tachecí I, Laco J. Morphological, immunohistochemical and molecular features of inflammatory bowel disease associated colorectal carcinoma and associated mucosal lesions - Single institution experience. Pathol Res Pract 2019;215:730-7. [PMID: 30679085 DOI: 10.1016/j.prp.2019.01.010] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 1.8] [Reference Citation Analysis]
|
| 74 |
González ML, Causada-Calo N, Santino JP, Dominguez-Valentin M, Ferro FA, Sammartino I, Kalfayan PG, Verzura MA, Piñero TA, Cajal AR, Pavicic W, Vaccaro C. Universal determination of microsatellite instability using BAT26 as a single marker in an Argentine colorectal cancer cohort. Fam Cancer 2018;17:395-402. [PMID: 29128931 DOI: 10.1007/s10689-017-0052-4] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 1.0] [Reference Citation Analysis]
|
| 75 |
Yurgelun MB, Kastrinos F. Tumor Testing for Microsatellite Instability to Identify Lynch Syndrome: New Insights Into an Old Diagnostic Strategy. J Clin Oncol 2019;37:263-5. [PMID: 30550362 DOI: 10.1200/JCO.18.01664] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 1.0] [Reference Citation Analysis]
|
| 76 |
Snyder C, Hampel H. Hereditary Colorectal Cancer Syndromes.Semin Oncol Nurs. 2019;35:58-78. [PMID: 30665732 DOI: 10.1016/j.soncn.2018.12.011] [Cited by in Crossref: 8] [Cited by in F6Publishing: 9] [Article Influence: 2.0] [Reference Citation Analysis]
|
| 77 |
Chen W, Frankel WL. A practical guide to biomarkers for the evaluation of colorectal cancer. Mod Pathol 2019;32:1-15. [PMID: 30600322 DOI: 10.1038/s41379-018-0136-1] [Cited by in Crossref: 32] [Cited by in F6Publishing: 33] [Article Influence: 8.0] [Reference Citation Analysis]
|
| 78 |
McCarthy AJ, Capo-Chichi JM, Spence T, Grenier S, Stockley T, Kamel-Reid S, Serra S, Sabatini P, Chetty R. Heterogenous loss of mismatch repair (MMR) protein expression: a challenge for immunohistochemical interpretation and microsatellite instability (MSI) evaluation. J Pathol Clin Res 2019;5:115-29. [PMID: 30387329 DOI: 10.1002/cjp2.120] [Cited by in Crossref: 49] [Cited by in F6Publishing: 52] [Article Influence: 9.8] [Reference Citation Analysis]
|
| 79 |
Yurgelun MB, Hampel H. Recent Advances in Lynch Syndrome: Diagnosis, Treatment, and Cancer Prevention. Am Soc Clin Oncol Educ Book 2018;38:101-9. [PMID: 30231390 DOI: 10.1200/EDBK_208341] [Cited by in Crossref: 47] [Cited by in F6Publishing: 49] [Article Influence: 9.4] [Reference Citation Analysis]
|
| 80 |
Dicks E, Pullman D, Kao K, MacMillan A, Simmonds C, Etchegary H. Universal tumor screening for Lynch syndrome: perspectives of Canadian pathologists and genetic counselors. J Community Genet 2019;10:335-44. [PMID: 30465127 DOI: 10.1007/s12687-018-0398-9] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 1.6] [Reference Citation Analysis]
|
| 81 |
Cha JM, La Selva D, Kozarek RA, Gluck M, Ross A, Lin OS. Young patients with sporadic colorectal adenomas: current endoscopic surveillance practices and outcomes. Gastrointest Endosc 2018;88:818-825.e1. [PMID: 29908175 DOI: 10.1016/j.gie.2018.06.012] [Cited by in Crossref: 10] [Cited by in F6Publishing: 9] [Article Influence: 2.0] [Reference Citation Analysis]
|
| 82 |
Karimi M, von Salomé J, Aravidis C, Silander G, Askmalm MS, Henriksson I, Gebre-Medhin S, Frödin JE, Björck E, Lagerstedt-Robinson K, Lindblom A, Tham E. A retrospective study of extracolonic, non-endometrial cancer in Swedish Lynch syndrome families. Hered Cancer Clin Pract 2018;16:16. [PMID: 30386444 DOI: 10.1186/s13053-018-0098-9] [Cited by in Crossref: 10] [Cited by in F6Publishing: 10] [Article Influence: 2.0] [Reference Citation Analysis]
|
| 83 |
Nouri Nojadeh J, Hashemzadeh S, Samadi Kafil H, Behrouz Sharif S, Eftekharsadat A, Ghasemnejad T, Ghojazadeh M, Sakhinia E. Evaluation of microsatellite instability in tumor and tumor marginal samples of sporadic colorectal cancer using mononucleotide markers. EXCLI J 2018;17:945-51. [PMID: 30564073 DOI: 10.17179/excli2018-1455] [Cited by in F6Publishing: 2] [Reference Citation Analysis]
|
| 84 |
Chan GHJ, Ong PY, Low JJH, Kong HL, Ow SGW, Tan DSP, Lim YW, Lim SE, Lee SC. Clinical genetic testing outcome with multi-gene panel in Asian patients with multiple primary cancers. Oncotarget 2018;9:30649-60. [PMID: 30093976 DOI: 10.18632/oncotarget.25769] [Cited by in Crossref: 11] [Cited by in F6Publishing: 13] [Article Influence: 2.2] [Reference Citation Analysis]
|
| 85 |
Bebington B, Singh E, Fabian J, Jan Kruger C, Prodehl L, Surridge D, Penny C, McNamara L, Ruff P. Design and methodology of a study on colorectal cancer in Johannesburg, South Africa. JGH Open 2018;2:139-43. [PMID: 30483579 DOI: 10.1002/jgh3.12061] [Cited by in Crossref: 8] [Cited by in F6Publishing: 9] [Article Influence: 1.6] [Reference Citation Analysis]
|
| 86 |
Smith S, Marino I, Schaller J, Arnell C, Moyes K, Manley S. Optimization of quality assurance to increase clinical utility and cost effectiveness of hereditary cancer testing. Per Med 2017;14:213-20. [PMID: 29767585 DOI: 10.2217/pme-2016-0091] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.2] [Reference Citation Analysis]
|
| 87 |
Leicher LW, Lammertink MHA, Offerman SR, Morreau H, de Jong MM, de Groot JWB, van Westreenen HL, Vasen HFA, de Vos Tot Nederveen Cappel WH. Consequences of testing for mismatch repair deficiency of colorectal cancer in clinical practice. Scand J Gastroenterol 2018;53:632-6. [PMID: 29161904 DOI: 10.1080/00365521.2017.1406534] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 1.2] [Reference Citation Analysis]
|
| 88 |
Köger N, Paulsen L, López-Kostner F, Della Valle A, Vaccaro CA, Palmero EI, Alvarez K, Sarroca C, Neffa F, Kalfayan PG, Gonzalez ML, Rossi BM, Reis RM, Brieger A, Zeuzem S, Hinrichsen I, Dominguez-Valentin M, Plotz G. Evaluation of MLH1 variants of unclear significance. Genes Chromosomes Cancer 2018;57:350-8. [PMID: 29520894 DOI: 10.1002/gcc.22536] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 1.8] [Reference Citation Analysis]
|
| 89 |
Blount J, Prakash A. The changing landscape of Lynch syndrome due to PMS2 mutations. Clin Genet 2018;94:61-9. [PMID: 29286535 DOI: 10.1111/cge.13205] [Cited by in Crossref: 14] [Cited by in F6Publishing: 12] [Article Influence: 2.8] [Reference Citation Analysis]
|
| 90 |
Dominguez-Valentin M, Nakken S, Tubeuf H, Vodak D, Ekstrøm PO, Nissen AM, Morak M, Holinski-Feder E, Martins A, Møller P, Hovig E. Identification of genetic variants for clinical management of familial colorectal tumors. BMC Med Genet 2018;19:26. [PMID: 29458332 DOI: 10.1186/s12881-018-0533-9] [Cited by in Crossref: 13] [Cited by in F6Publishing: 13] [Article Influence: 2.6] [Reference Citation Analysis]
|
| 91 |
Hunter JE, Arnold KA, Cook JE, Zepp J, Gilmore MJ, Rope AF, Davis JV, Bergen KM, Esterberg E, Muessig KR, Peterson SK, Syngal S, Acheson L, Wiesner G, Reiss J, Goddard KAB. Universal screening for Lynch syndrome among patients with colorectal cancer: patient perspectives on screening and sharing results with at-risk relatives. Fam Cancer 2017;16:377-87. [PMID: 28176204 DOI: 10.1007/s10689-017-9972-2] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 1.8] [Reference Citation Analysis]
|
| 92 |
Zorcolo L, Fantola G, Balestrino L, Restivo A, Vivanet C, Spina F, Cabras F, Ambu R, Casula G. MUTYH-associated colon disease: Adenomatous polyposis is only one of the possible phenotypes. A family report and literature review. Tumori 2011;97:676-80. [DOI: 10.1177/030089161109700523] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 1.2] [Reference Citation Analysis]
|
| 93 |
Zheng J, Huang B, Nie X, Zhu Y, Han N, Li Y. The clinicopathological features and prognosis of tumor MSI in East Asian colorectal cancer patients using NCI panel. Future Oncol. 2018;14:1355-1364. [PMID: 29366338 DOI: 10.2217/fon-2017-0662] [Cited by in Crossref: 7] [Cited by in F6Publishing: 8] [Article Influence: 1.4] [Reference Citation Analysis]
|
| 94 |
Nojadeh JN, Behrouz Sharif S, Sakhinia E. Microsatellite instability in colorectal cancer. EXCLI J 2018;17:159-68. [PMID: 29743854 DOI: 10.17179/excli2017-948] [Cited by in F6Publishing: 59] [Reference Citation Analysis]
|
| 95 |
Kastrinos F, Idos G, Parmigiani G. Prediction Models for Lynch Syndrome. Hereditary Colorectal Cancer 2018. [DOI: 10.1007/978-3-319-74259-5_19] [Cited by in Crossref: 1] [Article Influence: 0.2] [Reference Citation Analysis]
|
| 96 |
Stoffel EM, Yurgelun MB, Boland CR. Lynch Syndrome. Hereditary Colorectal Cancer 2018. [DOI: 10.1007/978-3-319-74259-5_1] [Reference Citation Analysis]
|
| 97 |
Mutch DG, Babb SA, Di Saia PJ. Genes and Cancer. Clinical Gynecologic Oncology 2018. [DOI: 10.1016/b978-0-323-40067-1.00019-x] [Reference Citation Analysis]
|
| 98 |
Alvarez K, Alvarez C, Domínguez M, Carvallo P. Screening for Hereditary Cancer in Latin America. Genomic Medicine in Emerging Economies 2018. [DOI: 10.1016/b978-0-12-811531-2.00003-5] [Cited by in Crossref: 1] [Article Influence: 0.2] [Reference Citation Analysis]
|
| 99 |
Okur V, Chung WK. The impact of hereditary cancer gene panels on clinical care and lessons learned. Cold Spring Harb Mol Case Stud 2017;3:a002154. [PMID: 29162654 DOI: 10.1101/mcs.a002154] [Cited by in Crossref: 30] [Cited by in F6Publishing: 31] [Article Influence: 5.0] [Reference Citation Analysis]
|
| 100 |
Caso R, Beamer M, Lofthus AD, Sosin M. Integrating surgery and genetic testing for the modern surgeon. Ann Transl Med 2017;5:399. [PMID: 29152499 DOI: 10.21037/atm.2017.06.50] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 1.0] [Reference Citation Analysis]
|
| 101 |
Bruegl AS, Kernberg A, Broaddus RR. Importance of PCR-based Tumor Testing in the Evaluation of Lynch Syndrome-associated Endometrial Cancer. Adv Anat Pathol 2017;24:372-8. [PMID: 28820751 DOI: 10.1097/PAP.0000000000000169] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 1.5] [Reference Citation Analysis]
|
| 102 |
Siraj AK, Masoodi T, Bu R, Parvathareddy SK, Al-badawi IA, Al-sanea N, Ashari LH, Abduljabbar A, Alhomoud S, Al-sobhi SS, Tulbah A, Ajarim D, Alzoman K, Aljuboury M, Yousef HB, Al-dawish M, Al-dayel F, Alkuraya FS, Al-kuraya KS. Expanding the spectrum of germline variants in cancer. Hum Genet 2017;136:1431-44. [DOI: 10.1007/s00439-017-1845-0] [Cited by in Crossref: 16] [Cited by in F6Publishing: 16] [Article Influence: 2.7] [Reference Citation Analysis]
|
| 103 |
Ziada-Bouchaar H, Sifi K, Filali T, Hammada T, Satta D, Abadi N. First description of mutational analysis of MLH1, MSH2 and MSH6 in Algerian families with suspected Lynch syndrome. Fam Cancer 2017;16:57-66. [PMID: 27468915 DOI: 10.1007/s10689-016-9917-1] [Cited by in Crossref: 7] [Cited by in F6Publishing: 6] [Article Influence: 1.2] [Reference Citation Analysis]
|
| 104 |
Tabatabaiefar MA, Moridnia A. Gastrointestinal Cancers. In: Mehdipour P, editor. Cancer Genetics and Psychotherapy. Cham: Springer International Publishing; 2017. pp. 589-625. [DOI: 10.1007/978-3-319-64550-6_12] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.2] [Reference Citation Analysis]
|
| 105 |
Rossi BM, Palmero EI, López-Kostner F, Sarroca C, Vaccaro CA, Spirandelli F, Ashton-Prolla P, Rodriguez Y, de Campos Reis Galvão H, Reis RM, Escremim de Paula A, Capochin Romagnolo LG, Alvarez K, Della Valle A, Neffa F, Kalfayan PG, Spirandelli E, Chialina S, Gutiérrez Angulo M, Castro-Mujica MDC, Sanchez de Monte J, Quispe R, da Silva SD, Rossi NT, Barletta-Carrillo C, Revollo S, Taborga X, Morillas LL, Tubeuf H, Monteiro-Santos EM, Piñero TA, Dominguez-Barrera C, Wernhoff P, Martins A, Hovig E, Møller P, Dominguez-Valentin M. A survey of the clinicopathological and molecular characteristics of patients with suspected Lynch syndrome in Latin America. BMC Cancer 2017;17:623. [PMID: 28874130 DOI: 10.1186/s12885-017-3599-4] [Cited by in Crossref: 25] [Cited by in F6Publishing: 26] [Article Influence: 4.2] [Reference Citation Analysis]
|
| 106 |
Bianchi F, Maccaroni E, Belvederesi L, Brugiati C, Giampieri R, Bini F, Bracci R, Pagliaretta S, Del Prete M, Piva F, Mandolesi A, Scarpelli M, Berardi R. A germline missense mutation in exon 3 of the MSH2 gene in a Lynch syndrome family: correlation with phenotype and localization assay. Fam Cancer 2018;17:215-24. [PMID: 28785832 DOI: 10.1007/s10689-017-0030-x] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.2] [Reference Citation Analysis]
|
| 107 |
Vasen HF, Velthuizen ME, Kleibeuker JH, Menko FH, Nagengast FM, Cats A, van der Meulen-de Jong AE, Breuning MH, Roukema AJ, van Leeuwen-Cornelisse I, de Vos Tot Nederveen Cappel WH, Wijnen JT. Hereditary cancer registries improve the care of patients with a genetic predisposition to cancer: contributions from the Dutch Lynch syndrome registry. Fam Cancer 2016;15:429-35. [PMID: 26973060 DOI: 10.1007/s10689-016-9897-1] [Cited by in Crossref: 19] [Cited by in F6Publishing: 19] [Article Influence: 3.2] [Reference Citation Analysis]
|
| 108 |
Hampel H. Genetic counseling and cascade genetic testing in Lynch syndrome. Fam Cancer 2016;15:423-7. [PMID: 26969309 DOI: 10.1007/s10689-016-9893-5] [Cited by in Crossref: 67] [Cited by in F6Publishing: 68] [Article Influence: 11.2] [Reference Citation Analysis]
|
| 109 |
Nallamilli BRR, Hegde M. Genetic Testing for Hereditary Nonpolyposis Colorectal Cancer (HNPCC). Curr Protoc Hum Genet 2017;94:10.12.1-10.12.23. [PMID: 28696559 DOI: 10.1002/cphg.40] [Cited by in Crossref: 3] [Cited by in F6Publishing: 5] [Article Influence: 0.5] [Reference Citation Analysis]
|
| 110 |
Ricker C. DE LAS FAMILIAS CON SÍNDROMES A LOS GENES. LAS PRIMERAS CARACTERIZACIONES CLÍNICAS Y GENÉTICAS DE DOS SÍNDROMES HEREDITARIOS CON PREDISPOSICIÓN AL CÁNCER: ¿CUÁL FUE EL COMIENZO? Revista Médica Clínica Las Condes 2017;28:491-499. [DOI: 10.1016/j.rmclc.2017.07.004] [Reference Citation Analysis]
|
| 111 |
Ricker C. FROM FAMILIES SYNDROMES TO GENES… THE FIRST CLINICAL AND GENETIC CHARACTERIZATIONS OF HEREDITARY SYNDROMES PREDISPOSING TO CANCER: WHAT WAS THE BEGINNING? Revista Médica Clínica Las Condes 2017;28:482-490. [DOI: 10.1016/j.rmclc.2017.06.011] [Reference Citation Analysis]
|
| 112 |
Lynch PM. HISTORY OF HEREDITARY NONPOLYPOSIS COLORECTAL CANCER OR “LYNCH SYNDROME”. Revista Médica Clínica Las Condes 2017;28:500-11. [DOI: 10.1016/j.rmclc.2017.07.005] [Cited by in Crossref: 1] [Article Influence: 0.2] [Reference Citation Analysis]
|
| 113 |
Lynch PM. HISTORIA DEL CÁNCER COLORRECTAL HEREDITARIO NO POLIPÓSICO (HNPCC). Revista Médica Clínica Las Condes 2017;28:512-523. [DOI: 10.1016/j.rmclc.2017.07.006] [Reference Citation Analysis]
|
| 114 |
Ricker CN, Hanna DL, Peng C, Nguyen NT, Stern MC, Schmit SL, Idos GE, Patel R, Tsai S, Ramirez V, Lin S, Shamasunadara V, Barzi A, Lenz HJ, Figueiredo JC. DNA mismatch repair deficiency and hereditary syndromes in Latino patients with colorectal cancer. Cancer 2017;123:3732-43. [PMID: 28640387 DOI: 10.1002/cncr.30790] [Cited by in Crossref: 13] [Cited by in F6Publishing: 15] [Article Influence: 2.2] [Reference Citation Analysis]
|
| 115 |
Ryan E, Sheahan K, Creavin B, Mohan HM, Winter DC. The current value of determining the mismatch repair status of colorectal cancer: A rationale for routine testing. Crit Rev Oncol Hematol. 2017;116:38-57. [PMID: 28693799 DOI: 10.1016/j.critrevonc.2017.05.006] [Cited by in Crossref: 72] [Cited by in F6Publishing: 78] [Article Influence: 12.0] [Reference Citation Analysis]
|
| 116 |
O'Kane GM, Ryan É, McVeigh TP, Creavin B, Hyland JM, O'Donoghue DP, Keegan D, Geraghty R, Flannery D, Nolan C, Donovan E, Mehigan BJ, McCormick P, Muldoon C, Farrell M, Shields C, Mulligan N, Kennedy MJ, Green AJ, Winter DC, MacMathuna P, Sheahan K, Gallagher DJ. Screening for mismatch repair deficiency in colorectal cancer: data from three academic medical centers. Cancer Med 2017;6:1465-72. [PMID: 28470797 DOI: 10.1002/cam4.1025] [Cited by in Crossref: 24] [Cited by in F6Publishing: 25] [Article Influence: 4.0] [Reference Citation Analysis]
|
| 117 |
Sunga AY, Ricker C, Espenschied CR, Castillo D, Melas M, Herzog J, Bannon S, Cruz-correa M, Lynch P, Solomon I, Gruber SB, Weitzel JN. Spectrum of mismatch repair gene mutations and clinical presentation of Hispanic individuals with Lynch syndrome. Cancer Genetics 2017;212-213:1-7. [DOI: 10.1016/j.cancergen.2017.01.003] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 0.7] [Reference Citation Analysis]
|
| 118 |
Chen W, Swanson BJ, Frankel WL. Molecular genetics of microsatellite-unstable colorectal cancer for pathologists. Diagn Pathol 2017;12:24. [PMID: 28259170 DOI: 10.1186/s13000-017-0613-8] [Cited by in Crossref: 58] [Cited by in F6Publishing: 68] [Article Influence: 9.7] [Reference Citation Analysis]
|
| 119 |
Herzig DO, Buie WD, Weiser MR, You YN, Rafferty JF, Feingold D, Steele SR. Clinical Practice Guidelines for the Surgical Treatment of Patients With Lynch Syndrome. Dis Colon Rectum 2017;60:137-43. [PMID: 28059909 DOI: 10.1097/DCR.0000000000000785] [Cited by in Crossref: 43] [Cited by in F6Publishing: 42] [Article Influence: 7.2] [Reference Citation Analysis]
|
| 120 |
Kinsella T, Leonard KL. MLH1. Cancer Therapeutic Targets 2017. [DOI: 10.1007/978-1-4419-0717-2_8] [Reference Citation Analysis]
|
| 121 |
Lindberg LJ, Ladelund S, Frederiksen BL, Smith-Hansen L, Bernstein I. Outcome of 24 years national surveillance in different hereditary colorectal cancer subgroups leading to more individualised surveillance. J Med Genet 2017;54:297-304. [PMID: 28039328 DOI: 10.1136/jmedgenet-2016-104284] [Cited by in Crossref: 13] [Cited by in F6Publishing: 13] [Article Influence: 1.9] [Reference Citation Analysis]
|
| 122 |
Parikh AR, Keating NL, Liu PH, Gray SW, Klabunde CN, Kahn KL, Haggstrom DA, Syngal S, Kim B. Oncologists' Selection of Genetic and Molecular Testing in the Evolving Landscape of Stage II Colorectal Cancer. J Oncol Pract 2016;12:e308-19, 259-60. [PMID: 26962170 DOI: 10.1200/JOP.2015.007062] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 0.3] [Reference Citation Analysis]
|
| 123 |
Dominguez-Valentin M, Wernhoff P, Cajal AR, Kalfayan PG, Piñero TA, Gonzalez ML, Ferro A, Sammartino I, Causada Calo NS, Vaccaro CA. MLH1 Ile219Val Polymorphism in Argentinean Families with Suspected Lynch Syndrome. Front Oncol 2016;6:189. [PMID: 27606285 DOI: 10.3389/fonc.2016.00189] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 0.6] [Reference Citation Analysis]
|
| 124 |
Kast K, Dobberschütz C, Sadowski CE, Pistorius S, Wimberger P. Prevalence of Lynch syndrome in unselected patients with endometrial or ovarian cancer. Arch Gynecol Obstet 2016;294:1299-303. [PMID: 27535758 DOI: 10.1007/s00404-016-4180-0] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 0.6] [Reference Citation Analysis]
|
| 125 |
Randall LM, Pothuri B. The genetic prediction of risk for gynecologic cancers. Gynecol Oncol 2016;141:10-6. [PMID: 27016223 DOI: 10.1016/j.ygyno.2016.03.007] [Cited by in Crossref: 36] [Cited by in F6Publishing: 36] [Article Influence: 5.1] [Reference Citation Analysis]
|
| 126 |
de Rosa N, Rodriguez-Bigas MA, Chang GJ, Veerapong J, Borras E, Krishnan S, Bednarski B, Messick CA, Skibber JM, Feig BW. DNA Mismatch Repair Deficiency in Rectal Cancer: Benchmarking Its Impact on Prognosis, Neoadjuvant Response Prediction, and Clinical Cancer Genetics. J Clin Oncol. 2016;34:3039-3046. [PMID: 27432916 DOI: 10.1200/JCO.2016.66.6826] [Cited by in Crossref: 62] [Cited by in F6Publishing: 64] [Article Influence: 8.9] [Reference Citation Analysis]
|
| 127 |
Rashid MU, Naeemi H, Muhammad N, Loya A, Yusuf MA, Lubiński J, Jakubowska A, Hamann U. A novel deleterious c.2656G>T MSH2 germline mutation in a Pakistani family with a phenotypic overlap of hereditary breast and ovarian cancer and Lynch syndrome. Hered Cancer Clin Pract 2016;14:14. [PMID: 27413415 DOI: 10.1186/s13053-016-0056-3] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 0.7] [Reference Citation Analysis]
|
| 128 |
Schell MJ, Yang M, Teer JK, Lo FY, Madan A, Coppola D, Monteiro AN, Nebozhyn MV, Yue B, Loboda A, Bien-Willner GA, Greenawalt DM, Yeatman TJ. A multigene mutation classification of 468 colorectal cancers reveals a prognostic role for APC. Nat Commun 2016;7:11743. [PMID: 27302369 DOI: 10.1038/ncomms11743] [Cited by in Crossref: 124] [Cited by in F6Publishing: 129] [Article Influence: 17.7] [Reference Citation Analysis]
|
| 129 |
Bonfanti M, Gambino M, Pisani S, Carnevali I, Pinotti G, Croce D, Capella C, Sessa F, Tibiletti M. A cost analysis of inherited colorectal cancer care in Varese Province. Journal of Cancer Policy 2016;8:1-6. [DOI: 10.1016/j.jcpo.2016.03.006] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.3] [Reference Citation Analysis]
|
| 130 |
Rosa I, Fidalgo P, Filipe B, Albuquerque C, Fonseca R, Chaves P, Pereira AD. Sporadic colorectal cancer: Studying ways to an end. United European Gastroenterol J 2016;4:288-96. [PMID: 27087959 DOI: 10.1177/2050640615599329] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
|
| 131 |
Atta IS, AlQahtani FN. Thyroid, Renal, and Breast Carcinomas, Chondrosarcoma, Colon Adenomas, and Ganglioneuroma: A New Cancer Syndrome, FAP, or Just Coincidence. Case Rep Med 2016;2016:2928084. [PMID: 27087812 DOI: 10.1155/2016/2928084] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
|
| 132 |
Waldmann E, Ferlitsch M, Binder N, Sellner F, Karner J, Heinisch B, Klimpfinger M, Trauner M. Tumor and Patient Characteristics of Individuals with Mismatch Repair Deficient Colorectal Cancer. Digestion 2015;91:286-93. [PMID: 25924923 DOI: 10.1159/000381284] [Cited by in Crossref: 6] [Cited by in F6Publishing: 8] [Article Influence: 0.9] [Reference Citation Analysis]
|
| 133 |
Jung WB, Kim CW, Yoon YS, Park IJ, Lim SB, Yu CS, Kim JC. Observational Study: Familial Relevance and Oncological Significance of Revised Bethesda Guidelines in Colorectal Patients That Have Undergone Curative Resection. Medicine (Baltimore) 2016;95:e2723. [PMID: 26871811 DOI: 10.1097/MD.0000000000002723] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
|
| 134 |
Tezcan G, Tunca B, Ak S, Cecener G, Egeli U. Molecular approach to genetic and epigenetic pathogenesis of early-onset colorectal cancer. World J Gastrointest Oncol 2016; 8(1): 83-98 [PMID: 26798439 DOI: 10.4251/wjgo.v8.i1.83] [Cited by in CrossRef: 17] [Cited by in F6Publishing: 21] [Article Influence: 2.4] [Reference Citation Analysis]
|
| 135 |
Kalady MF, You YN. Molecular Basis of Colorectal Cancer and Overview of Inherited Colorectal Cancer Syndromes. The ASCRS Textbook of Colon and Rectal Surgery 2016. [DOI: 10.1007/978-3-319-25970-3_23] [Reference Citation Analysis]
|
| 136 |
Grenert JP. Hereditary Nonpolyposis Colorectal Cancer and Lynch Syndrome. Molecular Pathology in Clinical Practice 2016. [DOI: 10.1007/978-3-319-19674-9_24] [Reference Citation Analysis]
|
| 137 |
de Freitas IN, de Campos FG, Alves VA, Cavalcante JM, Carraro D, Coudry Rde A, Diniz MA, Nahas SC, Ribeiro U Jr. Proficiency of DNA repair genes and microsatellite instability in operated colorectal cancer patients with clinical suspicion of lynch syndrome. J Gastrointest Oncol 2015;6:628-37. [PMID: 26697194 DOI: 10.3978/j.issn.2078-6891.2015.089] [Cited by in F6Publishing: 3] [Reference Citation Analysis]
|
| 138 |
Kastrinos F, Ojha RP, Leenen C, Alvero C, Mercado RC, Balmaña J, Valenzuela I, Balaguer F, Green R, Lindor NM, Thibodeau SN, Newcomb P, Win AK, Jenkins M, Buchanan DD, Bertario L, Sala P, Hampel H, Syngal S, Steyerberg EW; Lynch Syndrome prediction model validation study group. Comparison of Prediction Models for Lynch Syndrome Among Individuals With Colorectal Cancer. J Natl Cancer Inst 2016;108:djv308. [PMID: 26582061 DOI: 10.1093/jnci/djv308] [Cited by in Crossref: 22] [Cited by in F6Publishing: 25] [Article Influence: 2.8] [Reference Citation Analysis]
|
| 139 |
Koehly LM, Morris BA, Skapinsky K, Goergen A, Ludden A. Evaluation of the Families SHARE workbook: an educational tool outlining disease risk and healthy guidelines to reduce risk of heart disease, diabetes, breast cancer and colorectal cancer. BMC Public Health 2015;15:1120. [PMID: 26566980 DOI: 10.1186/s12889-015-2483-x] [Cited by in Crossref: 25] [Cited by in F6Publishing: 28] [Article Influence: 3.1] [Reference Citation Analysis]
|
| 140 |
Carneiro da Silva F, Ferreira JR, Torrezan GT, Figueiredo MC, Santos ÉM, Nakagawa WT, Brianese RC, Petrolini de Oliveira L, Begnani MD, Aguiar-Junior S, Rossi BM, Ferreira Fde O, Carraro DM. Clinical and Molecular Characterization of Brazilian Patients Suspected to Have Lynch Syndrome. PLoS One 2015;10:e0139753. [PMID: 26437257 DOI: 10.1371/journal.pone.0139753] [Cited by in Crossref: 22] [Cited by in F6Publishing: 24] [Article Influence: 2.8] [Reference Citation Analysis]
|
| 141 |
Germini DE, Mader AM, Gomes LG, Teodoro TR, Franco MI, Waisberg J. Detection of DNA repair protein in colorectal cancer of patients up to 50 years old can increase the identification of Lynch syndrome? Tumour Biol 2016;37:2757-64. [PMID: 26408182 DOI: 10.1007/s13277-015-4108-5] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.4] [Reference Citation Analysis]
|
| 142 |
Stoffel EM. Colorectal Cancer in Young Individuals: Opportunities for Prevention. J Clin Oncol 2015;33:3525-7. [PMID: 26371141 DOI: 10.1200/JCO.2015.62.8446] [Cited by in Crossref: 5] [Cited by in F6Publishing: 6] [Article Influence: 0.6] [Reference Citation Analysis]
|
| 143 |
Richman S. Deficient mismatch repair: Read all about it (Review). Int J Oncol 2015;47:1189-202. [PMID: 26315971 DOI: 10.3892/ijo.2015.3119] [Cited by in Crossref: 117] [Cited by in F6Publishing: 124] [Article Influence: 14.6] [Reference Citation Analysis]
|
| 144 |
Stadler ZK. Diagnosis and management of DNA mismatch repair-deficient colorectal cancer. Hematol Oncol Clin North Am 2015;29:29-41. [PMID: 25475571 DOI: 10.1016/j.hoc.2014.09.008] [Cited by in Crossref: 14] [Cited by in F6Publishing: 12] [Article Influence: 1.8] [Reference Citation Analysis]
|
| 145 |
Jasperson K, Burt RW. The Genetics of Colorectal Cancer. Surg Oncol Clin N Am 2015;24:683-703. [PMID: 26363537 DOI: 10.1016/j.soc.2015.06.006] [Cited by in Crossref: 16] [Cited by in F6Publishing: 18] [Article Influence: 2.0] [Reference Citation Analysis]
|
| 146 |
Pelizzo MR, Pennelli G, Zane M, Galuppini F, Colletti PM, Merante Boschin I, Rubello D. Papillary thyroid carcinoma (PTC) in Lynch syndrome: Report of two cases and discussion on Lynch syndrome behaviour and genetics. Biomed Pharmacother 2015;74:9-16. [PMID: 26349957 DOI: 10.1016/j.biopha.2015.06.008] [Cited by in Crossref: 8] [Cited by in F6Publishing: 9] [Article Influence: 1.0] [Reference Citation Analysis]
|
| 147 |
Wong A, Ngeow J. Hereditary Syndromes Manifesting as Endometrial Carcinoma: How Can Pathological Features Aid Risk Assessment? Biomed Res Int 2015;2015:219012. [PMID: 26161390 DOI: 10.1155/2015/219012] [Cited by in Crossref: 11] [Cited by in F6Publishing: 14] [Article Influence: 1.4] [Reference Citation Analysis]
|
| 148 |
Shai A, Segev Y, Narod SA. Genetics of endometrial cancer. Fam Cancer 2014;13:499-505. [PMID: 24838932 DOI: 10.1007/s10689-014-9722-7] [Cited by in Crossref: 13] [Cited by in F6Publishing: 10] [Article Influence: 1.6] [Reference Citation Analysis]
|
| 149 |
Busambwa K, Verghse M, Cebert R, Dalrymple L, Allen J, Boateng J, Shackelfor L, Walker L. Lentils, Green and Yellow Split-Peas (Sprouted and Non-Sprouted) on Azoxymethane-Induced Colon Carcinogenesis. J of Pharmacology and Toxicology 2015;10:36-48. [DOI: 10.3923/jpt.2015.36.48] [Reference Citation Analysis]
|
| 150 |
Hunter JE, Zepp JM, Gilmore MJ, Davis JV, Esterberg EJ, Muessig KR, Peterson SK, Syngal S, Acheson LS, Wiesner GL, Reiss JA, Goddard KA. Universal tumor screening for Lynch syndrome: Assessment of the perspectives of patients with colorectal cancer regarding benefits and barriers. Cancer 2015;121:3281-9. [PMID: 26036338 DOI: 10.1002/cncr.29470] [Cited by in Crossref: 25] [Cited by in F6Publishing: 27] [Article Influence: 3.1] [Reference Citation Analysis]
|
| 151 |
Lynch HT, Drescher K, Knezetic J, Lanspa S. Genetics, biomarkers, hereditary cancer syndrome diagnosis, heterogeneity and treatment: a review. Curr Treat Options Oncol. 2014;15:429-442. [PMID: 24827900 DOI: 10.1007/s11864-014-0293-5] [Cited by in Crossref: 14] [Cited by in F6Publishing: 17] [Article Influence: 1.8] [Reference Citation Analysis]
|
| 152 |
Shin SH, Yu EJ, Lee YK, Song YS, Seong MW, Park SS. Characteristics of hereditary nonpolyposis colorectal cancer patients with double primary cancers in endometrium and colorectum. Obstet Gynecol Sci 2015;58:112-6. [PMID: 25798424 DOI: 10.5468/ogs.2015.58.2.112] [Cited by in Crossref: 5] [Cited by in F6Publishing: 7] [Article Influence: 0.6] [Reference Citation Analysis]
|
| 153 |
Agoston AT, Odze RD. Neoplastic diseases of the small and large intestines. Silverberg's Principles and Practice of Surgical Pathology and Cytopathology 2015. [DOI: 10.1017/9781139137201.028] [Reference Citation Analysis]
|
| 154 |
Lynch HT, Snyder CL, Shaw TG, Heinen CD, Hitchins MP. Milestones of Lynch syndrome: 1895-2015. Nat Rev Cancer 2015;15:181-94. [PMID: 25673086 DOI: 10.1038/nrc3878] [Cited by in Crossref: 495] [Cited by in F6Publishing: 498] [Article Influence: 61.9] [Reference Citation Analysis]
|
| 155 |
Samadder NJ, Jasperson K, Burt RW. Hereditary and common familial colorectal cancer: evidence for colorectal screening. Dig Dis Sci 2015;60:734-47. [PMID: 25501924 DOI: 10.1007/s10620-014-3465-z] [Cited by in Crossref: 31] [Cited by in F6Publishing: 36] [Article Influence: 3.9] [Reference Citation Analysis]
|
| 156 |
Patel SG, Lowery JT, Gatof D, Ahnen DJ. Practical opportunities to improve early detection and prevention of colorectal cancer (CRC) in members of high-risk families. Dig Dis Sci 2015;60:748-61. [PMID: 25698379 DOI: 10.1007/s10620-015-3567-2] [Cited by in Crossref: 13] [Cited by in F6Publishing: 12] [Article Influence: 1.6] [Reference Citation Analysis]
|
| 157 |
Yamamoto H, Imai K. Microsatellite instability: an update. Arch Toxicol. 2015;89:899-921. [PMID: 25701956 DOI: 10.1007/s00204-015-1474-0] [Cited by in Crossref: 119] [Cited by in F6Publishing: 107] [Article Influence: 14.9] [Reference Citation Analysis]
|
| 158 |
Vasen HF, Tomlinson I, Castells A. Clinical management of hereditary colorectal cancer syndromes. Nat Rev Gastroenterol Hepatol 2015;12:88-97. [PMID: 25582351 DOI: 10.1038/nrgastro.2014.229] [Cited by in Crossref: 71] [Cited by in F6Publishing: 73] [Article Influence: 8.9] [Reference Citation Analysis]
|
| 159 |
Ríos A, Rodríguez JM, Carbonel P, Parrilla P. Selection criteria for search for germ mutations in colorectal cancer hereditary nonpolyposis. Medicina Clínica (English Edition) 2015;144:185-186. [DOI: 10.1016/j.medcle.2015.05.027] [Reference Citation Analysis]
|
| 160 |
Ríos A, Rodríguez JM, Carbonel P, Parrilla P. Criterios de selección para la búsqueda de mutaciones germinales en el cáncer colorrectal hereditario no polipósico. Medicina Clínica 2015;144:185-186. [DOI: 10.1016/j.medcli.2014.09.006] [Reference Citation Analysis]
|
| 161 |
Frolova AI, Babb SA, Zantow E, Hagemann AR, Powell MA, Thaker PH, Gao F, Mutch DG. Impact of an immunohistochemistry-based universal screening protocol for Lynch syndrome in endometrial cancer on genetic counseling and testing. Gynecol Oncol 2015;137:7-13. [PMID: 25617771 DOI: 10.1016/j.ygyno.2015.01.535] [Cited by in Crossref: 33] [Cited by in F6Publishing: 36] [Article Influence: 4.1] [Reference Citation Analysis]
|
| 162 |
Trpkov K, Smith SC, Patel P, Amin MB. Upper Urinary Tract Urothelial Carcinoma Pathology. Upper Tract Urothelial Carcinoma 2015. [DOI: 10.1007/978-1-4939-1501-9_3] [Reference Citation Analysis]
|
| 163 |
Hubosky SG, Boman BM. Hereditary Upper Tract Urothelial Carcinoma: Lynch Syndrome, Hereditary Nonpolyposis Colorectal Cancer Syndrome (HNPCC). Upper Urinary Tract Urothelial Carcinoma 2015. [DOI: 10.1007/978-3-319-13869-5_9] [Reference Citation Analysis]
|
| 164 |
Kinsella T, Leonard KL. MLH1. Cancer Therapeutic Targets 2015. [DOI: 10.1007/978-1-4614-6613-0_8-4] [Reference Citation Analysis]
|
| 165 |
Prasad MA, Jung B. Microsatellite Instability and Intestinal Tumorigenesis. Intestinal Tumorigenesis 2015. [DOI: 10.1007/978-3-319-19986-3_2] [Reference Citation Analysis]
|
| 166 |
Cho EE, Gibbs JF, Rodriguez-bigas M, Rodriguez LM. Hereditary Colorectal Cancer and Polyposis Syndromes. Surgical Oncology 2015. [DOI: 10.1007/978-1-4939-1423-4_20] [Reference Citation Analysis]
|
| 167 |
Desouki MM, Fadare O. Gynecologic Tumors. Molecular Oncology Testing for Solid Tumors 2015. [DOI: 10.1007/978-3-319-16304-8_15] [Reference Citation Analysis]
|
| 168 |
Yan ZH, Cui LH, Wang XH, Li C, He X. Comparative study of mutations in SNP loci of K-RAS, hMLH1 and hMSH2 genes in neoplastic intestinal polyps and colorectal cancer. World J Gastroenterol 2014; 20(48): 18338-18345 [PMID: 25561800 DOI: 10.3748/wjg.v20.i48.18338] [Cited by in CrossRef: 4] [Cited by in F6Publishing: 5] [Article Influence: 0.4] [Reference Citation Analysis]
|
| 169 |
Kushnir VM, Nalbantoglu I, Watson R, Goodwin J, Safar E, Chokshi RV, Azar RR, Davidson NO. Advanced colorectal adenomas in patients under 45 years of age are mostly sporadic. Dig Dis Sci 2014;59:2757-64. [PMID: 24925148 DOI: 10.1007/s10620-014-3245-9] [Cited by in Crossref: 18] [Cited by in F6Publishing: 13] [Article Influence: 2.0] [Reference Citation Analysis]
|
| 170 |
Vilar E, Mork ME, Cuddy A, Borras E, Bannon SA, Taggart MW, Ying J, Broaddus RR, Luthra R, Rodriguez-Bigas MA, Lynch PM, You YQ. Role of microsatellite instability-low as a diagnostic biomarker of Lynch syndrome in colorectal cancer. Cancer Genet 2014;207:495-502. [PMID: 25432668 DOI: 10.1016/j.cancergen.2014.10.002] [Cited by in Crossref: 17] [Cited by in F6Publishing: 17] [Article Influence: 1.9] [Reference Citation Analysis]
|
| 171 |
Liu F, Yang L, Zhou X, Sheng W, Cai S, Liu L, Nan P, Xu Y. Clinicopathological and genetic features of Chinese hereditary nonpolyposis colorectal cancer (HNPCC). Med Oncol 2014;31:223. [PMID: 25216868 DOI: 10.1007/s12032-014-0223-1] [Cited by in Crossref: 12] [Cited by in F6Publishing: 15] [Article Influence: 1.3] [Reference Citation Analysis]
|
| 172 |
Sun Z, Yu X, Wang H, Zhang S, Zhao Z, Xu R. Clinical significance of mismatch repair gene expression in sporadic colorectal cancer. Exp Ther Med 2014;8:1416-22. [PMID: 25289032 DOI: 10.3892/etm.2014.1927] [Cited by in Crossref: 9] [Cited by in F6Publishing: 10] [Article Influence: 1.0] [Reference Citation Analysis]
|
| 173 |
Loizidou MA, Neophytou I, Papamichael D, Kountourakis P, Vassiliou V, Marcou Y, Kakouri E, Ioannidis G, Philippou C, Spanou E, Tanteles GA, Anastasiadou V, Hadjisavvas A, Kyriacou K. The mutational spectrum of Lynch syndrome in cyprus. PLoS One 2014;9:e105501. [PMID: 25133505 DOI: 10.1371/journal.pone.0105501] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 0.7] [Reference Citation Analysis]
|
| 174 |
Tanyi M, Olasz J, Tanyi JL, Tóth L, Antal-Szalmás P, Ress Z, Bubán T, Palatka K, András C, Urbancsek H, Garami Z, Csuka O, Damjanovich L. MLH1 and MSH2 mutation screening in HNPCC families of Hungary - Two new MMR gene mutations. Eur J Surg Oncol 2014;40:1445-52. [PMID: 25107687 DOI: 10.1016/j.ejso.2014.07.032] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 0.4] [Reference Citation Analysis]
|
| 175 |
Cohen SA, Leininger A. The genetic basis of Lynch syndrome and its implications for clinical practice and risk management. Appl Clin Genet. 2014;7:147-158. [PMID: 25161364 DOI: 10.2147/tacg.s51483] [Cited by in Crossref: 41] [Cited by in F6Publishing: 44] [Article Influence: 4.6] [Reference Citation Analysis]
|
| 176 |
Macaron C, Leach BH, Burke CA. Hereditary colorectal cancer syndromes and genetic testing. J Surg Oncol 2015;111:103-11. [PMID: 24975382 DOI: 10.1002/jso.23706] [Cited by in Crossref: 12] [Cited by in F6Publishing: 12] [Article Influence: 1.3] [Reference Citation Analysis]
|
| 177 |
Sehgal R, Sheahan K, O'Connell PR, Hanly AM, Martin ST, Winter DC. Lynch syndrome: an updated review. Genes (Basel) 2014;5:497-507. [PMID: 24978665 DOI: 10.3390/genes5030497] [Cited by in Crossref: 82] [Cited by in F6Publishing: 86] [Article Influence: 9.1] [Reference Citation Analysis]
|
| 178 |
Kastrinos F, Stoffel EM. History, genetics, and strategies for cancer prevention in Lynch syndrome. Clin Gastroenterol Hepatol 2014;12:715-27; quiz e41-3. [PMID: 23891921 DOI: 10.1016/j.cgh.2013.06.031] [Cited by in Crossref: 54] [Cited by in F6Publishing: 57] [Article Influence: 6.0] [Reference Citation Analysis]
|
| 179 |
Chew MH, Koh PK, Tan M, Lim KH, Carol L, Tang CL. Mismatch repair deficiency screening via immunohistochemical staining in young Asians with colorectal cancers. World J Surg 2013;37:2468-75. [PMID: 23887594 DOI: 10.1007/s00268-013-2134-2] [Cited by in Crossref: 9] [Cited by in F6Publishing: 10] [Article Influence: 1.0] [Reference Citation Analysis]
|
| 180 |
Kastrinos F, Balmaña J, Syngal S. Prediction models in Lynch syndrome. Fam Cancer 2013;12:217-28. [PMID: 23553450 DOI: 10.1007/s10689-013-9632-0] [Cited by in Crossref: 15] [Cited by in F6Publishing: 14] [Article Influence: 1.7] [Reference Citation Analysis]
|
| 181 |
Rodriguez-Bigas MA, Möeslein G. Surgical treatment of hereditary nonpolyposis colorectal cancer (HNPCC, Lynch syndrome). Fam Cancer. 2013;12:295-300. [PMID: 23508345 DOI: 10.1007/s10689-013-9626-y] [Cited by in Crossref: 12] [Cited by in F6Publishing: 14] [Article Influence: 1.3] [Reference Citation Analysis]
|
| 182 |
Steinke V, Holzapfel S, Loeffler M, Holinski-Feder E, Morak M, Schackert HK, Görgens H, Pox C, Royer-Pokora B, von Knebel-Doeberitz M. Evaluating the performance of clinical criteria for predicting mismatch repair gene mutations in Lynch syndrome: a comprehensive analysis of 3,671 families. Int J Cancer. 2014;135:69-77. [PMID: 24493211 DOI: 10.1002/ijc.28650] [Cited by in Crossref: 26] [Cited by in F6Publishing: 28] [Article Influence: 2.9] [Reference Citation Analysis]
|
| 183 |
Baiocchi GL, Portolani N, Vermi W, Baronchelli C, Gheza F, Zogno C, Scaglia A, Marchina E, Tiberio GA, Giulini SM. Lynch syndrome from a surgeon perspective: retrospective study of clinical impact of mismatch repair protein expression analysis in colorectal cancer patients less than 50 years old. BMC Surg. 2014;14:9. [PMID: 24533633 DOI: 10.1186/1471-2482-14-9] [Cited by in Crossref: 6] [Cited by in F6Publishing: 7] [Article Influence: 0.7] [Reference Citation Analysis]
|
| 184 |
Deb S, Fox SB. Molecular profiling in colorectal cancer: current state of play and future directions. Colorectal Cancer 2014;3:41-56. [DOI: 10.2217/crc.13.82] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
|
| 185 |
Rosner G, Strul H. Should Microsatellite Instability Be Tested in All Cases of Colorectal Cancer? Curr Colorectal Cancer Rep 2014;10:27-35. [DOI: 10.1007/s11888-013-0204-3] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
|
| 186 |
Ward PM, Dubeau L. Molecular testing in Gynecological Malignancies. Molecular Testing in Cancer 2014. [DOI: 10.1007/978-1-4899-8050-2_14] [Reference Citation Analysis]
|
| 187 |
Morgan M, Boyd J, Drapkin R, Seiden MV. Cancers Arising in the Ovary. Abeloff's Clinical Oncology 2014. [DOI: 10.1016/b978-1-4557-2865-7.00089-8] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
|
| 188 |
Schrader KA, Sharaf R, Alanee S, Offit K. Genetic Factors. Abeloff's Clinical Oncology 2014. [DOI: 10.1016/b978-1-4557-2865-7.00012-6] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.2] [Reference Citation Analysis]
|
| 189 |
Hodgson SV, Foulkes WD, Eng C, Maher ER. Gastrointestinal System. A Practical Guide to Human Cancer Genetics 2014. [DOI: 10.1007/978-1-4471-2375-0_5] [Reference Citation Analysis]
|
| 190 |
Dominguez-Valentin M, Nilbert M, Wernhoff P, López-Köstner F, Vaccaro C, Sarroca C, Palmero EI, Giraldo A, Ashton-Prolla P, Alvarez K, Ferro A, Neffa F, Caris J, Carraro DM, Rossi BM. Mutation spectrum in South American Lynch syndrome families. Hered Cancer Clin Pract 2013;11:18. [PMID: 24344984 DOI: 10.1186/1897-4287-11-18] [Cited by in Crossref: 25] [Cited by in F6Publishing: 25] [Article Influence: 2.5] [Reference Citation Analysis]
|
| 191 |
Pettman M. Verifying patient information in the colorectal family history clinic. Gastrointestinal Nursing 2013;11:37-42. [DOI: 10.12968/gasn.2013.11.10.37] [Reference Citation Analysis]
|
| 192 |
Bellizzi AM. Contributions of molecular analysis to the diagnosis and treatment of gastrointestinal neoplasms. Seminars in Diagnostic Pathology 2013;30:329-61. [DOI: 10.1053/j.semdp.2013.11.001] [Cited by in Crossref: 11] [Cited by in F6Publishing: 11] [Article Influence: 1.1] [Reference Citation Analysis]
|
| 193 |
Chen CW, Zhu Z, Dong J. Hereditary nonpolyposis colorectal cancer. Shijie Huaren Xiaohua Zazhi 2013; 21(28): 2963-2968 [DOI: 10.11569/wcjd.v21.i28.2963] [Reference Citation Analysis]
|
| 194 |
Masson AL, Talseth-Palmer BA, Evans TJ, Grice DM, Duesing K, Hannan GN, Scott RJ. Copy number variation in hereditary non-polyposis colorectal cancer. Genes (Basel) 2013;4:536-55. [PMID: 24705261 DOI: 10.3390/genes4040536] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 0.7] [Reference Citation Analysis]
|
| 195 |
Romero A, Garre P, Valentin O, Sanz J, Pérez-Segura P, Llovet P, Díaz-Rubio E, de la Hoya M, Caldés T. Frequency and variability of genomic rearrangements on MSH2 in Spanish Lynch Syndrome families. PLoS One 2013;8:e72195. [PMID: 24039744 DOI: 10.1371/journal.pone.0072195] [Cited by in Crossref: 6] [Cited by in F6Publishing: 7] [Article Influence: 0.6] [Reference Citation Analysis]
|
| 196 |
Schildberg CW, Croner R, Schellerer V, Haupt W, Schildberg FW, Schildberg M, Hohenberger W, Horbach T. Differences in the treatment of young gastric cancer patients: patients under 50 years have better 5-year survival than older patients. Adv Med Sci 2012;57:259-65. [PMID: 23314560 DOI: 10.2478/v10039-012-0052-4] [Cited by in Crossref: 11] [Cited by in F6Publishing: 13] [Article Influence: 1.1] [Reference Citation Analysis]
|
| 197 |
Goldberg Y, Kedar I, Kariiv R, Halpern N, Plesser M, Hubert A, Kaduri L, Sagi M, Lerer I, Abeliovich D, Hamburger T, Nissan A, Goldshmidt H, Solar I, Geva R, Strul H, Rosner G, Baris H, Levi Z, Peretz T. Lynch Syndrome in high risk Ashkenazi Jews in Israel. Familial Cancer 2014;13:65-73. [DOI: 10.1007/s10689-013-9675-2] [Cited by in Crossref: 12] [Cited by in F6Publishing: 12] [Article Influence: 1.2] [Reference Citation Analysis]
|
| 198 |
Duffy MJ, Lamerz R, Haglund C, Nicolini A, Kalousová M, Holubec L, Sturgeon C. Tumor markers in colorectal cancer, gastric cancer and gastrointestinal stromal cancers: European group on tumor markers 2014 guidelines update. Int J Cancer 2014;134:2513-22. [PMID: 23852704 DOI: 10.1002/ijc.28384] [Cited by in Crossref: 207] [Cited by in F6Publishing: 224] [Article Influence: 20.7] [Reference Citation Analysis]
|
| 199 |
Win AK, Macinnis RJ, Dowty JG, Jenkins MA. Criteria and prediction models for mismatch repair gene mutations: a review. J Med Genet 2013;50:785-93. [PMID: 23956446 DOI: 10.1136/jmedgenet-2013-101803] [Cited by in Crossref: 22] [Cited by in F6Publishing: 26] [Article Influence: 2.2] [Reference Citation Analysis]
|
| 200 |
Sourrouille I, Coulet F, Lefevre JH, Colas C, Eyries M, Svrcek M, Bardier-Dupas A, Parc Y, Soubrier F. Somatic mosaicism and double somatic hits can lead to MSI colorectal tumors. Fam Cancer. 2013;12:27-33. [PMID: 22987205 DOI: 10.1007/s10689-012-9568-9] [Cited by in Crossref: 101] [Cited by in F6Publishing: 103] [Article Influence: 10.1] [Reference Citation Analysis]
|
| 201 |
Kessels K, Fidder HH, de Groot NL, Letteboer TG, Timmer R, van Dalen T, Consten EC, Offerhaus GJ, Siersema PD. Adherence to microsatellite instability testing in young-onset colorectal cancer patients. Dis Colon Rectum 2013;56:825-33. [PMID: 23739188 DOI: 10.1097/DCR.0b013e31828b6617] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 0.4] [Reference Citation Analysis]
|
| 202 |
Mishra N, Hall J. Identification of patients at risk for hereditary colorectal cancer. Clin Colon Rectal Surg. 2012;25:67-82. [PMID: 23730221 DOI: 10.1055/s-0032-1313777] [Cited by in Crossref: 16] [Cited by in F6Publishing: 13] [Article Influence: 1.6] [Reference Citation Analysis]
|
| 203 |
Niendorf KB, Thomas BC. Genetic Counseling for Cancer: Technology Promises Better Screening for Hereditary Cancer Patients. Curr Genet Med Rep 2013;1:135-141. [DOI: 10.1007/s40142-013-0015-5] [Cited by in Crossref: 1] [Article Influence: 0.1] [Reference Citation Analysis]
|
| 204 |
Fu L, Sheng JQ, Li XO, Jin P, Mu H, Han M, Huang JS, Sun ZQ, Li AQ, Wu ZT. Mismatch repair gene mutation analysis and colonoscopy surveillance in Chinese Lynch syndrome families. Cell Oncol (Dordr). 2013;36:225-231. [PMID: 23640085 DOI: 10.1007/s13402-013-0130-z] [Cited by in Crossref: 11] [Cited by in F6Publishing: 7] [Article Influence: 1.1] [Reference Citation Analysis]
|
| 205 |
Oh JR, Kim DW, Lee HS, Lee HE, Lee SM, Jang JH, Kang SB, Ku JL, Jeong SY, Park JG. Microsatellite instability testing in Korean patients with colorectal cancer. Fam Cancer. 2012;11:459-466. [PMID: 22669410 DOI: 10.1007/s10689-012-9536-4] [Cited by in Crossref: 30] [Cited by in F6Publishing: 32] [Article Influence: 3.0] [Reference Citation Analysis]
|
| 206 |
Serrano M, Lage P, Belga S, Filipe B, Francisco I, Rodrigues P, Fonseca R, Chaves P, Claro I, Albuquerque C, Pereira AD. Bethesda criteria for microsatellite instability testing: impact on the detection of new cases of Lynch syndrome. Fam Cancer 2012;11:571-8. [PMID: 22776989 DOI: 10.1007/s10689-012-9550-6] [Cited by in Crossref: 9] [Cited by in F6Publishing: 13] [Article Influence: 0.9] [Reference Citation Analysis]
|
| 207 |
Tian XX, Zhu Z, Huang J, Ren JY, Wang Y, Zhang N, Chen MQ, Dong J. Serum microRNAs as promising novel biomarkers for hereditary nonpolyposis colorectal cancer. Shijie Huaren Xiaohua Zazhi 2013; 21(11): 1040-1045 [DOI: 10.11569/wcjd.v21.i11.1040] [Cited by in CrossRef: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
|
| 208 |
Lee SH, Ahn BK, Baek SU, Chang HK. BRAF mutation in multiple primary cancer with colorectal cancer and stomach cancer. Gastroenterol Rep (Oxf) 2013;1:70-4. [PMID: 24759670 DOI: 10.1093/gastro/got004] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 0.5] [Reference Citation Analysis]
|
| 209 |
Kessels K, de Groot NL, Fidder HH, Timmer R, Stolk MF, Offerhaus GJ, Siersema PD; Familial Colorectal Cancer Study Group Utrecht. Recording of family history is associated with colorectal cancer stage. Eur J Gastroenterol Hepatol 2013;25:482-7. [PMID: 23470269 DOI: 10.1097/MEG.0b013e32835c45a3] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 0.6] [Reference Citation Analysis]
|
| 210 |
Li X, Yao X, Wang Y, Hu F, Wang F, Jiang L, Liu Y, Wang D, Sun G, Zhao Y. MLH1 promoter methylation frequency in colorectal cancer patients and related clinicopathological and molecular features. PLoS One 2013;8:e59064. [PMID: 23555617 DOI: 10.1371/journal.pone.0059064] [Cited by in Crossref: 62] [Cited by in F6Publishing: 65] [Article Influence: 6.2] [Reference Citation Analysis]
|
| 211 |
Win AK, Lindor NM, Jenkins MA. Risk of breast cancer in Lynch syndrome: a systematic review. Breast Cancer Res 2013;15:R27. [PMID: 23510156 DOI: 10.1186/bcr3405] [Cited by in Crossref: 87] [Cited by in F6Publishing: 96] [Article Influence: 8.7] [Reference Citation Analysis]
|
| 212 |
Vilar E, Tabernero J. Molecular dissection of microsatellite instable colorectal cancer. Cancer Discov 2013;3:502-11. [PMID: 23454900 DOI: 10.1158/2159-8290.CD-12-0471] [Cited by in Crossref: 71] [Cited by in F6Publishing: 73] [Article Influence: 7.1] [Reference Citation Analysis]
|
| 213 |
Sturgeon D, McCutcheon T, Geiger TM, Muldoon RL, Herline AJ, Wise PE. Increasing Lynch syndrome identification through establishment of a hereditary colorectal cancer registry. Dis Colon Rectum 2013;56:308-14. [PMID: 23392144 DOI: 10.1097/DCR.0b013e31827edfff] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 0.5] [Reference Citation Analysis]
|
| 214 |
Zhang X, Li J. Era of universal testing of microsatellite instability in colorectal cancer. World J Gastrointest Oncol 2013; 5(2): 12-19 [PMID: 23556052 DOI: 10.4251/wjgo.v5.i2.12] [Cited by in CrossRef: 43] [Cited by in F6Publishing: 53] [Article Influence: 4.3] [Reference Citation Analysis]
|
| 215 |
Kastrinos F, Steyerberg EW, Balmaña J, Mercado R, Gallinger S, Haile R, Casey G, Hopper JL, LeMarchand L, Lindor NM, Newcomb PA, Thibodeau SN, Syngal S; Colon Cancer Family Registry. Comparison of the clinical prediction model PREMM(1,2,6) and molecular testing for the systematic identification of Lynch syndrome in colorectal cancer. Gut 2013;62:272-9. [PMID: 22345660 DOI: 10.1136/gutjnl-2011-301265] [Cited by in Crossref: 36] [Cited by in F6Publishing: 40] [Article Influence: 3.6] [Reference Citation Analysis]
|
| 216 |
Chun N, Ford JM. Genetic testing by cancer site: stomach. Cancer J. 2012;18:355-363. [PMID: 22846738 DOI: 10.1097/ppo.0b013e31826246dc] [Cited by in Crossref: 53] [Cited by in F6Publishing: 57] [Article Influence: 5.3] [Reference Citation Analysis]
|
| 217 |
Bettington M, Walker N, Clouston A, Brown I, Leggett B, Whitehall V. The serrated pathway to colorectal carcinoma: current concepts and challenges. Histopathology 2013;62:367-86. [DOI: 10.1111/his.12055] [Cited by in Crossref: 309] [Cited by in F6Publishing: 325] [Article Influence: 30.9] [Reference Citation Analysis]
|
| 218 |
Steinke V, Engel C, Büttner R, Schackert HK, Schmiegel WH, Propping P. Hereditary nonpolyposis colorectal cancer (HNPCC)/Lynch syndrome. Dtsch Arztebl Int 2013;110:32-8. [PMID: 23413378 DOI: 10.3238/arztebl.2013.0032] [Cited by in Crossref: 18] [Cited by in F6Publishing: 31] [Article Influence: 1.8] [Reference Citation Analysis]
|
| 219 |
Bruwer Z, Futter M, Ramesar R. A mobile colonoscopic unit for lynch syndrome: trends in surveillance uptake and patient experiences of screening in a developing country. J Genet Couns 2013;22:125-37. [PMID: 23299947 DOI: 10.1007/s10897-012-9523-9] [Cited by in Crossref: 7] [Cited by in F6Publishing: 8] [Article Influence: 0.7] [Reference Citation Analysis]
|
| 220 |
Corso G, Velho S. Gastric Cancer in Other Inherited Syndromes. Spotlight on Familial and Hereditary Gastric Cancer 2013. [DOI: 10.1007/978-94-007-6570-2_15] [Reference Citation Analysis]
|
| 221 |
Hudler P. Genetic Testing, an Optimal Strategy for Lynch Syndrome Identification. DNA Alterations in Lynch Syndrome 2013. [DOI: 10.1007/978-94-007-6597-9_4] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
|
| 222 |
Lynch HT, Lanspa SJ, Snyder CL, Shaw TG, Lynch PM. Historical Development of Lynch Syndrome. DNA Alterations in Lynch Syndrome 2013. [DOI: 10.1007/978-94-007-6597-9_1] [Reference Citation Analysis]
|
| 223 |
Landsbergen KM, Prins JB, Brunner HG, van Duijvendijk P, Nagengast FM, van Krieken JH, Ligtenberg M, Hoogerbrugge N. Psychological distress in newly diagnosed colorectal cancer patients following microsatellite instability testing for Lynch syndrome on the pathologist's initiative. Fam Cancer. 2012;11:259-267. [PMID: 22311584 DOI: 10.1007/s10689-012-9510-1] [Cited by in Crossref: 14] [Cited by in F6Publishing: 13] [Article Influence: 1.3] [Reference Citation Analysis]
|
| 224 |
Kast K, Neuhann TM, Görgens H, Becker K, Keller K, Klink B, Aust D, Distler W, Schröck E, Schackert HK. Germline truncating-mutations in BRCA1 and MSH6 in a patient with early onset endometrial cancer. BMC Cancer 2012;12:531. [PMID: 23164213 DOI: 10.1186/1471-2407-12-531] [Cited by in Crossref: 6] [Cited by in F6Publishing: 7] [Article Influence: 0.5] [Reference Citation Analysis]
|
| 225 |
Chen J, Pande M, Huang YJ, Wei C, Amos CI, Talseth-Palmer BA, Meldrum CJ, Chen WV, Gorlov IP, Lynch PM, Scott RJ, Frazier ML. Cell cycle-related genes as modifiers of age of onset of colorectal cancer in Lynch syndrome: a large-scale study in non-Hispanic white patients. Carcinogenesis 2013;34:299-306. [PMID: 23125224 DOI: 10.1093/carcin/bgs344] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 0.8] [Reference Citation Analysis]
|
| 226 |
Hiljadnikova-bajro M, Josifovski T, Panovski M, J. Dimovski A. Molecular profile of the Lynch Syndrome in the Republic of Macedonia. Maced Pharm Bull 2012;58:15-24. [DOI: 10.33320/maced.pharm.bull.2012.58.002] [Reference Citation Analysis]
|
| 227 |
Engel C, Loeffler M, Steinke V, Rahner N, Holinski-Feder E, Dietmaier W, Schackert HK, Goergens H, von Knebel Doeberitz M, Goecke TO. Risks of less common cancers in proven mutation carriers with lynch syndrome. J Clin Oncol. 2012;30:4409-4415. [PMID: 23091106 DOI: 10.1200/JCO.2012.43.2278] [Cited by in Crossref: 198] [Cited by in F6Publishing: 215] [Article Influence: 18.0] [Reference Citation Analysis]
|
| 228 |
Schneider R, Schneider C, Kloor M, Fürst A, Möslein G. Das Lynch-Syndrom: Klinische, pathologische und genetische Erkenntnisse. coloproctology 2012;34:329-40. [DOI: 10.1007/s00053-012-0309-1] [Reference Citation Analysis]
|
| 229 |
Jung SB, Lee HI, Oh HK, Shin IH, Jeon CH. Clinico-pathologic Parameters for Prediction of Microsatellite Instability in Colorectal Cancer. Cancer Res Treat. 2012;44:179-186. [PMID: 23091444 DOI: 10.4143/crt.2012.44.3.179] [Cited by in Crossref: 17] [Cited by in F6Publishing: 18] [Article Influence: 1.5] [Reference Citation Analysis]
|
| 230 |
Kamat N, Khidhir MA, Jaloudi M, Hussain S, Alashari MM, Al Qawasmeh KH, Rannug U. High incidence of microsatellite instability and loss of heterozygosity in three loci in breast cancer patients receiving chemotherapy: a prospective study. BMC Cancer 2012;12:373. [PMID: 22928966 DOI: 10.1186/1471-2407-12-373] [Cited by in Crossref: 10] [Cited by in F6Publishing: 10] [Article Influence: 0.9] [Reference Citation Analysis]
|
| 231 |
Bozzao C, Lastella P, Stella A. Anticipation in lynch syndrome: where we are where we go. Curr Genomics 2011;12:451-65. [PMID: 22547953 DOI: 10.2174/138920211797904070] [Cited by in Crossref: 19] [Cited by in F6Publishing: 19] [Article Influence: 1.7] [Reference Citation Analysis]
|
| 232 |
Krivokapić Z, Marković S, Antić J, Dimitrijević I, Bojić D, Svorcan P, Jojić N, Damjanović S. Clinical and pathological tools for identifying microsatellite instability in colorectal cancer. Croat Med J 2012;53:328-35. [PMID: 22911525 DOI: 10.3325/cmj.2012.53.328] [Reference Citation Analysis]
|
| 233 |
Kang KJ, Min BH, Ryu K, Kim KM, Kim ER, Kim JY, Chang DK, Kim JJ, Rhee JC, Kim YH. Clinical usefulness of microsatellite instability test in Korean young patients with high-risk features associated with adenoma. Clin Res Hepatol Gastroenterol 2012;36:378-83. [PMID: 22361441 DOI: 10.1016/j.clinre.2012.01.005] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 0.6] [Reference Citation Analysis]
|
| 234 |
Colas C, Coulet F, Svrcek M, Collura A, Fléjou JF, Duval A, Hamelin R. Lynch or not Lynch? Is that always a question? Adv Cancer Res 2012;113:121-66. [PMID: 22429854 DOI: 10.1016/B978-0-12-394280-7.00004-X] [Cited by in Crossref: 21] [Cited by in F6Publishing: 26] [Article Influence: 1.9] [Reference Citation Analysis]
|
| 235 |
Plaschke J, Preußler M, Ziegler A, Schackert HK. Aberrant protein expression and frequent allelic loss of MSH3 in colorectal cancer with low-level microsatellite instability. Int J Colorectal Dis 2012;27:911-9. [PMID: 22249440 DOI: 10.1007/s00384-011-1408-0] [Cited by in Crossref: 18] [Cited by in F6Publishing: 19] [Article Influence: 1.6] [Reference Citation Analysis]
|
| 236 |
Senter L. Genetic Testing by Cancer Site: Colon (Nonpolyposis Syndromes). The Cancer Journal 2012;18:334-7. [DOI: 10.1097/ppo.0b013e31826094b2] [Cited by in Crossref: 11] [Cited by in F6Publishing: 12] [Article Influence: 1.0] [Reference Citation Analysis]
|
| 237 |
Laukaitis CM, Erdman SH, Gerner EW. Chemoprevention in patients with genetic risk of colorectal cancers. Colorectal Cancer 2012;1:225-40. [PMID: 25221625 DOI: 10.2217/crc.12.22] [Cited by in Crossref: 6] [Cited by in F6Publishing: 8] [Article Influence: 0.5] [Reference Citation Analysis]
|
| 238 |
Fernandez-flores A. Considerations on the Performance of Immunohistochemistry for Mismatch Repair Gene Proteins in Cases of Sebaceous Neoplasms and Keratoacanthomas With Reference to Muir–Torre Syndrome. The American Journal of Dermatopathology 2012;34:416-22. [DOI: 10.1097/dad.0b013e3182226a28] [Cited by in Crossref: 14] [Cited by in F6Publishing: 14] [Article Influence: 1.3] [Reference Citation Analysis]
|
| 239 |
Pieper C, Kolankowska I, Jöckel K. Does a screening questionnaire for familial and hereditary colorectal cancer risk work in a health insurance population?: Evaluation of a screening questionnaire. European Journal of Cancer Care 2012;21:758-65. [DOI: 10.1111/j.1365-2354.2012.01358.x] [Cited by in Crossref: 11] [Cited by in F6Publishing: 12] [Article Influence: 1.0] [Reference Citation Analysis]
|
| 240 |
Shields BM, McDonald TJ, Ellard S, Campbell MJ, Hyde C, Hattersley AT. The development and validation of a clinical prediction model to determine the probability of MODY in patients with young-onset diabetes. Diabetologia 2012;55:1265-72. [PMID: 22218698 DOI: 10.1007/s00125-011-2418-8] [Cited by in Crossref: 192] [Cited by in F6Publishing: 128] [Article Influence: 17.5] [Reference Citation Analysis]
|
| 241 |
Aarnio M. Clinicopathological features and management of cancers in lynch syndrome. Patholog Res Int 2012;2012:350309. [PMID: 22619739 DOI: 10.1155/2012/350309] [Cited by in Crossref: 14] [Cited by in F6Publishing: 14] [Article Influence: 1.3] [Reference Citation Analysis]
|
| 242 |
Medeiros F, Lindor NM, Couch FJ, Highsmith WE Jr. The germline MLH1 K618A variant and susceptibility to Lynch syndrome-associated tumors. J Mol Diagn 2012;14:264-73. [PMID: 22426235 DOI: 10.1016/j.jmoldx.2012.01.006] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 0.6] [Reference Citation Analysis]
|
| 243 |
Valentin MD, da Silva FC, dos Santos EM, Lisboa BG, de Oliveira LP, Ferreira Fde O, Gomy I, Nakagawa WT, Aguiar Junior S, Redal M, Vaccaro C, Valle AD, Sarroca C, Carraro DM, Rossi BM. Characterization of germline mutations of MLH1 and MSH2 in unrelated south American suspected Lynch syndrome individuals. Fam Cancer 2011;10:641-7. [PMID: 21681552 DOI: 10.1007/s10689-011-9461-y] [Cited by in Crossref: 22] [Cited by in F6Publishing: 21] [Article Influence: 2.0] [Reference Citation Analysis]
|
| 244 |
Schneider R, Schneider C, Kloor M, Fürst A, Möslein G. Lynch syndrome: clinical, pathological, and genetic insights. Langenbecks Arch Surg 2012;397:513-25. [PMID: 22362054 DOI: 10.1007/s00423-012-0918-8] [Cited by in Crossref: 14] [Cited by in F6Publishing: 16] [Article Influence: 1.3] [Reference Citation Analysis]
|
| 245 |
Dreyer G. Screening for gynaecologic cancers in genetically predisposed women. Best Pract Res Clin Obstet Gynaecol 2012;26:267-82. [PMID: 22361688 DOI: 10.1016/j.bpobgyn.2011.11.002] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
|
| 246 |
Kastrinos F, Syngal S. Screening patients with colorectal cancer for Lynch syndrome: what are we waiting for? J Clin Oncol 2012;30:1024-7. [PMID: 22355054 DOI: 10.1200/JCO.2011.40.7171] [Cited by in Crossref: 26] [Cited by in F6Publishing: 30] [Article Influence: 2.4] [Reference Citation Analysis]
|
| 247 |
Monteiro Santos EM, Valentin MD, Carneiro F, de Oliveira LP, de Oliveira Ferreira F, Junior SA, Nakagawa WT, Gomy I, de Faria Ferraz VE, da Silva Junior WA, Carraro DM, Rossi BM. Predictive models for mutations in mismatch repair genes: implication for genetic counseling in developing countries. BMC Cancer 2012;12:64. [PMID: 22321913 DOI: 10.1186/1471-2407-12-64] [Cited by in Crossref: 9] [Cited by in F6Publishing: 11] [Article Influence: 0.8] [Reference Citation Analysis]
|
| 248 |
Friedrichs N, Kahl P, Aust D, Steinke V, Baretton G, Büttner R. Diagnostik hereditärer Tumorerkrankungen. Forum 2012;27:42-46. [DOI: 10.1007/s12312-011-0724-1] [Reference Citation Analysis]
|
| 249 |
van Lier MG, Leenen CH, Wagner A, Ramsoekh D, Dubbink HJ, van den Ouweland AM, Westenend PJ, de Graaf EJ, Wolters LM, Vrijland WW, Kuipers EJ, van Leerdam ME, Steyerberg EW, Dinjens WN; LIMO Study Group. Yield of routine molecular analyses in colorectal cancer patients ≤70 years to detect underlying Lynch syndrome. J Pathol 2012;226:764-74. [PMID: 22081473 DOI: 10.1002/path.3963] [Cited by in Crossref: 52] [Cited by in F6Publishing: 58] [Article Influence: 4.7] [Reference Citation Analysis]
|
| 250 |
Sereno M, Aguayo C, Guillén Ponce C, Gómez-Raposo C, Zambrana F, Gómez-López M, Casado E. Gastric tumours in hereditary cancer syndromes: clinical features, molecular biology and strategies for prevention. Clin Transl Oncol. 2011;13:599-610. [PMID: 21865131 DOI: 10.1007/s12094-011-0705-y] [Cited by in Crossref: 24] [Cited by in F6Publishing: 19] [Article Influence: 2.2] [Reference Citation Analysis]
|
| 251 |
Mutch DG, Di Saia PJ. Genes and Cancer. Clinical Gynecologic Oncology 2012. [DOI: 10.1016/b978-0-323-07419-3.00019-9] [Reference Citation Analysis]
|
| 252 |
Casey G. Genetics of Colon Cancer Susceptibility. Energy Balance and Gastrointestinal Cancer 2012. [DOI: 10.1007/978-1-4614-2367-6_2] [Reference Citation Analysis]
|
| 253 |
Hung IH, Carey JC. Presymptomatic Genetic Testing: Shifting the Emphasis from Reaction to Prevention. Molecular Genetics and Personalized Medicine 2012. [DOI: 10.1007/978-1-61779-530-5_6] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
|
| 254 |
Lieberman D. Colorectal Cancer Screening and Surveillance. Clinical Gastrointestinal Endoscopy 2012. [DOI: 10.1016/b978-1-4377-1529-3.00035-x] [Reference Citation Analysis]
|
| 255 |
Petersson F, Šíma R, Sperga M, Kazakov DV, Michal M, Hora M, Ferda J, Šulc M, Mičulka P, Haferník J, Rychnovský J, Hes O. Lymphocyte-rich Renal Cell Carcinoma: An Unusual Histomorphologic Manifestation of a Tumor That is not Part of Lynch Syndrome. Applied Immunohistochemistry & Molecular Morphology 2011;19:519-27. [DOI: 10.1097/pai.0b013e31821a931f] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.2] [Reference Citation Analysis]
|
| 256 |
Stupart DA, Goldberg PA, Baigrie RJ, Algar U, Ramesar R. Surgery for colonic cancer in HNPCC: total vs segmental colectomy. Colorectal Dis 2011;13:1395-9. [PMID: 20969713 DOI: 10.1111/j.1463-1318.2010.02467.x] [Cited by in Crossref: 24] [Cited by in F6Publishing: 26] [Article Influence: 2.0] [Reference Citation Analysis]
|
| 257 |
Heijink DM, de Vries EG, Koornstra JJ, Hospers GA, Hofstra RM, van Vugt MA, de Jong S, Kleibeuker JH. Perspectives for tailored chemoprevention and treatment of colorectal cancer in Lynch syndrome. Critical Reviews in Oncology/Hematology 2011;80:264-77. [DOI: 10.1016/j.critrevonc.2010.11.009] [Cited by in Crossref: 7] [Cited by in F6Publishing: 8] [Article Influence: 0.6] [Reference Citation Analysis]
|
| 258 |
Crépin M, Dieu MC, Lejeune S, Escande F, Boidin D, Porchet N, Morin G, Manouvrier S, Mathieu M, Buisine MP. Evidence of constitutional MLH1 epimutation associated to transgenerational inheritance of cancer susceptibility. Hum Mutat. 2012;33:180-188. [PMID: 21953887 DOI: 10.1002/humu.21617] [Cited by in Crossref: 38] [Cited by in F6Publishing: 41] [Article Influence: 3.2] [Reference Citation Analysis]
|
| 259 |
Buerki N, Gautier L, Kovac M, Marra G, Buser M, Mueller H, Heinimann K. Evidence for breast cancer as an integral part of Lynch syndrome. Genes Chromosomes Cancer. 2012;51:83-91. [PMID: 22034109 DOI: 10.1002/gcc.20935] [Cited by in Crossref: 45] [Cited by in F6Publishing: 51] [Article Influence: 3.8] [Reference Citation Analysis]
|
| 260 |
Corso G, Marrelli D, Roviello F. Familial gastric cancer: update for practice management. Fam Cancer 2011;10:391-6. [PMID: 21184285 DOI: 10.1007/s10689-010-9410-1] [Cited by in Crossref: 15] [Cited by in F6Publishing: 13] [Article Influence: 1.3] [Reference Citation Analysis]
|
| 261 |
Lastella P, Patruno M, Forte G, Montanaro A, Di Gregorio C, Sabbà C, Suppressa P, Piepoli A, Panza A, Andriulli A. Identification and surveillance of 19 Lynch syndrome families in southern Italy: report of six novel germline mutations and a common founder mutation. Fam Cancer. 2011;10:285-295. [PMID: 21286823 DOI: 10.1007/s10689-011-9419-0] [Cited by in Crossref: 9] [Cited by in F6Publishing: 10] [Article Influence: 0.8] [Reference Citation Analysis]
|
| 262 |
Shahmoradi S, Bidmeshkipour A, Salamian A, Emami MH, Kazemi Z, Salehi M. Two novel mutations in hMLH1 gene in Iranian hereditary non-polyposis colorectal cancer patients. Familial Cancer 2012;11:13-7. [DOI: 10.1007/s10689-011-9478-2] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 0.3] [Reference Citation Analysis]
|
| 263 |
Bessa X, Alenda C, Paya A, Álvarez C, Iglesias M, Seoane A, Dedeu JM, Abulí A, Ilzarbe L, Navarro G, Pellise M, Balaguer F, Castellvi-bel S, Llor X, Castells A, Jover R, Andreu M. Validation Microsatellite Path Score in a Population-Based Cohort of Patients With Colorectal Cancer. JCO 2011;29:3374-80. [DOI: 10.1200/jco.2010.34.3947] [Cited by in Crossref: 14] [Cited by in F6Publishing: 14] [Article Influence: 1.2] [Reference Citation Analysis]
|
| 264 |
Canard G, Lefevre JH, Colas C, Coulet F, Svrcek M, Lascols O, Hamelin R, Shields C, Duval A, Fléjou JF, Soubrier F, Tiret E, Parc Y. Screening for Lynch syndrome in colorectal cancer: are we doing enough? Ann Surg Oncol 2012;19:809-16. [PMID: 21879275 DOI: 10.1245/s10434-011-2014-7] [Cited by in Crossref: 41] [Cited by in F6Publishing: 45] [Article Influence: 3.4] [Reference Citation Analysis]
|
| 265 |
Tresallet C, Brouquet A, Julié C, Beauchet A, Vallot C, Ménégaux F, Mitry E, Radvanyi F, Malafosse R, Rougier P, Nordlinger B, Laurent-puig P, Boileau C, Emile J, Muti C, Penna C, Hofmann-radvanyi H. Evaluation of predictive models in daily practice for the identification of patients with Lynch syndrome. Int J Cancer 2012;130:1367-77. [DOI: 10.1002/ijc.26144] [Cited by in Crossref: 15] [Cited by in F6Publishing: 17] [Article Influence: 1.3] [Reference Citation Analysis]
|
| 266 |
Egoavil CM, Montenegro P, Soto JL, Casanova L, Sanchez-Lihon J, Castillejo MI, Martinez-Canto A, Perez-Carbonell L, Castillejo A, Guarinos C. Clinically important molecular features of Peruvian colorectal tumours: high prevalence of DNA mismatch repair deficiency and low incidence of KRAS mutations. Pathology. 2011;43:228-233. [PMID: 21436632 DOI: 10.1097/PAT.0b013e3283437613] [Cited by in Crossref: 12] [Cited by in F6Publishing: 12] [Article Influence: 1.0] [Reference Citation Analysis]
|
| 267 |
Gryfe R. Inherited colorectal cancer syndromes. Clin Colon Rectal Surg 2009;22:198-208. [PMID: 21037810 DOI: 10.1055/s-0029-1242459] [Cited by in Crossref: 36] [Cited by in F6Publishing: 21] [Article Influence: 3.0] [Reference Citation Analysis]
|
| 268 |
Ryan P, Mulligan AM, Aronson M, Ferguson SE, Bapat B, Semotiuk K, Holter S, Kwon J, Kalloger SE, Gilks CB, Gallinger S, Pollett A, Clarke BA. Comparison of clinical schemas and morphologic features in predicting Lynch syndrome in mutation-positive patients with endometrial cancer encountered in the context of familial gastrointestinal cancer registries. Cancer 2012;118:681-8. [DOI: 10.1002/cncr.26323] [Cited by in Crossref: 62] [Cited by in F6Publishing: 64] [Article Influence: 5.2] [Reference Citation Analysis]
|
| 269 |
Pino MS, Chung DC. Microsatellite instability in the management of colorectal cancer. Expert Rev Gastroenterol Hepatol 2011;5:385-99. [PMID: 21651356 DOI: 10.1586/egh.11.25] [Cited by in Crossref: 46] [Cited by in F6Publishing: 50] [Article Influence: 3.8] [Reference Citation Analysis]
|
| 270 |
Perea J, Rodríguez Y, Rueda D, Marín JC, Díaz-Tasende J, Álvaro E, Alegre C, Osorio I, Colina F, Lomas M. Early-onset colorectal cancer is an easy and effective tool to identify retrospectively Lynch syndrome. Ann Surg Oncol. 2011;18:3285-3291. [PMID: 21590452 DOI: 10.1245/s10434-011-1782-4] [Cited by in Crossref: 20] [Cited by in F6Publishing: 20] [Article Influence: 1.7] [Reference Citation Analysis]
|
| 271 |
Tie J, Gibbs P, Lipton L, Christie M, Jorissen RN, Burgess AW, Croxford M, Jones I, Langland R, Kosmider S, McKay D, Bollag G, Nolop K, Sieber OM, Desai J. Optimizing targeted therapeutic development: analysis of a colorectal cancer patient population with the BRAF(V600E) mutation. Int J Cancer. 2011;128:2075-2084. [PMID: 20635392 DOI: 10.1002/ijc.25555] [Cited by in Crossref: 160] [Cited by in F6Publishing: 179] [Article Influence: 13.3] [Reference Citation Analysis]
|
| 272 |
Moussa SA, Moussa A, Kourda N, Mezlini A, Abdelli N, Zerimech F, Najjar T, Jilani SB, Porchet N, Ayed FB, Manai M, Buisine MP. Lynch syndrome in Tunisia: first description of clinical features and germline mutations. Int J Colorectal Dis 2011;26:455-67. [PMID: 21311894 DOI: 10.1007/s00384-010-1129-9] [Cited by in Crossref: 9] [Cited by in F6Publishing: 10] [Article Influence: 0.8] [Reference Citation Analysis]
|
| 273 |
Nardon E, Glavač D, Benhattar J, Groenen PJ, Höfler G, Höfler H, Jung A, Keller G, Kirchner T, Lessi F, Ligtenberg MJ, Mazzanti CM, Winter G, Stanta G. A multicenter study to validate the reproducibility of MSI testing with a panel of 5 quasimonomorphic mononucleotide repeats. Diagn Mol Pathol 2010;19:236-42. [PMID: 21051996 DOI: 10.1097/PDM.0b013e3181db67af] [Cited by in Crossref: 26] [Cited by in F6Publishing: 30] [Article Influence: 2.2] [Reference Citation Analysis]
|
| 274 |
Chen WC, Lin SC, Lee JC. A novel nonsense mutation of MSH2 gene in a Taiwanese family with hereditary nonpolyposis colorectal cancer. Kaohsiung J Med Sci 2011;27:68-71. [PMID: 21354521 DOI: 10.1016/j.kjms.2010.05.002] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
|
| 275 |
Manders P, Spruijt L, Kets CM, Willems HW, Bodmer D, Hebeda KM, Nagtegaal ID, van Krieken JH, Ligtenberg MJ, Hoogerbrugge N. Young age and a positive family history of colorectal cancer are complementary selection criteria for the identification of Lynch syndrome. Eur J Cancer 2011;47:1407-13. [PMID: 21273057 DOI: 10.1016/j.ejca.2010.12.024] [Cited by in Crossref: 10] [Cited by in F6Publishing: 12] [Article Influence: 0.8] [Reference Citation Analysis]
|
| 276 |
Devlin LA, Morrison PJ. Inherited gynaecological cancer syndromes. The Obstetrician & Gynaecologist 2008;10:9-15. [DOI: 10.1576/toag.10.1.009.27371] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.3] [Reference Citation Analysis]
|
| 277 |
Gill S, Brown C, Miller R, Bathe O. Colon Cancer. Gastrointestinal Oncology 2011. [DOI: 10.1007/978-3-642-13306-0_12] [Reference Citation Analysis]
|
| 278 |
Kastrinos F, Steyerberg EW, Mercado R, Balmaña J, Holter S, Gallinger S, Siegmund KD, Church JM, Jenkins MA, Lindor NM, Thibodeau SN, Burbidge LA, Wenstrup RJ, Syngal S. The PREMM(1,2,6) model predicts risk of MLH1, MSH2, and MSH6 germline mutations based on cancer history. Gastroenterology 2011;140:73-81. [PMID: 20727894 DOI: 10.1053/j.gastro.2010.08.021] [Cited by in Crossref: 130] [Cited by in F6Publishing: 153] [Article Influence: 10.8] [Reference Citation Analysis]
|
| 279 |
Steinke V, Propping P. Lynch-Syndrom – deutsche Erfahrungen. Viszeralmedizin 2011;27:275-280. [DOI: 10.1159/000330596] [Reference Citation Analysis]
|
| 280 |
Buie WD, Maclean AR. Hereditary Nonpolyposis Colorectal Cancer. Inherited Cancer Syndromes 2011. [DOI: 10.1007/978-1-4419-6821-0_9] [Cited by in Crossref: 1] [Article Influence: 0.1] [Reference Citation Analysis]
|
| 281 |
Church J. Hereditary Colorectal Cancer. The ASCRS Textbook of Colon and Rectal Surgery 2011. [DOI: 10.1007/978-1-4419-1584-9_37] [Cited by in Crossref: 2] [Article Influence: 0.2] [Reference Citation Analysis]
|
| 282 |
Sawai K, Goi T, Nakazawa M, Iida A, Katayama K, Yamaguchi A. A Case of Quintuple Cancer of the Colon, Stomach, Bladder, Rectum and Gallbladder. JJCS 2011;36:840-845. [DOI: 10.4030/jjcs.36.840] [Reference Citation Analysis]
|
| 283 |
Hall JF, Read TE. Colorectal Cancer: Screening. The ASCRS Textbook of Colon and Rectal Surgery 2011. [DOI: 10.1007/978-1-4419-1584-9_39] [Reference Citation Analysis]
|
| 284 |
Mukherjee A, McGarrity TJ, Ruggiero F, Koltun W, McKenna K, Poritz L, Baker MJ. The revised Bethesda guidelines: extent of utilization in a university hospital medical center with a cancer genetics program. Hered Cancer Clin Pract 2010;8:9. [PMID: 21092199 DOI: 10.1186/1897-4287-8-9] [Cited by in Crossref: 10] [Cited by in F6Publishing: 11] [Article Influence: 0.8] [Reference Citation Analysis]
|
| 285 |
Pino MS, Chung DC. Application of molecular diagnostics for the detection of Lynch syndrome. Expert Rev Mol Diagn. 2010;10:651-665. [PMID: 20629513 DOI: 10.1586/erm.10.45] [Cited by in Crossref: 19] [Cited by in F6Publishing: 22] [Article Influence: 1.5] [Reference Citation Analysis]
|
| 286 |
Weissman SM, Bellcross C, Bittner CC, Freivogel ME, Haidle JL, Kaurah P, Leininger A, Palaniappan S, Steenblock K, Vu TM, Daniels MS. Genetic counseling considerations in the evaluation of families for Lynch syndrome--a review. J Genet Couns 2011;20:5-19. [PMID: 20931355 DOI: 10.1007/s10897-010-9325-x] [Cited by in Crossref: 45] [Cited by in F6Publishing: 39] [Article Influence: 3.5] [Reference Citation Analysis]
|
| 287 |
Ko CJ. Muir-Torre syndrome: Facts and controversies. Clin Dermatol 2010;28:324-9. [PMID: 20541687 DOI: 10.1016/j.clindermatol.2009.07.001] [Cited by in Crossref: 20] [Cited by in F6Publishing: 20] [Article Influence: 1.5] [Reference Citation Analysis]
|
| 288 |
Perera S, Li B, Tsitsikotas S, Ramyar L, Pollett A, Semotiuk K, Bapat B. A novel and rapid method of determining the effect of unclassified MLH1 genetic variants on differential allelic expression. J Mol Diagn 2010;12:757-64. [PMID: 20864636 DOI: 10.2353/jmoldx.2010.090240] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 0.6] [Reference Citation Analysis]
|
| 289 |
Albuquerque C, Baltazar C, Filipe B, Penha F, Pereira T, Smits R, Cravo M, Lage P, Fidalgo P, Claro I, Rodrigues P, Veiga I, Ramos JS, Fonseca I, Leitão CN, Fodde R. Colorectal cancers show distinct mutation spectra in members of the canonical WNT signaling pathway according to their anatomical location and type of genetic instability. Genes Chromosomes Cancer 2010;49:746-59. [PMID: 20544848 DOI: 10.1002/gcc.20786] [Cited by in Crossref: 46] [Cited by in F6Publishing: 49] [Article Influence: 3.5] [Reference Citation Analysis]
|
| 290 |
Bouzourene H, Hutter P, Losi L, Martin P, Benhattar J. Selection of patients with germline MLH1 mutated Lynch syndrome by determination of MLH1 methylation and BRAF mutation. Fam Cancer. 2010;9:167-172. [PMID: 19949877 DOI: 10.1007/s10689-009-9302-4] [Cited by in Crossref: 36] [Cited by in F6Publishing: 34] [Article Influence: 2.8] [Reference Citation Analysis]
|
| 291 |
Jasperson KW, Vu TM, Schwab AL, Neklason DW, Rodriguez-Bigas MA, Burt RW, Weitzel JN. Evaluating Lynch syndrome in very early onset colorectal cancer probands without apparent polyposis. Fam Cancer 2010;9:99-107. [PMID: 19731080 DOI: 10.1007/s10689-009-9290-4] [Cited by in Crossref: 15] [Cited by in F6Publishing: 17] [Article Influence: 1.2] [Reference Citation Analysis]
|
| 292 |
Goldberg Y, Porat RM, Kedar I, Shochat C, Galinsky D, Hamburger T, Hubert A, Strul H, Kariiv R, Ben-Avi L, Savion M, Pikarsky E, Abeliovich D, Bercovich D, Lerer I, Peretz T. An Ashkenazi founder mutation in the MSH6 gene leading to HNPCC. Fam Cancer 2010;9:141-50. [PMID: 19851887 DOI: 10.1007/s10689-009-9298-9] [Cited by in Crossref: 16] [Cited by in F6Publishing: 18] [Article Influence: 1.2] [Reference Citation Analysis]
|
| 293 |
Pérez Segura P, Guillén Ponce C, Ramón y Cajal T, Serrano Blanch R, Aranda E. TTD consensus document on the diagnosis and management of hereditary colorectal cancer. Clin Transl Oncol 2010;12:356-66. [PMID: 20466620 DOI: 10.1007/s12094-010-0517-5] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
|
| 294 |
Buchanan DD, Roberts A, Walsh MD, Parry S, Young JP. Lessons from Lynch syndrome: a tumor biology-based approach to familial colorectal cancer. Future Oncol 2010;6:539-49. [PMID: 20373868 DOI: 10.2217/fon.10.16] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 0.4] [Reference Citation Analysis]
|
| 295 |
Vadaparampil ST, Quinn G, Malo TL, Alvarez A, Miree CA, Shibata D. Knowledge about hereditary colorectal cancer among colorectal cancer survivors. Genet Test Mol Biomarkers 2010;14:603-9. [PMID: 20722496 DOI: 10.1089/gtmb.2010.0004] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 0.3] [Reference Citation Analysis]
|
| 296 |
Stoffel EM, Mercado RC, Kohlmann W, Ford B, Grover S, Conrad P, Blanco A, Shannon KM, Powell M, Chung DC, Terdiman J, Gruber SB, Syngal S. Prevalence and predictors of appropriate colorectal cancer surveillance in Lynch syndrome. Am J Gastroenterol 2010;105:1851-60. [PMID: 20354509 DOI: 10.1038/ajg.2010.120] [Cited by in Crossref: 53] [Cited by in F6Publishing: 53] [Article Influence: 4.1] [Reference Citation Analysis]
|
| 297 |
Balaz P, Plaschke J, Krüger S, Görgens H, Schackert HK. TCF-3, 4 protein expression correlates with beta-catenin expression in MSS and MSI-H colorectal cancer from HNPCC patients but not in sporadic colorectal cancers. Int J Colorectal Dis 2010;25:931-9. [PMID: 20532534 DOI: 10.1007/s00384-010-0959-9] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 0.4] [Reference Citation Analysis]
|
| 298 |
Sjursen W, Haukanes BI, Grindedal EM, Aarset H, Stormorken A, Engebretsen LF, Jonsrud C, Bjørnevoll I, Andresen PA, Ariansen S, Lavik LA, Gilde B, Bowitz-Lothe IM, Maehle L, Møller P. Current clinical criteria for Lynch syndrome are not sensitive enough to identify MSH6 mutation carriers. J Med Genet 2010;47:579-85. [PMID: 20587412 DOI: 10.1136/jmg.2010.077677] [Cited by in Crossref: 61] [Cited by in F6Publishing: 64] [Article Influence: 4.7] [Reference Citation Analysis]
|
| 299 |
Steinke V, Vogt S, Aretz S. Klinik und Genetik des familiären Darmkrebses. Medizinische Genetik 2010;22:265-81. [DOI: 10.1007/s11825-010-0226-z] [Cited by in Crossref: 5] [Cited by in F6Publishing: 2] [Article Influence: 0.4] [Reference Citation Analysis]
|
| 300 |
Singh H, Schiesser R, Anand G, Richardson PA, El-Serag HB. Underdiagnosis of Lynch syndrome involves more than family history criteria. Clin Gastroenterol Hepatol 2010;8:523-9. [PMID: 20303416 DOI: 10.1016/j.cgh.2010.03.010] [Cited by in Crossref: 52] [Cited by in F6Publishing: 55] [Article Influence: 4.0] [Reference Citation Analysis]
|
| 301 |
Jensen LH, Dysager L, Lindebjerg J, Kølvrå S, Byriel L, Crüger DG. Molecular biology from bench-to-bedside - which colorectal cancer patients should be referred for genetic counselling and risk assessment. Eur J Cancer 2010;46:1823-8. [PMID: 20417091 DOI: 10.1016/j.ejca.2010.03.016] [Cited by in Crossref: 11] [Cited by in F6Publishing: 7] [Article Influence: 0.8] [Reference Citation Analysis]
|
| 302 |
Overbeek LI, Hermens RP, van Krieken JH, Adang EM, Casparie M, Nagengast FM, Ligtenberg MJ, Hoogerbrugge N; MIPA study group. Electronic reminders for pathologists promote recognition of patients at risk for Lynch syndrome: cluster-randomised controlled trial. Virchows Arch 2010;456:653-9. [PMID: 20379742 DOI: 10.1007/s00428-010-0907-7] [Cited by in Crossref: 16] [Cited by in F6Publishing: 16] [Article Influence: 1.2] [Reference Citation Analysis]
|
| 303 |
Kuiper RP, Ligtenberg MJ, Hoogerbrugge N, Geurts van Kessel A. Germline copy number variation and cancer risk. Curr Opin Genet Dev. 2010;20:282-289. [PMID: 20381334 DOI: 10.1016/j.gde.2010.03.005] [Cited by in Crossref: 85] [Cited by in F6Publishing: 92] [Article Influence: 6.5] [Reference Citation Analysis]
|
| 304 |
Rabinowitz-Abrams D, Morgan D, Morse J, Miesfeldt S. Building a tool to identify risk for Lynch syndrome among individuals presenting for screening colonoscopy. J Genet Couns 2010;19:353-9. [PMID: 20349120 DOI: 10.1007/s10897-010-9295-z] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
|
| 305 |
Koh P, Chew M, Tan Y, Lim K, Loi C, Tang C, Eu K. Preliminary Results of Mismatch Repair Deficiency Screening via Immunohistochemical Staining in Young Asian Colorectal Cancers. Proceedings of Singapore Healthcare 2010;19:3-11. [DOI: 10.1177/201010581001900102] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.2] [Reference Citation Analysis]
|
| 306 |
Chua AC, Klopcic B, Lawrance IC, Olynyk JK, Trinder D. Iron: An emerging factor in colorectal carcinogenesis. World J Gastroenterol 2010; 16(6): 663-672 [PMID: 20135713 DOI: 10.3748/wjg.v16.i6.663] [Cited by in CrossRef: 55] [Cited by in F6Publishing: 57] [Article Influence: 4.2] [Reference Citation Analysis]
|
| 307 |
Manne SL, Meropol NJ, Weinberg DS, Vig H, Ali-Khan Catts Z, Manning C, Ross E, Shannon K, Chung DC. Facilitating informed decisions regarding microsatellite instability testing among high-risk individuals diagnosed with colorectal cancer. J Clin Oncol 2010;28:1366-72. [PMID: 20142594 DOI: 10.1200/JCO.2009.25.0399] [Cited by in Crossref: 31] [Cited by in F6Publishing: 35] [Article Influence: 2.4] [Reference Citation Analysis]
|
| 308 |
Engel C, Rahner N, Schulmann K, Holinski-Feder E, Goecke TO, Schackert HK, Kloor M, Steinke V, Vogelsang H, Möslein G, Görgens H, Dechant S, von Knebel Doeberitz M, Rüschoff J, Friedrichs N, Büttner R, Loeffler M, Propping P, Schmiegel W; German HNPCC Consortium. Efficacy of annual colonoscopic surveillance in individuals with hereditary nonpolyposis colorectal cancer. Clin Gastroenterol Hepatol 2010;8:174-82. [PMID: 19835992 DOI: 10.1016/j.cgh.2009.10.003] [Cited by in Crossref: 128] [Cited by in F6Publishing: 135] [Article Influence: 9.8] [Reference Citation Analysis]
|
| 309 |
Menéndez M, Castellví-bel S, Pineda M, De Cid R, Muñoz J, González S, Teulé À, Balaguer F, Ramón y Cajal T, Reñé JM, Blanco I, Castells A, Capellà G. Founder effect of a pathogenic MSH2 mutation identified in Spanish families with Lynch syndrome. Clinical Genetics 2010;78:186-90. [DOI: 10.1111/j.1399-0004.2009.01346.x] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 0.7] [Reference Citation Analysis]
|
| 310 |
Walsh CS, Blum A, Walts A, Alsabeh R, Tran H, Koeffler HP, Karlan BY. Lynch syndrome among gynecologic oncology patients meeting Bethesda guidelines for screening. Gynecol Oncol. 2010;116:516-521. [PMID: 20034658 DOI: 10.1016/j.ygyno.2009.11.021] [Cited by in Crossref: 44] [Cited by in F6Publishing: 51] [Article Influence: 3.4] [Reference Citation Analysis]
|
| 311 |
Bernabe RD, Zhao R, Cruz-correa MR. Genetic Approaches to Colorectal Cancer. Coloproctology 2010. [DOI: 10.1007/978-1-84882-756-1_1] [Reference Citation Analysis]
|
| 312 |
Vasen HFA, Hardwick JCH. An Overview of the Lynch Syndrome (Hereditary Non-polyposis Colorectal Cancer). Hereditary Colorectal Cancer 2010. [DOI: 10.1007/978-1-4419-6603-2_15] [Cited by in Crossref: 1] [Article Influence: 0.1] [Reference Citation Analysis]
|
| 313 |
Kim DH, Pickhardt PJ. Colorectal Cancer. CT Colonography: Principles and Practice of Virtual Colonoscopy 2010. [DOI: 10.1016/b978-1-4160-6168-7.00012-1] [Cited by in Crossref: 1] [Article Influence: 0.1] [Reference Citation Analysis]
|
| 314 |
Lynch HT, Hitchins MP, Shaw TG, Lynch JF, Roy H. Historical Aspects of Lynch Syndrome. Hereditary Colorectal Cancer 2010. [DOI: 10.1007/978-1-4419-6603-2_2] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.2] [Reference Citation Analysis]
|
| 315 |
Bresalier RS. Colorectal Cancer. Sleisenger and Fordtran's Gastrointestinal and Liver Disease 2010. [DOI: 10.1016/b978-1-4160-6189-2.00123-2] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.2] [Reference Citation Analysis]
|
| 316 |
Pal T, Wey JP, Sellers TA. Genetic Epidemiology of Mismatch Repair Deficiency in Ovarian Cancer. Environmental Factors, Genes, and the Development of Human Cancers 2010. [DOI: 10.1007/978-1-4419-6752-7_14] [Reference Citation Analysis]
|
| 317 |
Wiesner G, Slavin T, Barnholtz-sloan J. Colorectal Cancer. Essentials of Genomic and Personalized Medicine 2010. [DOI: 10.1016/b978-0-12-374934-5.00036-2] [Reference Citation Analysis]
|
| 318 |
Barrasa Shaw A, López-Guerrero JA, Calatrava Fons A, García-Casado Z, Alapont Olavarrieta V, Campos Máñez J, Vázquez Albaladejo C. Value of the identification of microsatellite instability in colorectal cancer. Clin Transl Oncol 2009;11:465-9. [PMID: 19574205 DOI: 10.1007/s12094-009-0386-y] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 0.3] [Reference Citation Analysis]
|
| 319 |
Lynch PM. The hMSH2 and hMLH1 genes in hereditary nonpolyposis colorectal cancer. Surg Oncol Clin N Am. 2009;18:611-624. [PMID: 19793569 DOI: 10.1016/j.soc.2009.08.002] [Cited by in Crossref: 16] [Cited by in F6Publishing: 16] [Article Influence: 1.1] [Reference Citation Analysis]
|
| 320 |
Hampel H. Genetic testing for hereditary colorectal cancer. Surg Oncol Clin N Am 2009;18:687-703. [PMID: 19793575 DOI: 10.1016/j.soc.2009.08.001] [Cited by in Crossref: 13] [Cited by in F6Publishing: 12] [Article Influence: 0.9] [Reference Citation Analysis]
|
| 321 |
Zavodna K, Krivulcik T, Bujalkova MG, Slamka T, Martinicky D, Ilencikova D, Bartosova Z. Partial loss of heterozygosity events at the mutated gene in tumors from MLH1/MSH2 large genomic rearrangement carriers. BMC Cancer 2009;9:405. [PMID: 19930554 DOI: 10.1186/1471-2407-9-405] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.2] [Reference Citation Analysis]
|
| 322 |
van Lier MG, Wagner A, van Leerdam ME, Biermann K, Kuipers EJ, Steyerberg EW, Dubbink HJ, Dinjens WN. A review on the molecular diagnostics of Lynch syndrome: a central role for the pathology laboratory. J Cell Mol Med 2010;14:181-97. [PMID: 19929944 DOI: 10.1111/j.1582-4934.2009.00977.x] [Cited by in Crossref: 53] [Cited by in F6Publishing: 57] [Article Influence: 3.8] [Reference Citation Analysis]
|
| 323 |
Pata G, Nascimbeni R, Di Lorenzo D, Gervasi M, Villanacci V, Salerni B. Hereditary multiple exostoses and juvenile colon carcinoma: A case with a common genetic background? J Surg Oncol 2009;100:520-2. [PMID: 19653241 DOI: 10.1002/jso.21365] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
|
| 324 |
Perera S, Ramyar L, Mitri A, Pollett A, Gallinger S, Speevak MD, Aronson M, Bapat B. A novel complex mutation in MSH2 contributes to both Muir-Torre and Lynch Syndrome. J Hum Genet 2010;55:37-41. [PMID: 19911012 DOI: 10.1038/jhg.2009.119] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 0.4] [Reference Citation Analysis]
|
| 325 |
Bellizzi AM, Frankel WL. Colorectal cancer due to deficiency in DNA mismatch repair function: a review. Adv Anat Pathol 2009;16:405-17. [PMID: 19851131 DOI: 10.1097/PAP.0b013e3181bb6bdc] [Cited by in Crossref: 98] [Cited by in F6Publishing: 106] [Article Influence: 7.0] [Reference Citation Analysis]
|
| 326 |
Hanson H, Hodgson S. Cancer genetics and reproduction. Best Pract Res Clin Obstet Gynaecol 2010;24:3-18. [PMID: 19864186 DOI: 10.1016/j.bpobgyn.2009.08.002] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.1] [Reference Citation Analysis]
|
| 327 |
Möckelmann N, von Schönfels W, Buch S, von Kampen O, Sipos B, Egberts JH, Rosenstiel P, Franke A, Brosch M, Hinz S. Investigation of innate immunity genes CARD4, CARD8 and CARD15 as germline susceptibility factors for colorectal cancer. BMC Gastroenterol. 2009;9:79. [PMID: 19843337 DOI: 10.1186/1471-230x-9-79] [Cited by in Crossref: 30] [Cited by in F6Publishing: 32] [Article Influence: 2.1] [Reference Citation Analysis]
|
| 328 |
Heinen CD. Genotype to phenotype: analyzing the effects of inherited mutations in colorectal cancer families. Mutat Res 2010;693:32-45. [PMID: 19766128 DOI: 10.1016/j.mrfmmm.2009.09.004] [Cited by in Crossref: 39] [Cited by in F6Publishing: 33] [Article Influence: 2.8] [Reference Citation Analysis]
|
| 329 |
Mueller J, Gazzoli I, Bandipalliam P, Garber JE, Syngal S, Kolodner RD. Comprehensive molecular analysis of mismatch repair gene defects in suspected Lynch syndrome (hereditary nonpolyposis colorectal cancer) cases. Cancer Res. 2009;69:7053-7061. [PMID: 19690142 DOI: 10.1158/0008-5472.can-09-0358] [Cited by in Crossref: 32] [Cited by in F6Publishing: 35] [Article Influence: 2.3] [Reference Citation Analysis]
|
| 330 |
Zighelboim I, Powell MA, Babb SA, Whelan AJ, Schmidt AP, Clendenning M, Senter L, Thibodeau SN, de la Chapelle A, Goodfellow PJ. Epitope-positive truncating MLH1 mutation and loss of PMS2: implications for IHC-directed genetic testing for Lynch syndrome. Fam Cancer 2009;8:501-4. [PMID: 19672700 DOI: 10.1007/s10689-009-9276-2] [Cited by in Crossref: 14] [Cited by in F6Publishing: 14] [Article Influence: 1.0] [Reference Citation Analysis]
|
| 331 |
Marafie MJ, Al-Awadi S, Al-Mosawi F, Elshafey A, Al-Ali W, Al-Mulla F. Impact of 226C>T MSH2 gene mutation on cancer phenotypes in two HNPCC-associated highly-consanguineous families from Kuwait: emphasis on premarital genetic testing. Fam Cancer 2009;8:289-98. [PMID: 19669601 DOI: 10.1007/s10689-009-9275-3] [Cited by in Crossref: 7] [Cited by in F6Publishing: 6] [Article Influence: 0.5] [Reference Citation Analysis]
|
| 332 |
Van Lier MG, De Wilt JH, Wagemakers JJ, Dinjens WN, Damhuis RA, Wagner A, Kuipers EJ, Van Leerdam ME. Underutilization of microsatellite instability analysis in colorectal cancer patients at high risk for Lynch syndrome. Scand J Gastroenterol 2009;44:600-4. [PMID: 19153873 DOI: 10.1080/00365520802706008] [Cited by in Crossref: 21] [Cited by in F6Publishing: 23] [Article Influence: 1.5] [Reference Citation Analysis]
|
| 333 |
Manchanda R, Menon U, Michaelson-Cohen R, Beller U, Jacobs I. Hereditary non-polyposis colorectal cancer or Lynch syndrome: the gynaecological perspective. Curr Opin Obstet Gynecol 2009;21:31-8. [PMID: 19125001 DOI: 10.1097/GCO.0b013e32831c844d] [Cited by in Crossref: 21] [Cited by in F6Publishing: 20] [Article Influence: 1.5] [Reference Citation Analysis]
|
| 334 |
Elmasry K, Davies AJ, Evans DG, Seif MN, Reynolds K. Strategies for endometrial screening in the Lynch syndrome population: a patient acceptability study. Familial Cancer 2009;8:431-9. [DOI: 10.1007/s10689-009-9259-3] [Cited by in Crossref: 10] [Cited by in F6Publishing: 11] [Article Influence: 0.7] [Reference Citation Analysis]
|
| 335 |
Chu H, Chen S, Louis TA. Random Effects Models in a Meta-Analysis of the Accuracy of Two Diagnostic Tests Without a Gold Standard. J Am Stat Assoc 2009;104:512-23. [PMID: 19562044 DOI: 10.1198/jasa.2009.0017] [Cited by in Crossref: 61] [Cited by in F6Publishing: 61] [Article Influence: 4.4] [Reference Citation Analysis]
|
| 336 |
Kastrinos F, Allen JI, Stockwell DH, Stoffel EM, Cook EF, Mutinga ML, Balmaña J, Syngal S. Development and validation of a colon cancer risk assessment tool for patients undergoing colonoscopy. Am J Gastroenterol 2009;104:1508-18. [PMID: 19491864 DOI: 10.1038/ajg.2009.135] [Cited by in Crossref: 52] [Cited by in F6Publishing: 50] [Article Influence: 3.7] [Reference Citation Analysis]
|
| 337 |
Hegde MR, Roa BB. Genetic testing for hereditary nonpolyposis colorectal cancer (HNPCC). Curr Protoc Hum Genet 2009;Chapter 10:Unit 10.12. [PMID: 19360696 DOI: 10.1002/0471142905.hg1012s61] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 0.4] [Reference Citation Analysis]
|
| 338 |
Lynch HT, Boland CR, Gong G, Shaw TG, Lynch PM, Fodde R, Lynch JF, de la Chapelle A. Phenotypic and genotypic heterogeneity in the Lynch syndrome: diagnostic, surveillance and management implications. Eur J Hum Genet 2006;14:390-402. [PMID: 16479259 DOI: 10.1038/sj.ejhg.5201584] [Cited by in Crossref: 113] [Cited by in F6Publishing: 121] [Article Influence: 8.1] [Reference Citation Analysis]
|
| 339 |
Skoglund Lundin J, Vandrovcova J, Song B, Zhou X, Zelada-Hedman M, Werelius B, Houlston RS, Lindblom A. TGFBR1 variants TGFBR1(*)6A and Int7G24A are not associated with an increased familial colorectal cancer risk. Br J Cancer 2009;100:1674-9. [PMID: 19401691 DOI: 10.1038/sj.bjc.6605054] [Cited by in Crossref: 11] [Cited by in F6Publishing: 14] [Article Influence: 0.8] [Reference Citation Analysis]
|
| 340 |
Hadziavdić V, Pavlović-Calić N, Eminović I. Molecular analysis: microsatellity instability and loss of heterozygosity of tumor suppressor gene in hereditary non-polyposis colorectal cancers (HNPCC). Bosn J Basic Med Sci 2009;9:10-8. [PMID: 19284389 DOI: 10.17305/bjbms.2009.2850] [Reference Citation Analysis]
|
| 341 |
Grover S, Syngal S. Genetic testing in gastroenterology: Lynch syndrome. Best Pract Res Clin Gastroenterol 2009;23:185-96. [PMID: 19414145 DOI: 10.1016/j.bpg.2009.02.006] [Cited by in Crossref: 12] [Cited by in F6Publishing: 12] [Article Influence: 0.9] [Reference Citation Analysis]
|
| 342 |
Learn PA, Kahlenberg MS. Hereditary colorectal cancer syndromes and the role of the surgical oncologist. Surg Oncol Clin N Am. 2009;18:121-44, ix. [PMID: 19056045 DOI: 10.1016/j.soc.2008.08.007] [Cited by in Crossref: 4] [Cited by in F6Publishing: 2] [Article Influence: 0.3] [Reference Citation Analysis]
|
| 343 |
Koopman M, Kortman GA, Mekenkamp L, Ligtenberg MJ, Hoogerbrugge N, Antonini NF, Punt CJ, van Krieken JH. Deficient mismatch repair system in patients with sporadic advanced colorectal cancer. Br J Cancer. 2009;100:266-273. [PMID: 19165197 DOI: 10.1038/sj.bjc.6604867] [Cited by in Crossref: 291] [Cited by in F6Publishing: 313] [Article Influence: 20.8] [Reference Citation Analysis]
|
| 344 |
Bapat B, Lindor NM, Baron J, Siegmund K, Li L, Zheng Y, Haile R, Gallinger S, Jass JR, Young JP, Cotterchio M, Jenkins M, Grove J, Casey G, Thibodeau SN, Bishop DT, Hopper JL, Ahnen D, Newcomb PA, Le Marchand L, Potter JD, Seminara D; Colon Cancer Family Registry. The association of tumor microsatellite instability phenotype with family history of colorectal cancer. Cancer Epidemiol Biomarkers Prev 2009;18:967-75. [PMID: 19258475 DOI: 10.1158/1055-9965.EPI-08-0878] [Cited by in Crossref: 22] [Cited by in F6Publishing: 23] [Article Influence: 1.6] [Reference Citation Analysis]
|
| 345 |
Olasz J. Significance of genetic instability in development and chemosensitivity of malignant tumors. Clinical and Experimental Medical Journal 2009;3:175-185. [DOI: 10.1556/cemed.3.2009.1.17] [Reference Citation Analysis]
|
| 346 |
Sheng JQ, Zhang H, Ji M, Fu L, Mu H, Zhang MZ, Huang JS, Han M, Li AQ, Wei Z, Sun ZQ, Wu ZT, Xia CH, Li SR. Genetic diagnosis strategy of hereditary non-polyposis colorectal cancer. World J Gastroenterol 2009; 15(8): 983-989 [PMID: 19248199 DOI: 10.3748/wjg.15.983] [Cited by in CrossRef: 8] [Cited by in F6Publishing: 9] [Article Influence: 0.6] [Reference Citation Analysis]
|
| 347 |
Green RC, Parfrey PS, Woods MO, Younghusband HB. Prediction of Lynch syndrome in consecutive patients with colorectal cancer. J Natl Cancer Inst 2009;101:331-40. [PMID: 19244167 DOI: 10.1093/jnci/djn499] [Cited by in Crossref: 69] [Cited by in F6Publishing: 77] [Article Influence: 4.9] [Reference Citation Analysis]
|
| 348 |
Bjorvatn C, Eide GE, Hanestad BR, Hamang A, Havik OE. Intrusion and avoidance in subjects undergoing genetic investigation and counseling for hereditary cancer. Support Care Cancer 2009;17:1371-81. [PMID: 19224252 DOI: 10.1007/s00520-009-0594-6] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 0.6] [Reference Citation Analysis]
|
| 349 |
Carlomagno N, Pelosio L, Jamshidi A, Duraturo F, Izzo P, Renda A. “DNA-Guided” Therapy. Multiple Primary Malignancies. [DOI: 10.1007/978-88-470-1095-6_17] [Reference Citation Analysis]
|
| 350 |
Hadziavdić V, Pavlović-Calić N, Eminović I. Microsatellite instability and loss of heterozygosity of tumor suppressor genes in Bosnian patients with sporadic colorectal cancer. Bosn J Basic Med Sci 2008;8:313-21. [PMID: 19125701 DOI: 10.17305/bjbms.2008.2883] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.1] [Reference Citation Analysis]
|
| 351 |
Yoon S, Park TS, Kim NK, Lee KA, Kim J, Song J, Kim BY, Choi JR. Three new nonsense mutations of MLH1 and MSH2 genes in Korean families with hereditary nonpolyposis colorectal cancer. Cancer Genet Cytogenet 2009;188:61-4. [PMID: 19100506 DOI: 10.1016/j.cancergencyto.2008.09.001] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.1] [Reference Citation Analysis]
|
| 352 |
Schafmayer C, Buch S, Völzke H, von Schönfels W, Egberts JH, Schniewind B, Brosch M, Ruether A, Franke A, Mathiak M, Sipos B, Henopp T, Catalcali J, Hellmig S, ElSharawy A, Katalinic A, Lerch MM, John U, Fölsch UR, Fändrich F, Kalthoff H, Schreiber S, Krawczak M, Tepel J, Hampe J. Investigation of the colorectal cancer susceptibility region on chromosome 8q24.21 in a large German case-control sample. Int J Cancer 2009;124:75-80. [PMID: 18839428 DOI: 10.1002/ijc.23872] [Cited by in Crossref: 38] [Cited by in F6Publishing: 40] [Article Influence: 2.7] [Reference Citation Analysis]
|
| 353 |
Rosner G, Strul H. Microsatellite instability in the evaluation of hereditary nonpolyposis colorectal cancer. Curr colorectal cancer rep 2009;5:40-47. [DOI: 10.1007/s11888-009-0007-8] [Reference Citation Analysis]
|
| 354 |
Wiesner G, Slavin T, Barnholtz-sloan J. Colorectal Cancer. Genomic and Personalized Medicine 2009. [DOI: 10.1016/b978-0-12-369420-1.00073-1] [Cited by in Crossref: 2] [Article Influence: 0.1] [Reference Citation Analysis]
|
| 355 |
Scott RJ, Lubinski J. Genetic epidemiology studies in hereditary non-polyposis colorectal cancer. Methods Mol Biol 2009;472:89-102. [PMID: 19107430 DOI: 10.1007/978-1-60327-492-0_4] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.2] [Reference Citation Analysis]
|
| 356 |
Petras RE, Frankel WL. Large Intestine (Colon). Modern Surgical Pathology 2009. [DOI: 10.1016/b978-1-4160-3966-2.00023-0] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
|
| 357 |
Thomas BC, Ferber MJ, Lindor NM. DNA Mismatch Repair and Lynch Syndrome. Genetics of Colorectal Cancer 2009. [DOI: 10.1007/978-0-387-09568-4_7] [Reference Citation Analysis]
|
| 358 |
Hornick JL, Odze RD. Polyps of the Large Intestine. Surgical Pathology of the GI Tract, Liver, Biliary Tract, and Pancreas 2009. [DOI: 10.1016/b978-141604059-0.50022-9] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.2] [Reference Citation Analysis]
|
| 359 |
Valadão M, Graziosi G, Carneiro M, Leal RA, Rosa AAPS, Almeida R, Muharre RJ. A importância da suspeição clínica no diagnóstico e tratamento do câncer colorretal hereditário. Rev bras colo-proctol 2008;28:454-61. [DOI: 10.1590/s0101-98802008000400008] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
|
| 360 |
Sanchez JA, Vogel JD, Kalady MF, Bronner MP, Skacel M, Church JM. Identifying Lynch syndrome: we are all responsible. Dis Colon Rectum 2008;51:1750-6. [PMID: 18682882 DOI: 10.1007/s10350-008-9414-1] [Cited by in Crossref: 19] [Cited by in F6Publishing: 19] [Article Influence: 1.3] [Reference Citation Analysis]
|
| 361 |
Polydorides AD, Mukherjee B, Gruber SB, McKenna BJ, Appelman HD, Greenson JK. Adenoma-infiltrating lymphocytes (AILs) are a potential marker of hereditary nonpolyposis colorectal cancer. Am J Surg Pathol 2008;32:1661-6. [PMID: 18753941 DOI: 10.1097/PAS.0b013e31816ffa80] [Cited by in Crossref: 16] [Cited by in F6Publishing: 17] [Article Influence: 1.1] [Reference Citation Analysis]
|
| 362 |
Hadziavdić V, Eminović I, Ascerić M, Komel R. Familial adenomatous polyposis: analysis of genetic instability of microsatellites Loci and genetic alternations of tumor suppressor genes. Bosn J Basic Med Sci 2008;8:160-4. [PMID: 18498268 DOI: 10.17305/bjbms.2008.2974] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.1] [Reference Citation Analysis]
|
| 363 |
Julié C, Trésallet C, Brouquet A, Vallot C, Zimmermann U, Mitry E, Radvanyi F, Rouleau E, Lidereau R, Coulet F, Olschwang S, Frébourg T, Rougier P, Nordlinger B, Laurent-Puig P, Penna C, Boileau C, Franc B, Muti C, Hofmann-Radvanyi H. Identification in daily practice of patients with Lynch syndrome (hereditary nonpolyposis colorectal cancer): revised Bethesda guidelines-based approach versus molecular screening. Am J Gastroenterol 2008;103:2825-35; quiz 2836. [PMID: 18759827 DOI: 10.1111/j.1572-0241.2008.02084.x] [Cited by in Crossref: 97] [Cited by in F6Publishing: 96] [Article Influence: 6.5] [Reference Citation Analysis]
|
| 364 |
Byfield SA, Syngal S. Clinical guidelines versus universal molecular testing: are we ready to choose an optimal strategy for Lynch syndrome identification? Am J Gastroenterol 2008;103:2837-40. [PMID: 19032469 DOI: 10.1111/j.1572-0241.2008.02091.x] [Cited by in Crossref: 8] [Cited by in F6Publishing: 10] [Article Influence: 0.5] [Reference Citation Analysis]
|
| 365 |
Pande M, Amos CI, Osterwisch DR, Chen J, Lynch PM, Broaddus R, Frazier ML. Genetic variation in genes for the xenobiotic-metabolizing enzymes CYP1A1, EPHX1, GSTM1, GSTT1, and GSTP1 and susceptibility to colorectal cancer in Lynch syndrome. Cancer Epidemiol Biomarkers Prev 2008;17:2393-401. [PMID: 18768509 DOI: 10.1158/1055-9965.EPI-08-0326] [Cited by in Crossref: 26] [Cited by in F6Publishing: 28] [Article Influence: 1.7] [Reference Citation Analysis]
|
| 366 |
Rahner N, Steinke V. Hereditary cancer syndromes. Dtsch Arztebl Int 2008;105:706-14. [PMID: 19623293 DOI: 10.3238/arztebl.2008.0706] [Cited by in Crossref: 22] [Cited by in F6Publishing: 32] [Article Influence: 1.5] [Reference Citation Analysis]
|
| 367 |
Nathanson JW, Zisman TL, Julian C, McCaffrey S, Rubin DT. Identification of patients at increased risk for colorectal cancer in an open access endoscopy center. J Clin Gastroenterol 2008;42:1025-31. [PMID: 18719509 DOI: 10.1097/MCG.0b013e3181468613] [Cited by in Crossref: 6] [Cited by in F6Publishing: 7] [Article Influence: 0.4] [Reference Citation Analysis]
|
| 368 |
Fracasso P, Crespi M. Epidemiologia e razionale per lo screening. La colonscopia virtuale. [DOI: 10.1007/978-88-470-1067-3_1] [Reference Citation Analysis]
|
| 369 |
Hampel H, Frankel WL, Martin E, Arnold M, Khanduja K, Kuebler P, Clendenning M, Sotamaa K, Prior T, Westman JA, Panescu J, Fix D, Lockman J, LaJeunesse J, Comeras I, de la Chapelle A. Feasibility of screening for Lynch syndrome among patients with colorectal cancer. J Clin Oncol 2008;26:5783-8. [PMID: 18809606 DOI: 10.1200/JCO.2008.17.5950] [Cited by in Crossref: 584] [Cited by in F6Publishing: 641] [Article Influence: 38.9] [Reference Citation Analysis]
|
| 370 |
Zivković V, Katić V, Gligorijević J, Andelković Z, Petrović A, Krstić M. [Lynch syndrome I: a case report]. Med Pregl 2008;61:79-82. [PMID: 18798480 DOI: 10.2298/mpns0802079z] [Reference Citation Analysis]
|
| 371 |
Bläker H, Mechtersheimer G, Sutter C, Hertkorn C, Kern MA, Rieker RJ, Penzel R, Schirmacher P, Kloor M. Recurrent deletions at 6q in early age of onset non-HNPCC- and non-FAP-associated intestinal carcinomas. Evidence for a novel cancer susceptibility locus at 6q14-q22. Genes Chromosomes Cancer 2008;47:159-64. [PMID: 18008368 DOI: 10.1002/gcc.20516] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 0.6] [Reference Citation Analysis]
|
| 372 |
Pal T, Permuth-Wey J, Sellers TA. A review of the clinical relevance of mismatch-repair deficiency in ovarian cancer. Cancer. 2008;113:733-742. [PMID: 18543306 DOI: 10.1002/cncr.23601] [Cited by in Crossref: 70] [Cited by in F6Publishing: 77] [Article Influence: 4.7] [Reference Citation Analysis]
|
| 373 |
Cheah PY. Recent advances in colorectal cancer genetics and diagnostics. Crit Rev Oncol Hematol 2009;69:45-55. [PMID: 18774731 DOI: 10.1016/j.critrevonc.2008.08.001] [Cited by in Crossref: 40] [Cited by in F6Publishing: 42] [Article Influence: 2.7] [Reference Citation Analysis]
|
| 374 |
Daniels M. Genetic Risk Assessment for Hereditary Endometrial Cancer. Hereditary Gynecologic Cancer 2008. [DOI: 10.3109/9781420052886-18] [Reference Citation Analysis]
|
| 375 |
Paraf F. [How and when to search for microsatellite instability in colorectal cancer in 2008?]. Ann Pathol 2007;27:433-8. [PMID: 18554553 DOI: 10.1016/S0242-6498(07)71415-3] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.2] [Reference Citation Analysis]
|
| 376 |
Laghi L, Bianchi P, Malesci A. Differences and evolution of the methods for the assessment of microsatellite instability. Oncogene 2008;27:6313-21. [PMID: 18679418 DOI: 10.1038/onc.2008.217] [Cited by in Crossref: 73] [Cited by in F6Publishing: 82] [Article Influence: 4.9] [Reference Citation Analysis]
|
| 377 |
Senter L, Clendenning M, Sotamaa K, Hampel H, Green J, Potter JD, Lindblom A, Lagerstedt K, Thibodeau SN, Lindor NM, Young J, Winship I, Dowty JG, White DM, Hopper JL, Baglietto L, Jenkins MA, de la Chapelle A. The clinical phenotype of Lynch syndrome due to germ-line PMS2 mutations. Gastroenterology 2008;135:419-28. [PMID: 18602922 DOI: 10.1053/j.gastro.2008.04.026] [Cited by in Crossref: 392] [Cited by in F6Publishing: 414] [Article Influence: 26.1] [Reference Citation Analysis]
|
| 378 |
Russo A, Calò V, Bruno L, Rizzo S, Bazan V, Di Fede G. Hereditary ovarian cancer. Crit Rev Oncol Hematol 2009;69:28-44. [PMID: 18656380 DOI: 10.1016/j.critrevonc.2008.06.003] [Cited by in Crossref: 74] [Cited by in F6Publishing: 67] [Article Influence: 4.9] [Reference Citation Analysis]
|
| 379 |
Chao EC, Velasquez JL, Witherspoon MS, Rozek LS, Peel D, Ng P, Gruber SB, Watson P, Rennert G, Anton-Culver H, Lynch H, Lipkin SM. Accurate classification of MLH1/MSH2 missense variants with multivariate analysis of protein polymorphisms-mismatch repair (MAPP-MMR). Hum Mutat 2008;29:852-60. [PMID: 18383312 DOI: 10.1002/humu.20735] [Cited by in Crossref: 89] [Cited by in F6Publishing: 93] [Article Influence: 5.9] [Reference Citation Analysis]
|
| 380 |
Zhang L. Immunohistochemistry vs microsatellite instability testing for screening colorectal cancer patients at risk for hereditary nonpolyposis colorectal cancer syndrome. Part II. The utility of microsatellite instability testing. J Mol Diagn. 2008;10:301-307. [PMID: 18556776 DOI: 10.2353/jmoldx.2008.080062] [Cited by in Crossref: 140] [Cited by in F6Publishing: 152] [Article Influence: 9.3] [Reference Citation Analysis]
|
| 381 |
Park SJ, Lee KA, Park TS, Kim NK, Song J, Kim BY, Choi JR. A novel missense MSH2 gene mutation in a patient of a Korean family with hereditary nonpolyposis colorectal cancer. Cancer Genet Cytogenet 2008;182:136-9. [PMID: 18406877 DOI: 10.1016/j.cancergencyto.2008.01.011] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.1] [Reference Citation Analysis]
|
| 382 |
Ferreira S, Claro I, Lage P, Filipe B, Fonseca R, Sousa R, Francisco I, Chaves P, Albuquerque C, Leitão CN. Colorectal adenomas in young patients: microsatellite instability is not a useful marker to detect new cases of Lynch syndrome. Dis Colon Rectum 2008;51:909-15. [PMID: 18306971 DOI: 10.1007/s10350-008-9224-5] [Cited by in Crossref: 16] [Cited by in F6Publishing: 16] [Article Influence: 1.1] [Reference Citation Analysis]
|
| 383 |
Winship IM, Dudding TE. Lessons from the skin--cutaneous features of familial cancer. Lancet Oncol 2008;9:462-72. [PMID: 18452857 DOI: 10.1016/S1470-2045(08)70126-8] [Cited by in Crossref: 37] [Cited by in F6Publishing: 39] [Article Influence: 2.5] [Reference Citation Analysis]
|
| 384 |
Giráldez MD, Castellví-Bel S, Balaguer F, Gonzalo V, Ocaña T, Castells A. Lynch syndrome in colorectal cancer patients. Expert Rev Anticancer Ther 2008;8:573-83. [PMID: 18402524 DOI: 10.1586/14737140.8.4.573] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 0.3] [Reference Citation Analysis]
|
| 385 |
Dierssen JWF, van Puijenbroek M, Dezentjé DA, Fleuren GJ, Cornelisse CJ, van Wezel T, Offringa R, Morreau H. Frequent mutations in the 3′-untranslated region of IFNGR1 lack functional impairment in microsatellite-unstable colorectal tumours. Eur J Hum Genet 2008;16:1235-9. [DOI: 10.1038/ejhg.2008.81] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.1] [Reference Citation Analysis]
|
| 386 |
Steyerberg EW, Balmaña J, Stockwell DH, Syngal S. Data reduction for prediction: a case study on robust coding of age and family history for the risk of having a genetic mutation. Stat Med 2007;26:5545-56. [PMID: 17948867 DOI: 10.1002/sim.3119] [Cited by in Crossref: 8] [Cited by in F6Publishing: 9] [Article Influence: 0.5] [Reference Citation Analysis]
|
| 387 |
Goldberg Y, Porat RM, Kedar I, Shochat C, Sagi M, Eilat A, Mendelson S, Hamburger T, Nissan A, Hubert A. Mutation spectrum in HNPCC in the Israeli population. Fam Cancer. 2008;7:309-317. [PMID: 18389388 DOI: 10.1007/s10689-008-9191-y] [Cited by in Crossref: 15] [Cited by in F6Publishing: 14] [Article Influence: 1.0] [Reference Citation Analysis]
|
| 388 |
Barnetson RA, Cartwright N, van Vliet A, Haq N, Drew K, Farrington S, Williams N, Warner J, Campbell H, Porteous ME, Dunlop MG. Classification of ambiguous mutations in DNA mismatch repair genes identified in a population-based study of colorectal cancer. Hum Mutat 2008;29:367-74. [PMID: 18033691 DOI: 10.1002/humu.20635] [Cited by in Crossref: 65] [Cited by in F6Publishing: 68] [Article Influence: 4.3] [Reference Citation Analysis]
|
| 389 |
Imai K, Yamamoto H. Carcinogenesis and microsatellite instability: the interrelationship between genetics and epigenetics. Carcinogenesis 2008;29:673-680. [DOI: 10.1093/carcin/bgm228] [Cited by in Crossref: 300] [Cited by in F6Publishing: 307] [Article Influence: 20.0] [Reference Citation Analysis]
|
| 390 |
Kirchhoff AC, Newcomb PA, Trentham-Dietz A, Nichols HB, Hampton JM. Family history and colorectal cancer survival in women. Fam Cancer. 2008;7:287-292. [PMID: 18360806 DOI: 10.1007/s10689-008-9190-z] [Cited by in Crossref: 12] [Cited by in F6Publishing: 11] [Article Influence: 0.8] [Reference Citation Analysis]
|
| 391 |
Aldred PM, Borts RH. Humanizing mismatch repair in yeast: towards effective identification of hereditary non-polyposis colorectal cancer alleles. Biochem Soc Trans 2007;35:1525-8. [PMID: 18031259 DOI: 10.1042/BST0351525] [Cited by in Crossref: 8] [Cited by in F6Publishing: 12] [Article Influence: 0.5] [Reference Citation Analysis]
|
| 392 |
Bjorvatn C, Eide GE, Hanestad BR, Havik OE. Anxiety and depression among subjects attending genetic counseling for hereditary cancer. Patient Educ Couns 2008;71:234-43. [PMID: 18295433 DOI: 10.1016/j.pec.2008.01.008] [Cited by in Crossref: 17] [Cited by in F6Publishing: 16] [Article Influence: 1.1] [Reference Citation Analysis]
|
| 393 |
Stoffel EM, Ford B, Mercado RC, Punglia D, Kohlmann W, Conrad P, Blanco A, Shannon KM, Powell M, Gruber SB, Terdiman J, Chung DC, Syngal S. Sharing genetic test results in Lynch syndrome: communication with close and distant relatives. Clin Gastroenterol Hepatol 2008;6:333-8. [PMID: 18258490 DOI: 10.1016/j.cgh.2007.12.014] [Cited by in Crossref: 89] [Cited by in F6Publishing: 92] [Article Influence: 5.9] [Reference Citation Analysis]
|
| 394 |
Yang KY, Chen L. Gynecologic decisions for women at risk for Lynch syndrome. Expert Review of Obstetrics & Gynecology 2008;3:231-237. [DOI: 10.1586/17474108.3.2.231] [Reference Citation Analysis]
|
| 395 |
Steinke V, Rahner N, Morak M, Keller G, Schackert HK, Görgens H, Schmiegel W, Royer-pokora B, Dietmaier W, Kloor M, Engel C, Propping P, Aretz S; for The German HNPCC Consortium. No association between MUTYH and MSH6 germline mutations in 64 HNPCC patients. Eur J Hum Genet 2008;16:587-92. [DOI: 10.1038/ejhg.2008.26] [Cited by in Crossref: 15] [Cited by in F6Publishing: 16] [Article Influence: 1.0] [Reference Citation Analysis]
|
| 396 |
Yan HL, Hao LQ, Jin HY, Xing QH, Xue G, Mei Q, He J, He L, Sun SH. Clinical features and mismatch repair genes analyses of Chinese suspected hereditary non-polyposis colorectal cancer: a cost-effective screening strategy proposal. Cancer Sci. 2008;99:770-780. [PMID: 18307539 DOI: 10.1111/j.1349-7006.2008.00737.x] [Cited by in Crossref: 19] [Cited by in F6Publishing: 19] [Article Influence: 1.3] [Reference Citation Analysis]
|
| 397 |
Hes FJ. Lynch syndrome: still not a familiar picture. World J Surg Oncol 2008;6:21. [PMID: 18284705 DOI: 10.1186/1477-7819-6-21] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 0.3] [Reference Citation Analysis]
|
| 398 |
Truta B, Chen Y, Blanco AM, Deng G, Conrad PG, Kim YH, Park ET, Kakar S, Kim YS, Velayos F, Sleisenger MH, Terdiman JP. Tumor histology helps to identify Lynch syndrome among colorectal cancer patients. Familial Cancer 2008;7:267-74. [DOI: 10.1007/s10689-008-9186-8] [Cited by in Crossref: 12] [Cited by in F6Publishing: 11] [Article Influence: 0.8] [Reference Citation Analysis]
|
| 399 |
Jin HY, Liu X, Li VK, Ding Y, Yang B, Geng J, Lai R, Ding S, Ni M, Zhao R. Detection of mismatch repair gene germline mutation carrier among Chinese population with colorectal cancer. BMC Cancer. 2008;8:44. [PMID: 18257912 DOI: 10.1186/1471-2407-8-44] [Cited by in Crossref: 29] [Cited by in F6Publishing: 33] [Article Influence: 1.9] [Reference Citation Analysis]
|
| 400 |
Bessa X, Ballesté B, Andreu M, Castells A, Bellosillo B, Balaguer F, Castellví-Bel S, Paya A, Jover R, Alenda C, Titó L, Martinez-Villacampa M, Vilella A, Xicola RM, Pons E, Llor X; Gastrointestinal Oncology Group of Spanish Gastroenterological Association. A prospective, multicenter, population-based study of BRAF mutational analysis for Lynch syndrome screening. Clin Gastroenterol Hepatol 2008;6:206-14. [PMID: 18096441 DOI: 10.1016/j.cgh.2007.10.011] [Cited by in Crossref: 72] [Cited by in F6Publishing: 76] [Article Influence: 4.8] [Reference Citation Analysis]
|
| 401 |
Chen JR, Chiang JM, Changchien CR, Chen JS, Tang RP, Wang JY. Mismatch repair protein expression in Amsterdam II criteria-positive patients in Taiwan. Br J Surg 2008;95:102-10. [PMID: 18064717 DOI: 10.1002/bjs.5786] [Cited by in Crossref: 10] [Cited by in F6Publishing: 10] [Article Influence: 0.7] [Reference Citation Analysis]
|
| 402 |
Lynch PM. Prevention of colorectal cancer in high-risk populations: the increasing role for endoscopy and chemoprevention in FAP and HNPCC. Digestion 2007;76:68-76. [PMID: 17947820 DOI: 10.1159/000108395] [Cited by in Crossref: 14] [Cited by in F6Publishing: 16] [Article Influence: 0.9] [Reference Citation Analysis]
|
| 403 |
Rubin DT, Hetzel JT. Endoscopic guidelines for hereditary non-polyposis colorectal cancer, familial adenomatous polyposis, inflammatory bowel disease and sporadic colorectal cancer. Falk Symposium. [DOI: 10.1007/978-1-4020-6826-3_8] [Reference Citation Analysis]
|
| 404 |
Kets CM, van Krieken JH, van Erp PE, Feuth T, Jacobs YH, Brunner HG, Ligtenberg MJ, Hoogerbrugge N. Is early-onset microsatellite and chromosomally stable colorectal cancer a hallmark of a genetic susceptibility syndrome? Int J Cancer 2008;122:796-801. [PMID: 17957798 DOI: 10.1002/ijc.23121] [Cited by in Crossref: 10] [Cited by in F6Publishing: 10] [Article Influence: 0.7] [Reference Citation Analysis]
|
| 405 |
Papi L. Turcot Syndrome. Neurocutaneous Disorders Phakomatoses and Hamartoneoplastic Syndromes 2008. [DOI: 10.1007/978-3-211-69500-5_47] [Reference Citation Analysis]
|
| 406 |
Offit K, Thom P, Bernstein D. Genetic Factors: Hereditary Cancer Predisposition Syndromes. Abeloff's Clinical Oncology 2008. [DOI: 10.1016/b978-0-443-06694-8.50015-4] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
|
| 407 |
Balaguer F, Castellví-bel S, Gonzalo V, Giráldez MD, Ocaña T, Castells A. Who requires genetic testing? Curr colorectal cancer rep 2008;4:48-54. [DOI: 10.1007/s11888-008-0009-y] [Reference Citation Analysis]
|
| 408 |
Matuchansky C. Le syndrome de Lynch. De Barrett à Zollinger-Ellison Quelques cas historiques en gastroentérologie 2008. [DOI: 10.1007/978-2-287-77052-4_6] [Reference Citation Analysis]
|
| 409 |
Capellá G, Balart J, Peinado MA. Genomic Instability, DNA Repair Pathways and Cancer. Principles of Molecular Oncology 2008. [DOI: 10.1007/978-1-59745-470-4_13] [Cited by in Crossref: 1] [Article Influence: 0.1] [Reference Citation Analysis]
|
| 410 |
Zhang S, Davidson DD, Cheng L. Conceptual Evolution in Cancer Biology. Molecular Genetic Pathology 2008. [DOI: 10.1007/978-1-59745-405-6_7] [Reference Citation Analysis]
|
| 411 |
Overbeek LI, Hoogerbrugge N, van Krieken JH, Nagengast FM, Ruers TJ, Ligtenberg MJ, Hermens RP; MIPA Study Group. Most patients with colorectal tumors at young age do not visit a cancer genetics clinic. Dis Colon Rectum 2008;51:1249-54. [PMID: 18536968 DOI: 10.1007/s10350-008-9345-x] [Cited by in Crossref: 29] [Cited by in F6Publishing: 27] [Article Influence: 1.9] [Reference Citation Analysis]
|
| 412 |
Janjan NA, Lin EH, Delclos ME, Crane C, Rodriguez-bigas MA, Skibber JM. Rectal Cancer. Gastrointestinal Cancer. [DOI: 10.1007/0-387-27285-2_10] [Reference Citation Analysis]
|
| 413 |
Amos CI, Bosken CH, Soliman AS, Frazier ML. Risk Factors for Colorectal Cancer Susceptibility. Gastrointestinal Cancer. [DOI: 10.1007/0-387-27285-2_6] [Reference Citation Analysis]
|
| 414 |
Daly MB. Genetic Screening and Counseling for High-Risk Populations. Oncology. [DOI: 10.1007/0-387-31056-8_25] [Reference Citation Analysis]
|
| 415 |
Ramsoekh D, Van Leerdam ME, Wagner A, Kuipers EJ. Review article: Detection and management of hereditary non-polyposis colorectal cancer (Lynch syndrome). Aliment Pharmacol Ther 2007;26 Suppl 2:101-11. [PMID: 18081654 DOI: 10.1111/j.1365-2036.2007.03492.x] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 0.4] [Reference Citation Analysis]
|
| 416 |
Vasen HF. Review article: The Lynch syndrome (hereditary nonpolyposis colorectal cancer). Aliment Pharmacol Ther 2007;26 Suppl 2:113-26. [PMID: 18081655 DOI: 10.1111/j.1365-2036.2007.03479.x] [Cited by in Crossref: 52] [Cited by in F6Publishing: 50] [Article Influence: 3.3] [Reference Citation Analysis]
|
| 417 |
Dionigi G, Bianchi V, Rovera F, Boni L, Annoni M, Castano P, Villa F, Dionigi R. Genetic alteration in hereditary colorectal cancer. Surg Oncol. 2007;16 Suppl 1:S11-S15. [PMID: 18023570 DOI: 10.1016/j.suronc.2007.10.020] [Cited by in Crossref: 10] [Cited by in F6Publishing: 9] [Article Influence: 0.6] [Reference Citation Analysis]
|
| 418 |
Case AS, Zighelboim I, Mutch DG, Babb SA, Schmidt AP, Whelan AJ, Thibodeau SN, Goodfellow PJ. Clustering of Lynch syndrome malignancies with no evidence for a role of DNA mismatch repair. Gynecol Oncol. 2008;108:438-444. [PMID: 18022218 DOI: 10.1016/j.ygyno.2007.09.036] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 0.2] [Reference Citation Analysis]
|
| 419 |
Kauff ND. How Should Women With Early-Onset Endometrial Cancer Be Evaluated for Lynch Syndrome? JCO 2007;25:5143-6. [DOI: 10.1200/jco.2007.13.4940] [Cited by in Crossref: 8] [Cited by in F6Publishing: 9] [Article Influence: 0.5] [Reference Citation Analysis]
|
| 420 |
Kastrinos F, Syngal S. Recently identified colon cancer predispositions: MYH and MSH6 mutations. Semin Oncol 2007;34:418-24. [PMID: 17920897 DOI: 10.1053/j.seminoncol.2007.07.005] [Cited by in Crossref: 20] [Cited by in F6Publishing: 22] [Article Influence: 1.3] [Reference Citation Analysis]
|
| 421 |
Markowitz AJ. Colorectal Cancer Screening and Surveillance. Current Clinical Oncology. [DOI: 10.1007/978-1-59745-215-1_3] [Reference Citation Analysis]
|
| 422 |
Velayos FS, Varma MG, Terdiman JP. Polyposis and Familial Cancer Syndromes. Endoscopic Oncology. [DOI: 10.1007/978-1-59745-172-7_18] [Reference Citation Analysis]
|
| 423 |
Köhne CH, Rödel C. Kolorektales Karzinom. Therapiekonzepte Onkologie. [DOI: 10.1007/978-3-540-28978-4_37] [Reference Citation Analysis]
|
| 424 |
Yan SY, Zhou XY, Du X, Zhang TM, Lu YM, Cai SJ, Xu XL, Yu BH, Zhou HH, Shi DR. Three novel missense germline mutations in different exons of MSH6 gene in Chinese hereditary non-polyposis colorectal cancer families. World J Gastroenterol 2007; 13(37): 5021-5024 [PMID: 17854147 DOI: 10.3748/wjg.v13.i37.5021] [Cited by in CrossRef: 10] [Cited by in F6Publishing: 11] [Article Influence: 0.6] [Reference Citation Analysis]
|
| 425 |
Kehoe SM, Kauff ND. Screening and Prevention of Hereditary Gynecologic Cancers. Seminars in Oncology 2007;34:406-10. [DOI: 10.1053/j.seminoncol.2007.07.004] [Cited by in Crossref: 14] [Cited by in F6Publishing: 16] [Article Influence: 0.9] [Reference Citation Analysis]
|
| 426 |
Peltomäki P. Tracking mutations in a family: Recognizing indicators of germline mutation in Lynch syndrome. Curr colorectal cancer rep 2007;3:199-205. [DOI: 10.1007/s11888-007-0031-5] [Reference Citation Analysis]
|
| 427 |
Ewald J, Rodrigue CM, Mourra N, Lefèvre JH, Fléjou JF, Tiret E, Gespach C, Parc YR. Immunohistochemical staining for mismatch repair proteins, and its relevance in the diagnosis of hereditary non-polyposis colorectal cancer. Br J Surg 2007;94:1020-7. [PMID: 17440950 DOI: 10.1002/bjs.5704] [Cited by in Crossref: 16] [Cited by in F6Publishing: 16] [Article Influence: 1.0] [Reference Citation Analysis]
|
| 428 |
van Dijk DA, Oostindiër MJ, Kloosterman-Boele WM, Krijnen P, Vasen HF; Hereditary Tumor Study Group of the Comprehensive Cancer Centre West. Family history is neglected in the work-up of patients with colorectal cancer: a quality assessment using cancer registry data. Fam Cancer 2007;6:131-4. [PMID: 17237905 DOI: 10.1007/s10689-006-9114-8] [Cited by in Crossref: 38] [Cited by in F6Publishing: 36] [Article Influence: 2.4] [Reference Citation Analysis]
|
| 429 |
Green RC, Green JS, Buehler SK, Robb JD, Daftary D, Gallinger S, McLaughlin JR, Parfrey PS, Younghusband HB. Very high incidence of familial colorectal cancer in Newfoundland: a comparison with Ontario and 13 other population-based studies. Fam Cancer 2007;6:53-62. [PMID: 17039269 DOI: 10.1007/s10689-006-9104-x] [Cited by in Crossref: 54] [Cited by in F6Publishing: 61] [Article Influence: 3.4] [Reference Citation Analysis]
|
| 430 |
Geary J, Thomas HJ, Mackay J, Dorkins H, Barwell J, Hodgson SV. The management of families affected by hereditary non-polyposis colorectal cancer (HNPCC). Fam Cancer 2007;6:13-9. [PMID: 16937234 DOI: 10.1007/s10689-006-9000-4] [Cited by in Crossref: 8] [Cited by in F6Publishing: 11] [Article Influence: 0.5] [Reference Citation Analysis]
|
| 431 |
Mak T, Speake D, Lalloo F, Hill J, Evans DG. Familial colorectal cancer referral to regional genetics department--a single centre experience. Fam Cancer. 2007;6:81-87. [PMID: 17160434 DOI: 10.1007/s10689-006-9108-6] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 0.3] [Reference Citation Analysis]
|
| 432 |
Bianchi F, Galizia E, Porfiri E, Belvederesi L, Catalani R, Loretelli C, Bracci R, Bearzi I, Turchi C, Viel A, Cellerino R. A missense germline mutation in exon 7 of the MSH2 gene in a HNPCC family from center-Italy. Fam Cancer 2007;6:97-102. [PMID: 17165155 DOI: 10.1007/s10689-006-9110-z] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 0.3] [Reference Citation Analysis]
|
| 433 |
Ollikainen M, Gylling A, Puputti M, Nupponen NN, Abdel-Rahman WM, Butzow R, Peltomäki P. Patterns of PIK3CA alterations in familial colorectal and endometrial carcinoma. Int J Cancer 2007;121:915-20. [PMID: 17471559 DOI: 10.1002/ijc.22768] [Cited by in Crossref: 50] [Cited by in F6Publishing: 52] [Article Influence: 3.1] [Reference Citation Analysis]
|
| 434 |
Castells A, Balaguer F, Castellví-Bel S, Gonzalo V, Ocaña T. Identification of Lynch syndrome: How should we proceed in the 21st century? World J Gastroenterol 2007; 13(33): 4413-4416 [PMID: 17724794 DOI: 10.3748/wjg.v13.i33.4413] [Cited by in CrossRef: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.2] [Reference Citation Analysis]
|
| 435 |
Lu L, Macdonald AS, Waters HR, Yu F. A Dynamic Family History model Of Hereditary Nonpolyposis Colorectal Cancer and Critical Illness Insurance. Ann actuar sci 2007;2:289-325. [DOI: 10.1017/s1748499500000373] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.2] [Reference Citation Analysis]
|
| 436 |
Khilko N, Bourne P, Qi Yang, Ping Tang. Mismatch repair genes hMLH1 and hMSH2 may not play an essential role in breast carcinogenesis. Int J Surg Pathol 2007;15:233-41. [PMID: 17652529 DOI: 10.1177/1066896907302116] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 0.4] [Reference Citation Analysis]
|
| 437 |
Schafmayer C, Buch S, Egberts JH, Franke A, Brosch M, El Sharawy A, Conring M, Koschnick M, Schwiedernoch S, Katalinic A. Genetic investigation of DNA-repair pathway genes PMS2, MLH1, MSH2, MSH6, MUTYH, OGG1 and MTH1 in sporadic colon cancer. Int J Cancer. 2007;121:555-558. [PMID: 17417778 DOI: 10.1002/ijc.22735] [Cited by in Crossref: 38] [Cited by in F6Publishing: 41] [Article Influence: 2.4] [Reference Citation Analysis]
|
| 438 |
Lazar AJ, Lyle S, Calonje E. Sebaceous neoplasia and Torre-Muir syndrome. Curr Diagn Pathol 2007;13:301-19. [PMID: 18670585 DOI: 10.1016/j.cdip.2007.05.001] [Cited by in Crossref: 49] [Cited by in F6Publishing: 52] [Article Influence: 3.1] [Reference Citation Analysis]
|
| 439 |
Zheng D, Li T, Liu X, Hu W, Chen H, Yang Y. A novel MSH2 mutation in a Chinese family with hereditary non-polyposis colorectal cancer. Int J Colorectal Dis 2007;22:875-9. [PMID: 17333219 DOI: 10.1007/s00384-006-0253-z] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.2] [Reference Citation Analysis]
|
| 440 |
Matuchansky C. Henry Thomson Lynch, un itinéraire exemplaire de la génétique clinique à la biologie moléculaire. Acta Endosc 2007;37:491-508. [DOI: 10.1007/bf02961797] [Reference Citation Analysis]
|
| 441 |
Woods MO, Williams P, Careen A, Edwards L, Bartlett S, McLaughlin JR, Younghusband HB. A new variant database for mismatch repair genes associated with Lynch syndrome. Hum Mutat 2007;28:669-73. [PMID: 17347989 DOI: 10.1002/humu.20502] [Cited by in Crossref: 86] [Cited by in F6Publishing: 96] [Article Influence: 5.4] [Reference Citation Analysis]
|
| 442 |
Jenkins MA, Hayashi S, O'Shea AM, Burgart LJ, Smyrk TC, Shimizu D, Waring PM, Ruszkiewicz AR, Pollett AF, Redston M, Barker MA, Baron JA, Casey GR, Dowty JG, Giles GG, Limburg P, Newcomb P, Young JP, Walsh MD, Thibodeau SN, Lindor NM, Lemarchand L, Gallinger S, Haile RW, Potter JD, Hopper JL, Jass JR; Colon Cancer Family Registry. Pathology features in Bethesda guidelines predict colorectal cancer microsatellite instability: a population-based study. Gastroenterology 2007;133:48-56. [PMID: 17631130 DOI: 10.1053/j.gastro.2007.04.044] [Cited by in Crossref: 252] [Cited by in F6Publishing: 259] [Article Influence: 15.8] [Reference Citation Analysis]
|
| 443 |
Koh DC, Luchtefeld MA, Kim DG, Attal H, Monroe T, Ingersoll K. Microsatellite instability and MLH1 hypermethylation - incidence and significance in colorectal polyps in young patients. Colorectal Dis 2007;9:521-6. [PMID: 17573746 DOI: 10.1111/j.1463-1318.2007.01175.x] [Cited by in Crossref: 11] [Cited by in F6Publishing: 12] [Article Influence: 0.7] [Reference Citation Analysis]
|
| 444 |
Valadão M, Castro LDS. Câncer colo-retal hereditário. Rev Col Bras Cir 2007;34:193-200. [DOI: 10.1590/s0100-69912007000300011] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 0.3] [Reference Citation Analysis]
|
| 445 |
Diergaarde B, Braam H, Vasen HF, Nagengast FM, van Muijen GN, Kok FJ, Kampman E. Environmental factors and colorectal tumor risk in individuals with hereditary nonpolyposis colorectal cancer. Clin Gastroenterol Hepatol 2007;5:736-42. [PMID: 17544999 DOI: 10.1016/j.cgh.2007.02.019] [Cited by in Crossref: 54] [Cited by in F6Publishing: 56] [Article Influence: 3.4] [Reference Citation Analysis]
|
| 446 |
Bjorvatn C, Eide GE, Hanestad BR, Øyen N, Havik OE, Carlsson A, Berglund G. Risk perception, worry and satisfaction related to genetic counseling for hereditary cancer. J Genet Couns 2007;16:211-22. [PMID: 17279329 DOI: 10.1007/s10897-006-9061-4] [Cited by in Crossref: 48] [Cited by in F6Publishing: 46] [Article Influence: 3.0] [Reference Citation Analysis]
|
| 447 |
Modica I, Soslow RA, Black D, Tornos C, Kauff N, Shia J. Utility of immunohistochemistry in predicting microsatellite instability in endometrial carcinoma. Am J Surg Pathol 2007;31:744-51. [PMID: 17460459 DOI: 10.1097/01.pas.0000213428.61374.06] [Cited by in Crossref: 103] [Cited by in F6Publishing: 107] [Article Influence: 6.4] [Reference Citation Analysis]
|
| 448 |
Doxey BW, Kuwada SK. Hereditary nonpolyposis colon cancer: Revised Bethesda criteria, immunohistochemistry, microsatellite instability, germline analysis, and emerging issues in genetic testing. Curr colorectal cancer rep 2007;3:10-5. [DOI: 10.1007/s11888-007-0010-x] [Reference Citation Analysis]
|
| 449 |
Papp J, Kovacs ME, Olah E. Germline MLH1 and MSH2 mutational spectrum including frequent large genomic aberrations in Hungarian hereditary non-polyposis colorectal cancer families: Implications for genetic testing. World J Gastroenterol 2007; 13(19): 2727-2732 [PMID: 17569143 DOI: 10.3748/wjg.v13.i19.2727] [Cited by in CrossRef: 30] [Cited by in F6Publishing: 30] [Article Influence: 1.9] [Reference Citation Analysis]
|
| 450 |
Duffy MJ, van Dalen A, Haglund C, Hansson L, Holinski-Feder E, Klapdor R, Lamerz R, Peltomaki P, Sturgeon C, Topolcan O. Tumour markers in colorectal cancer: European Group on Tumour Markers (EGTM) guidelines for clinical use. Eur J Cancer. 2007;43:1348-1360. [PMID: 17512720 DOI: 10.1016/j.ejca.2007.03.021] [Cited by in Crossref: 321] [Cited by in F6Publishing: 342] [Article Influence: 20.1] [Reference Citation Analysis]
|
| 451 |
Loughrey MB, Waring PM, Tan A, Trivett M, Kovalenko S, Beshay V, Young M, Mcarthur G, Boussioutas A, Dobrovic A. Incorporation of somatic BRAF mutation testing into an algorithm for the investigation of hereditary non-polyposis colorectal cancer. Familial Cancer 2007;6:301-10. [DOI: 10.1007/s10689-007-9124-1] [Cited by in Crossref: 121] [Cited by in F6Publishing: 135] [Article Influence: 7.6] [Reference Citation Analysis]
|
| 452 |
Overbeek LI, Kets CM, Hebeda KM, Bodmer D, van der Looij E, Willems R, Goossens M, Arts N, Brunner HG, van Krieken JH, Hoogerbrugge N, Ligtenberg MJ. Patients with an unexplained microsatellite instable tumour have a low risk of familial cancer. Br J Cancer 2007;96:1605-12. [PMID: 17453009 DOI: 10.1038/sj.bjc.6603754] [Cited by in Crossref: 33] [Cited by in F6Publishing: 37] [Article Influence: 2.1] [Reference Citation Analysis]
|
| 453 |
Bianchi F, Galizia E, Bracci R, Belvederesi L, Catalani R, Loretelli C, Giorgetti G, Ferretti C, Bearzi I, Porfiri E. Effectiveness of the CRCAPRO program in identifying patients suspected for HNPCC. Clin Genet. 2007;71:158-164. [PMID: 17250665 DOI: 10.1111/j.1399-0004.2007.00746.x] [Cited by in Crossref: 8] [Cited by in F6Publishing: 9] [Article Influence: 0.5] [Reference Citation Analysis]
|
| 454 |
Caspari R, Lamberti C. Impact de la génétique moléculaire sur le dépistage du cancer colorectal héréditaire non polypoïde. Acta Endosc 2007;37:165-179. [DOI: 10.1007/bf02961788] [Cited by in Crossref: 2] [Article Influence: 0.1] [Reference Citation Analysis]
|
| 455 |
Castells A, Andreu M; Grupo de Oncología Gastrointestinal de la Asociación Española de Gastroenterología. [EPICOLON project: contribution to the knowledge of Lynch syndrome and other familial or hereditary colorectal cancer]. Med Clin (Barc) 2007;128:55-60. [PMID: 17266903 DOI: 10.1157/13097470] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 0.3] [Reference Citation Analysis]
|
| 456 |
Wang J, Luo MH, Zhang ZX, Zhang PD, Jiang XL, Ma DW, Suo RZ, Zhao LZ, Qi QH. Clinical and molecular analysis of hereditary non-polyposis colorectal cancer in Chinese colorectal cancer patients. World J Gastroenterol 2007; 13(10): 1612-1617 [PMID: 17461458 DOI: 10.3748/wjg.v13.i10.1612] [Cited by in CrossRef: 6] [Cited by in F6Publishing: 6] [Article Influence: 0.4] [Reference Citation Analysis]
|
| 457 |
Lynch HT, Lynch JF, Lynch PM. Toward a consensus in molecular diagnosis of hereditary nonpolyposis colorectal cancer (Lynch syndrome). J Natl Cancer Inst 2007;99:261-3. [PMID: 17312298 DOI: 10.1093/jnci/djk077] [Cited by in Crossref: 40] [Cited by in F6Publishing: 43] [Article Influence: 2.5] [Reference Citation Analysis]
|
| 458 |
Xicola RM, Llor X, Pons E, Castells A, Alenda C, Piñol V, Andreu M, Castellví-Bel S, Payá A, Jover R, Bessa X, Girós A, Duque JM, Nicolás-Pérez D, Garcia AM, Rigau J, Gassull MA; Gastrointestinal Oncology Group of the Spanish Gastroenterological Association. Performance of different microsatellite marker panels for detection of mismatch repair-deficient colorectal tumors. J Natl Cancer Inst 2007;99:244-52. [PMID: 17284719 DOI: 10.1093/jnci/djk033] [Cited by in Crossref: 132] [Cited by in F6Publishing: 141] [Article Influence: 8.3] [Reference Citation Analysis]
|
| 459 |
Vasen HF, Möslein G, Alonso A, Bernstein I, Bertario L, Blanco I, Burn J, Capella G, Engel C, Frayling I. Guidelines for the clinical management of Lynch syndrome (hereditary non-polyposis cancer). J Med Genet. 2007;44:353-362. [PMID: 17327285 DOI: 10.1136/jmg.2007.048991] [Cited by in Crossref: 381] [Cited by in F6Publishing: 410] [Article Influence: 23.8] [Reference Citation Analysis]
|
| 460 |
Pistorius S, Goergens H, Engel C, Plaschke J, Krueger S, Hoehl R, Saeger HD, Schackert HK. N-Acetyltransferase (NAT) 2 acetylator status and age of tumour onset in patients with sporadic and familial, microsatellite stable (MSS) colorectal cancer. Int J Colorectal Dis 2007;22:137-43. [PMID: 16896994 DOI: 10.1007/s00384-006-0171-0] [Cited by in Crossref: 6] [Cited by in F6Publishing: 7] [Article Influence: 0.4] [Reference Citation Analysis]
|
| 461 |
Kloor M, von Knebel Doeberitz M, Gebert JF. Molecular testing for microsatellite instability and its value in tumor characterization. Expert Rev Mol Diagn 2005;5:599-611. [PMID: 16013977 DOI: 10.1586/14737159.5.4.599] [Cited by in Crossref: 10] [Cited by in F6Publishing: 10] [Article Influence: 0.6] [Reference Citation Analysis]
|
| 462 |
Valle L, Perea J, Carbonell P, Fernandez V, Dotor AM, Benitez J, Urioste M. Clinicopathologic and pedigree differences in amsterdam I-positive hereditary nonpolyposis colorectal cancer families according to tumor microsatellite instability status. J Clin Oncol 2007;25:781-6. [PMID: 17228022 DOI: 10.1200/JCO.2006.06.9781] [Cited by in Crossref: 54] [Cited by in F6Publishing: 58] [Article Influence: 3.4] [Reference Citation Analysis]
|
| 463 |
Krüger S, Engel C, Bier A, Silber AS, Görgens H, Mangold E, Pagenstecher C, Holinski-Feder E, von Knebel Doeberitz M, Royer-Pokora B, Dechant S, Pox C, Rahner N, Müller A, Schackert HK; German HNPCC Consortium. The additive effect of p53 Arg72Pro and RNASEL Arg462Gln genotypes on age of disease onset in Lynch syndrome patients with pathogenic germline mutations in MSH2 or MLH1. Cancer Lett 2007;252:55-64. [PMID: 17224235 DOI: 10.1016/j.canlet.2006.12.006] [Cited by in Crossref: 20] [Cited by in F6Publishing: 22] [Article Influence: 1.3] [Reference Citation Analysis]
|
| 464 |
Sheng JQ, Chan TL, Chan YW, Huang JS, Chen JG, Zhang MZ, Guo XL, Mu H, Chan AS, Li SR. Microsatellite instability and novel mismatch repair gene mutations in northern Chinese population with hereditary non-polyposis colorectal cancer. Chin J Dig Dis. 2006;7:197-205. [PMID: 17054581 DOI: 10.1111/j.1443-9573.2006.00269.x] [Cited by in Crossref: 17] [Cited by in F6Publishing: 20] [Article Influence: 1.1] [Reference Citation Analysis]
|
| 465 |
Wilbur JS, Rojan AA, Legare RD. The Genetics of Breast and Gynecologic Cancers. General Gynecology 2007. [DOI: 10.1016/b978-032303247-6.10003-6] [Reference Citation Analysis]
|
| 466 |
Rusin LC, Galandiuk S. Hereditary Nonpolyposis Colon Cancer. The ASCRS Textbook of Colon and Rectal Surgery 2007. [DOI: 10.1007/978-0-387-36374-5_38] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.1] [Reference Citation Analysis]
|
| 467 |
Søreide K. Molecular Testing for Microsatellite Instability and DNA Mismatch Repair Defects in Hereditary and Sporadic Colorectal Cancers – Ready for Prime Time? Tumor Biol 2007;28:290-300. [DOI: 10.1159/000110427] [Cited by in Crossref: 23] [Cited by in F6Publishing: 25] [Article Influence: 1.4] [Reference Citation Analysis]
|
| 468 |
Souglakos J. Genetic alterations in sporadic and hereditary colorectal cancer: implementations for screening and follow-up. Dig Dis 2007;25:9-19. [PMID: 17384504 DOI: 10.1159/000099166] [Cited by in Crossref: 22] [Cited by in F6Publishing: 22] [Article Influence: 1.4] [Reference Citation Analysis]
|
| 469 |
Stal A, Stembalska A, Śmigiel R, Tarkowski R, Grzebieniak Z, Sąsiadek M. Hereditary Nonpolyposis Colorectal Cancer in Lower Silesia. Polish Journal of Surgery 2007;79. [DOI: 10.2478/v10035-007-0028-4] [Reference Citation Analysis]
|
| 470 |
Köküer M, Naguib RN, Jančovič P, Younghusband HB, Green R. Towards Automatic Risk Analysis for Hereditary Non-Polyposis Colorectal Cancer Based on Pedigree Data. Outcome Prediction in Cancer 2007. [DOI: 10.1016/b978-044452855-1/50014-3] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
|
| 471 |
Read TE, Caushaj PF. Screening for Colorectal Neoplasms. The ASCRS Textbook of Colon and Rectal Surgery 2007. [DOI: 10.1007/978-0-387-36374-5_24] [Reference Citation Analysis]
|
| 472 |
Guillem JG, Wood WC, Moley JF, Berchuck A, Karlan BY, Mutch DG, Gagel RF, Weitzel J, Morrow M, Weber BL, Giardiello F, Rodriguez-Bigas MA, Church J, Gruber S, Offit K. ASCO/SSO review of current role of risk-reducing surgery in common hereditary cancer syndromes. Ann Surg Oncol. 2006;13:1296-1321. [PMID: 16990987 DOI: 10.1245/s10434-006-9036-6] [Cited by in Crossref: 38] [Cited by in F6Publishing: 35] [Article Influence: 2.2] [Reference Citation Analysis]
|
| 473 |
Yagyu T, Aihara T, Murayama M, Kikuchi S, Nakamura E, Hase K, Hatsuse K, Tamura K, Mochizuki H. Mucinous carcinoma of the duodenum associated with hereditary nonpolyposis colorectal cancer: report of a case. Surg Today 2006;36:1129-32. [PMID: 17123147 DOI: 10.1007/s00595-006-3321-7] [Cited by in Crossref: 10] [Cited by in F6Publishing: 3] [Article Influence: 0.6] [Reference Citation Analysis]
|
| 474 |
Kámory E, Tanyi M, Kolacsek O, Olasz L, Tóth L, Damjanovich L, Csuka O. Two germline alterations in mismatch repair genes found in a HNPCC patient with poor family history. Pathol Oncol Res. 2006;12:228-233. [PMID: 17189986 DOI: 10.1007/BF02893417] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 0.4] [Reference Citation Analysis]
|
| 475 |
Andus T. Resektionsausmaß und Therapiekonzept bei Verdacht auf hereditäres, nichtpolypöses kolorektales Karzinom – Sicht des Gastroenterologen. Visc Med 2006;22:38-42. [DOI: 10.1159/000096754] [Reference Citation Analysis]
|
| 476 |
Kaz AM, Brentnall TA. Genetic testing for colon cancer. Nat Clin Pract Gastroenterol Hepatol 2006;3:670-9. [PMID: 17130877 DOI: 10.1038/ncpgasthep0663] [Cited by in Crossref: 36] [Cited by in F6Publishing: 39] [Article Influence: 2.1] [Reference Citation Analysis]
|
| 477 |
Koo HL, Choi J, Kim KR, Kim JH. Pure non-gestational choriocarcinoma of the ovary diagnosed by DNA polymorphism analysis. Pathol Int 2006;56:613-6. [PMID: 16984618 DOI: 10.1111/j.1440-1827.2006.02016.x] [Cited by in Crossref: 36] [Cited by in F6Publishing: 39] [Article Influence: 2.1] [Reference Citation Analysis]
|
| 478 |
Kurzawski G. Some aspects of molecular diagnostics in Lynch syndrome. Hered Cancer Clin Pract 2006;4:197-205. [PMID: 20223024 DOI: 10.1186/1897-4287-4-4-197] [Reference Citation Analysis]
|
| 479 |
Kets CM, Hoogerbrugge N, Bodmer D, Willems R, Brunner HG, van Krieken JH, Ligtenberg MJ. Unfavorable pathological characteristics in familial colorectal cancer with low-level microsatellite instability. Mod Pathol 2006;19:1624-30. [PMID: 16980941 DOI: 10.1038/modpathol.3800701] [Cited by in Crossref: 10] [Cited by in F6Publishing: 10] [Article Influence: 0.6] [Reference Citation Analysis]
|
| 480 |
Camilleri M. Gastroenterology and hepatology clinical research update: 2005-2006. Clin Gastroenterol Hepatol 2006;4:1428-33. [PMID: 16949347 DOI: 10.1016/j.cgh.2006.06.027] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 0.2] [Reference Citation Analysis]
|
| 481 |
Niessen RC, Berends MJ, Wu Y, Sijmons RH, Hollema H, Ligtenberg MJ, de Walle HE, de Vries EG, Karrenbeld A, Buys CH, van der Zee AG, Hofstra RM, Kleibeuker JH. Identification of mismatch repair gene mutations in young patients with colorectal cancer and in patients with multiple tumours associated with hereditary non-polyposis colorectal cancer. Gut 2006;55:1781-8. [PMID: 16636019 DOI: 10.1136/gut.2005.090159] [Cited by in Crossref: 74] [Cited by in F6Publishing: 79] [Article Influence: 4.4] [Reference Citation Analysis]
|
| 482 |
Gaff CL, Rogers MT, Frayling IM. Variability and inequity in testing of somatic tissue for hereditary cancer: a survey of UK clinical practice. Clin Genet 2006;70:312-9. [PMID: 16965325 DOI: 10.1111/j.1399-0004.2006.00676.x] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 0.2] [Reference Citation Analysis]
|
| 483 |
Kets CM, van Krieken JH, Hebeda KM, Wezenberg SJ, Goossens M, Brunner HG, Ligtenberg MJ, Hoogerbrugge N. Very low prevalence of germline MSH6 mutations in hereditary non-polyposis colorectal cancer suspected patients with colorectal cancer without microsatellite instability. Br J Cancer 2006;95:1678-82. [PMID: 17117178 DOI: 10.1038/sj.bjc.6603478] [Cited by in Crossref: 11] [Cited by in F6Publishing: 12] [Article Influence: 0.6] [Reference Citation Analysis]
|
| 484 |
Guillem JG, Wood WC, Moley JF, Berchuck A, Karlan BY, Mutch DG, Gagel RF, Weitzel J, Morrow M, Weber BL. ASCO/SSO review of current role of risk-reducing surgery in common hereditary cancer syndromes. J Clin Oncol. 2006;24:4642-4660. [PMID: 17008706 DOI: 10.1200/jco.2005.04.5260] [Cited by in Crossref: 163] [Cited by in F6Publishing: 174] [Article Influence: 9.6] [Reference Citation Analysis]
|
| 485 |
Lindor NM, Lindor CJ, Greene MH. Hereditary Neoplastic Syndromes. Cancer Epidemiology and Prevention 2006. [DOI: 10.1093/acprof:oso/9780195149616.003.0028] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.2] [Reference Citation Analysis]
|
| 486 |
Hayashi T, Arai M, Ueno M, Kinoshita H, Tada Y, Koizumi K, Miki Y, Yamaguchi T, Kato Y, Utsunomiya J, Muto T, Sugihara K. Frequency of immunohistochemical loss of mismatch repair protein in double primary cancers of the colorectum and stomach in Japan. Dis Colon Rectum 2006;49:S23-9. [PMID: 17106811 DOI: 10.1007/s10350-006-0722-z] [Cited by in Crossref: 10] [Cited by in F6Publishing: 11] [Article Influence: 0.6] [Reference Citation Analysis]
|
| 487 |
Farrell C, Lyman M, Freitag K, Fahey C, Piver MS, Rodabaugh KJ. The role of hereditary nonpolyposis colorectal cancer in the management of familial ovarian cancer. Genet Med 2006;8:653-7. [DOI: 10.1097/01.gim.0000241895.20390.c5] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.2] [Reference Citation Analysis]
|
| 488 |
Ponti G, Losi L, Pedroni M, Lucci-cordisco E, Di Gregorio C, Pellacani G, Seidenari S. Value of MLH1 and MSH2 Mutations in the Appearance of Muir–Torre Syndrome Phenotype in HNPCC Patients Presenting Sebaceous Gland Tumors or Keratoacanthomas. Journal of Investigative Dermatology 2006;126:2302-7. [DOI: 10.1038/sj.jid.5700475] [Cited by in Crossref: 78] [Cited by in F6Publishing: 80] [Article Influence: 4.6] [Reference Citation Analysis]
|
| 489 |
Chen S, Wang W, Lee S, Nafa K, Lee J, Romans K, Watson P, Gruber SB, Euhus D, Kinzler KW, Jass J, Gallinger S, Lindor NM, Casey G, Ellis N, Giardiello FM, Offit K, Parmigiani G; Colon Cancer Family Registry. Prediction of germline mutations and cancer risk in the Lynch syndrome. JAMA 2006;296:1479-87. [PMID: 17003396 DOI: 10.1001/jama.296.12.1479] [Cited by in Crossref: 274] [Cited by in F6Publishing: 293] [Article Influence: 16.1] [Reference Citation Analysis]
|
| 490 |
Jasperson KW, Lowstuter K, Weitzel JN. Assessing the Predictive Accuracy of hMLH1 and hMSH2 Mutation Probability Models. J Genet Counsel 2006;15:339-47. [DOI: 10.1007/s10897-006-9035-6] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 0.2] [Reference Citation Analysis]
|
| 491 |
Jass JR. Hereditary non-polyposis colorectal cancer: The rise and fall of a confusing term. World J Gastroenterol 2006; 12(31): 4943-4950 [PMID: 16937488 DOI: 10.3748/wjg.v12.i31.4943] [Cited by in CrossRef: 103] [Cited by in F6Publishing: 114] [Article Influence: 6.1] [Reference Citation Analysis]
|
| 492 |
Goecke T, Schulmann K, Engel C, Holinski-Feder E, Pagenstecher C, Schackert HK, Kloor M, Kunstmann E, Vogelsang H, Keller G. Genotype-phenotype comparison of German MLH1 and MSH2 mutation carriers clinically affected with Lynch syndrome: a report by the German HNPCC Consortium. J Clin Oncol. 2006;24:4285-4292. [PMID: 16908935 DOI: 10.1200/jco.2005.03.7333] [Cited by in Crossref: 108] [Cited by in F6Publishing: 117] [Article Influence: 6.4] [Reference Citation Analysis]
|
| 493 |
Rogowski W. Genetic screening by DNA technology: A systematic review of health economic evidence. Int J Technol Assess Health Care 2006;22:327-37. [DOI: 10.1017/s0266462306051221] [Cited by in Crossref: 40] [Cited by in F6Publishing: 43] [Article Influence: 2.4] [Reference Citation Analysis]
|
| 494 |
Pistorius S, Kruger S, Hohl R, Plaschke J, Distler W, Saeger H, Schackert HK. Occult endometrial cancer and decision making for prophylactic hysterectomy in hereditary nonpolyposis colorectal cancer patients. Gynecologic Oncology 2006;102:189-94. [DOI: 10.1016/j.ygyno.2005.12.032] [Cited by in Crossref: 24] [Cited by in F6Publishing: 24] [Article Influence: 1.4] [Reference Citation Analysis]
|
| 495 |
Lamoril J, Deybach J, Bouizegarène P. L'instabilité des microsatellites dans les cancers du côlon. Immuno-analyse & Biologie Spécialisée 2006;21:211-222. [DOI: 10.1016/j.immbio.2006.04.006] [Reference Citation Analysis]
|
| 496 |
Gryfe R. Clinical Implications of Our Advancing Knowledge of Colorectal Cancer Genetics: Inherited Syndromes, Prognosis, Prevention, Screening and Therapeutics. Surgical Clinics of North America 2006;86:787-817. [DOI: 10.1016/j.suc.2006.05.007] [Cited by in Crossref: 18] [Cited by in F6Publishing: 18] [Article Influence: 1.1] [Reference Citation Analysis]
|
| 497 |
Krüger S, Engel C, Bier A, Mangold E, Pagenstecher C, Doeberitz Mv, Holinski-Feder E, Moeslein G, Keller G, Kunstmann E, Friedl W, Plaschke J, Rüschoff J, Schackert HK; German HNPCC-Consortium. Absence of association between cyclin D1 (CCND1) G870A polymorphism and age of onset in hereditary nonpolyposis colorectal cancer. Cancer Lett 2006;236:191-7. [PMID: 16832876 DOI: 10.1016/j.canlet.2005.05.013] [Cited by in Crossref: 25] [Cited by in F6Publishing: 20] [Article Influence: 1.5] [Reference Citation Analysis]
|
| 498 |
Pistorius S, Görgens H, Plaschke J, Hoehl R, Krüger S, Engel C, Saeger HD, Schackert HK. Genomic rearrangements in MSH2, MLH1 or MSH6 are rare in HNPCC patients carrying point mutations. Cancer Lett 2007;248:89-95. [PMID: 16837128 DOI: 10.1016/j.canlet.2006.06.002] [Cited by in Crossref: 16] [Cited by in F6Publishing: 17] [Article Influence: 0.9] [Reference Citation Analysis]
|
| 499 |
Lynch PM. Medicolegal Aspects of Endoscopic Screening and Genetic Testing in Hereditary Colon Cancer Syndromes. Techniques in Gastrointestinal Endoscopy 2006;8:133-139. [DOI: 10.1016/j.tgie.2006.04.004] [Reference Citation Analysis]
|
| 500 |
Plaschke J, Linnebacher M, Kloor M, Gebert J, Cremer FW, Tinschert S, Aust DE, von Knebel Doeberitz M, Schackert HK. Compound heterozygosity for two MSH6 mutations in a patient with early onset of HNPCC-associated cancers, but without hematological malignancy and brain tumor. Eur J Hum Genet. 2006;14:561-566. [PMID: 16418736 DOI: 10.1038/sj.ejhg.5201568] [Cited by in Crossref: 41] [Cited by in F6Publishing: 45] [Article Influence: 2.4] [Reference Citation Analysis]
|
| 501 |
Lanza G, Gafà R, Santini A, Maestri I, Guerzoni L, Cavazzini L. Immunohistochemical test for MLH1 and MSH2 expression predicts clinical outcome in stage II and III colorectal cancer patients. J Clin Oncol. 2006;24:2359-2367. [PMID: 16710035 DOI: 10.1200/jco.2005.03.2433] [Cited by in Crossref: 157] [Cited by in F6Publishing: 168] [Article Influence: 9.2] [Reference Citation Analysis]
|
| 502 |
Yearsley M, Hampel H, Lehman A, Nakagawa H, de la Chapelle A, Frankel WL. Histologic features distinguish microsatellite-high from microsatellite-low and microsatellite-stable colorectal carcinomas, but do not differentiate germline mutations from methylation of the MLH1 promoter. Hum Pathol 2006;37:831-8. [PMID: 16784982 DOI: 10.1016/j.humpath.2006.02.009] [Cited by in Crossref: 39] [Cited by in F6Publishing: 43] [Article Influence: 2.3] [Reference Citation Analysis]
|
| 503 |
Grabowski M, Mueller-Koch Y, Grasbon-Frodl E, Koehler U, Keller G, Vogelsang H, Dietmaier W, Kopp R, Siebers U, Schmitt W, Neitzel B, Gruber M, Doerner C, Kerker B, Ruemmele P, Henke G, Holinski-Feder E. Deletions account for 17% of pathogenic germline alterations in MLH1 and MSH2 in hereditary nonpolyposis colorectal cancer (HNPCC) families. Genet Test 2005;9:138-46. [PMID: 15943554 DOI: 10.1089/gte.2005.9.138] [Cited by in Crossref: 42] [Cited by in F6Publishing: 45] [Article Influence: 2.5] [Reference Citation Analysis]
|
| 504 |
Belvederesi L, Bianchi F, Loretelli C, Gagliardini D, Galizia E, Bracci R, Rosati S, Bearzi I, Viel A, Cellerino R, Porfiri E. Assessing the pathogenicity of MLH1 missense mutations in patients with suspected hereditary nonpolyposis colorectal cancer: correlation with clinical, genetic and functional features. Eur J Hum Genet 2006;14:853-9. [DOI: 10.1038/sj.ejhg.5201628] [Cited by in Crossref: 24] [Cited by in F6Publishing: 24] [Article Influence: 1.4] [Reference Citation Analysis]
|
| 505 |
Olschwang S, Bonaïti-Pellié C, Feingold J, Frébourg T, Grandjouan S, Lasset C, Laurent-Puig P, Lecuru F, Millat B, Sobol H, Thomas G, Eisinger F. [Identification and management of HNPCC syndrome (hereditary non polyposis colon cancer), hereditary predisposition to colorectal and endometrial adenocarcinomas]. Pathol Biol (Paris) 2006;54:215-29. [PMID: 16677780 DOI: 10.1016/j.patbio.2006.02.008] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 0.2] [Reference Citation Analysis]
|
| 506 |
Rodríguez-Moranta F, Castells A, Andreu M, Piñol V, Castellví-Bel S, Alenda C, Llor X, Xicola RM, Jover R, Payá A, Bessa X, Balaguer F, Cubiella J, Argüello L, Morillas JD, Bujanda L; Gastrointestinal Oncology Group of the Spanish Gastroenterological Association. Clinical performance of original and revised Bethesda guidelines for the identification of MSH2/MLH1 gene carriers in patients with newly diagnosed colorectal cancer: proposal of a new and simpler set of recommendations. Am J Gastroenterol 2006;101:1104-11. [PMID: 16696788 DOI: 10.1111/j.1572-0241.2006.00522.x] [Cited by in Crossref: 28] [Cited by in F6Publishing: 31] [Article Influence: 1.6] [Reference Citation Analysis]
|
| 507 |
Brand MI, Church JM. High Risk Premalignant Colorectal Conditions. Surgical Oncology. [DOI: 10.1007/0-387-21701-0_38] [Cited by in Crossref: 1] [Article Influence: 0.1] [Reference Citation Analysis]
|
| 508 |
Söreide K, Janssen EA, Söiland H, Körner H, Baak JP. Microsatellite instability in colorectal cancer. Br J Surg. 2006;93:395-406. [PMID: 16555243 DOI: 10.1002/bjs.5328] [Cited by in Crossref: 169] [Cited by in F6Publishing: 184] [Article Influence: 9.9] [Reference Citation Analysis]
|
| 509 |
Schiemann U, Gunther S, Gross M, Henke G, Muller-Koch Y, Konig A, Muders M, Folwaczny C, Mussack T, Holinski-Feder E. Preoperative serum levels of the carcinoembryonic antigen in hereditary non-polyposis colorectal cancer compared to levels in sporadic colorectal cancer. Cancer Detect Prev. 2005;29:356-360. [PMID: 16122885 DOI: 10.1016/j.cdp.2005.04.003] [Cited by in Crossref: 9] [Cited by in F6Publishing: 12] [Article Influence: 0.5] [Reference Citation Analysis]
|
| 510 |
Bandipalliam P. Syndrome of early onset colon cancers, hematologic malignancies & features of neurofibromatosis in HNPCC families with homozygous mismatch repair gene mutations. Fam Cancer 2005;4:323-33. [PMID: 16341812 DOI: 10.1007/s10689-005-8351-6] [Cited by in Crossref: 77] [Cited by in F6Publishing: 62] [Article Influence: 4.5] [Reference Citation Analysis]
|
| 511 |
Chan RC, Katelaris PH, Stewart P, Lin BP. Small bowel adenocarcinoma with high levels of microsatellite instability in Crohn’s disease. Hum Pathol. 2006;37:631-634. [PMID: 16647963 DOI: 10.1016/j.humpath.2005.12.013] [Cited by in Crossref: 11] [Cited by in F6Publishing: 11] [Article Influence: 0.6] [Reference Citation Analysis]
|
| 512 |
Lawes D, Pearson T, Sengupta S, Boulos P. Is MSI-H of value in predicting the development of metachronous colorectal cancer? European Journal of Cancer 2006;42:473-6. [DOI: 10.1016/j.ejca.2005.11.019] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 0.5] [Reference Citation Analysis]
|
| 513 |
Ricciardiello L, Boland CR. Lynch syndrome (hereditary non-polyposis colorectal cancer): current concepts and approaches to management. Curr Gastroenterol Rep 2005;7:412-20. [PMID: 16168241 DOI: 10.1007/s11894-005-0012-2] [Cited by in Crossref: 11] [Cited by in F6Publishing: 12] [Article Influence: 0.6] [Reference Citation Analysis]
|
| 514 |
Soliman PT, Broaddus RR, Schmeler KM, Daniels MS, Gonzalez D, Slomovitz BM, Gershenson DM, Lu KH. Women with synchronous primary cancers of the endometrium and ovary: do they have Lynch syndrome? J Clin Oncol 2005;23:9344-50. [PMID: 16361634 DOI: 10.1200/JCO.2005.03.5915] [Cited by in Crossref: 76] [Cited by in F6Publishing: 82] [Article Influence: 4.5] [Reference Citation Analysis]
|
| 515 |
Gruber SB. New developments in Lynch syndrome (hereditary nonpolyposis colorectal cancer) and mismatch repair gene testing. Gastroenterology 2006;130:577-87. [PMID: 16472609 DOI: 10.1053/j.gastro.2006.01.031] [Cited by in Crossref: 45] [Cited by in F6Publishing: 49] [Article Influence: 2.6] [Reference Citation Analysis]
|
| 516 |
Abdel-Rahman WM, Mecklin JP, Peltomäki P. The genetics of HNPCC: application to diagnosis and screening. Crit Rev Oncol Hematol. 2006;58:208-220. [PMID: 16434208 DOI: 10.1016/j.critrevonc.2005.11.001] [Cited by in Crossref: 70] [Cited by in F6Publishing: 77] [Article Influence: 4.1] [Reference Citation Analysis]
|
| 517 |
Mangold E, Pagenstecher C, Friedl W, Fischer HP, Merkelbach-Bruse S, Ohlendorf M, Friedrichs N, Aretz S, Buettner R, Propping P. Tumours from MSH2 mutation carriers show loss of MSH2 expression but many tumours from MLH1 mutation carriers exhibit weak positive MLH1 staining. J Pathol. 2005;207:385-395. [PMID: 16216036 DOI: 10.1002/path.1858] [Cited by in Crossref: 77] [Cited by in F6Publishing: 78] [Article Influence: 4.5] [Reference Citation Analysis]
|
| 518 |
Olschwang S, Eisinger F. Prédisposition héréditaire au cancer colorectal et inactivation de la fonction de réparation des mésappariements de l'ADN. EMC - Gastro-entérologie 2006;1:1-6. [DOI: 10.1016/s1155-1968(05)38974-7] [Reference Citation Analysis]
|
| 519 |
Bumm R, Harder F. Kolon. Chirurgie 2006. [DOI: 10.1007/978-3-540-30639-9_70] [Reference Citation Analysis]
|
| 520 |
Rodriguez-bigas MA, Chang GJ, Skibber JM. Surgical Implications of Colorectal Cancer Genetics. Surgical Oncology Clinics of North America 2006;15:51-66. [DOI: 10.1016/j.soc.2005.08.002] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 0.4] [Reference Citation Analysis]
|
| 521 |
Engel C, Forberg J, Holinski-Feder E, Pagenstecher C, Plaschke J, Kloor M, Poremba C, Pox CP, Rüschoff J, Keller G. Novel strategy for optimal sequential application of clinical criteria, immunohistochemistry and microsatellite analysis in the diagnosis of hereditary nonpolyposis colorectal cancer. Int J Cancer. 2006;118:115-122. [PMID: 16003745 DOI: 10.1002/ijc.21313] [Cited by in Crossref: 71] [Cited by in F6Publishing: 76] [Article Influence: 3.9] [Reference Citation Analysis]
|
| 522 |
Raab R, Lang H. Kolon - Rektum. Pichlmayrs Chirurgische Therapie. [DOI: 10.1007/3-540-29184-9_17] [Reference Citation Analysis]
|
| 523 |
Vasen HF. Clinical description of the Lynch syndrome [hereditary nonpolyposis colorectal cancer (HNPCC)]. Fam Cancer 2005;4:219-25. [PMID: 16136381 DOI: 10.1007/s10689-004-3906-5] [Cited by in Crossref: 72] [Cited by in F6Publishing: 62] [Article Influence: 4.0] [Reference Citation Analysis]
|
| 524 |
Boland CR. Evolution of the nomenclature for the hereditary colorectal cancer syndromes. Fam Cancer 2005;4:211-8. [PMID: 16136380 DOI: 10.1007/s10689-004-4489-x] [Cited by in Crossref: 98] [Cited by in F6Publishing: 81] [Article Influence: 5.4] [Reference Citation Analysis]
|
| 525 |
Bermejo JL, Eng C, Hemminki K. Cancer characteristics in Swedish families fulfilling criteria for hereditary nonpolyposis colorectal cancer. Gastroenterology 2005;129:1889-99. [PMID: 16344057 DOI: 10.1053/j.gastro.2005.09.012] [Cited by in Crossref: 35] [Cited by in F6Publishing: 38] [Article Influence: 1.9] [Reference Citation Analysis]
|
| 526 |
Rajkumar T, Soumittra N, Vidubala E, Sridevi V, Mahajan V, Ramanan S, Vijaya S. Organization and running of the first comprehensive hereditary cancer clinic in India. Hered Cancer Clin Pract 2005;3:165-70. [PMID: 20223043 DOI: 10.1186/1897-4287-3-4-165] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
|
| 527 |
Shu Z, Yanqin H, Ying Y. Hereditary colorectal cancer in china. Hered Cancer Clin Pract 2005;3:155-64. [PMID: 20223042 DOI: 10.1186/1897-4287-3-4-155] [Cited by in Crossref: 5] [Cited by in F6Publishing: 7] [Article Influence: 0.3] [Reference Citation Analysis]
|
| 528 |
Dovrat S, Figer A, Fidder HH, Neophytou P, Fireman Z, Geva R, Zidan J, Flex D, Meir SB, Friedman E. Mutational analysis of hMsh6 in Israeli HNPCC and HNPCC-like Families. Familial Cancer 2005;4:291-4. [DOI: 10.1007/s10689-005-1255-7] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 0.4] [Reference Citation Analysis]
|
| 529 |
Rädle J, Trojan J, Zeuzem S. Hereditäres nichtpolypöses kolorektales Karzinom (HNPCC). Therapie gastroenterologischer Krankheiten. [DOI: 10.1007/3-540-26660-7_31] [Reference Citation Analysis]
|
| 530 |
Schmiegel WH, Bechstein WO. Kolorektales Karzinom. Therapie gastroenterologischer Krankheiten. [DOI: 10.1007/3-540-26660-7_32] [Reference Citation Analysis]
|
| 531 |
Chow E, Macrae F, Burn J; respondents from 18 international ICG-HNPCC Familial Cancer Clinics. Survey of HNPCC Management Analysis of Responses from 18 International Cancer Centres. Hered Cancer Clin Pract 2005;3:137-46. [PMID: 20223040 DOI: 10.1186/1897-4287-3-4-137] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
|
| 532 |
Abajo AS, Hoya ML, Tosar A, Godino J, Fernández JM, Asenjo JL, Villamil BP, Segura PP, Diaz-Rubio E, Caldes T. Low prevalence of germline hMSH6 mutations in colorectal cancer families from Spain. World J Gastroenterol 2005; 11(37): 5770-5776 [PMID: 16270383 DOI: 10.3748/wjg.v11.i37.5770] [Cited by in CrossRef: 16] [Cited by in F6Publishing: 16] [Article Influence: 0.9] [Reference Citation Analysis]
|
| 533 |
Wolf B, Gruber S, Henglmueller S, Kappel S, Bergmann M, Wrba F, Karner-hanusch J. Efficiency of the revised Bethesda guidelines (2003) for the detection of mutations in mismatch repair genes in Austrian HNPCC patients. Int J Cancer 2006;118:1465-70. [DOI: 10.1002/ijc.21524] [Cited by in Crossref: 20] [Cited by in F6Publishing: 21] [Article Influence: 1.1] [Reference Citation Analysis]
|
| 534 |
Marzo Castillejo M, Piñol V, Mascort J, Piqué Badia J. Estrategias de cribado en el cáncer colorrectal. FMC - Formación Médica Continuada en Atención Primaria 2005;12:527-535. [DOI: 10.1016/s1134-2072(05)71241-x] [Reference Citation Analysis]
|
| 535 |
Lawes DA, Pearson T, Sengupta S, Boulos PB. The role of MLH1, MSH2 and MSH6 in the development of multiple colorectal cancers. Br J Cancer. 2005;93:472-477. [PMID: 16106253 DOI: 10.1038/sj.bjc.6602708] [Cited by in Crossref: 41] [Cited by in F6Publishing: 45] [Article Influence: 2.3] [Reference Citation Analysis]
|
| 536 |
Thomas BC, Thibodeau SN, Lindor NM. Clinical significance of tumor microsatellite instability and immunohistochemistry for mismatch repair deficiency in colorectal cancers. Curr colorectal cancer rep 2005;1:103-109. [DOI: 10.1007/s11888-005-0006-3] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
|
| 537 |
Jatoi I, Anderson WF. Cancer Screening. Current Problems in Surgery 2005;42:620-82. [DOI: 10.1067/j.cpsurg.2005.06.003] [Cited by in Crossref: 13] [Cited by in F6Publishing: 15] [Article Influence: 0.7] [Reference Citation Analysis]
|
| 538 |
Southey MC, Jenkins MA, Mead L, Whitty J, Trivett M, Tesoriero AA, Smith LD, Jennings K, Grubb G, Royce SG. Use of molecular tumor characteristics to prioritize mismatch repair gene testing in early-onset colorectal cancer. J Clin Oncol. 2005;23:6524-6532. [PMID: 16116158 DOI: 10.1200/jco.2005.04.671] [Cited by in Crossref: 154] [Cited by in F6Publishing: 168] [Article Influence: 8.6] [Reference Citation Analysis]
|
| 539 |
Stormorken AT, Bowitz-Lothe IM, Norèn T, Kure E, Aase S, Wijnen J, Apold J, Heimdal K, Møller P. Immunohistochemistry identifies carriers of mismatch repair gene defects causing hereditary nonpolyposis colorectal cancer. J Clin Oncol. 2005;23:4705-4712. [PMID: 16034045 DOI: 10.1200/jco.2005.05.180] [Cited by in Crossref: 29] [Cited by in F6Publishing: 34] [Article Influence: 1.6] [Reference Citation Analysis]
|
| 540 |
Merkelbach-bruse S, Büttner R. Molekulare Diagnostik bei nicht-hämatologischen malignen Erkrankungen. Onkologe 2005;11:873-888. [DOI: 10.1007/s00761-005-0917-2] [Reference Citation Analysis]
|
| 541 |
Krüger S, Silber A, Engel C, Görgens H, Mangold E, Pagenstecher C, Holinski-feder E, von Knebel Doeberitz M, Moeslein G, Dietmaier W, Stemmler S, Friedl W, Rüschoff J, Schackert HK. Arg462Gln sequence variation in the prostate-cancer-susceptibility gene RNASEL and age of onset of hereditary non-polyposis colorectal cancer: a case-control study. The Lancet Oncology 2005;6:566-72. [DOI: 10.1016/s1470-2045(05)70253-9] [Cited by in Crossref: 41] [Cited by in F6Publishing: 43] [Article Influence: 2.3] [Reference Citation Analysis]
|
| 542 |
Schmeler KM, Soliman PT, Sun CC, Slomovitz BM, Gershenson DM, Lu KH. Endometrial cancer in young, normal-weight women. Gynecol Oncol 2005;99:388-92. [PMID: 16051336 DOI: 10.1016/j.ygyno.2005.06.029] [Cited by in Crossref: 56] [Cited by in F6Publishing: 41] [Article Influence: 3.1] [Reference Citation Analysis]
|
| 543 |
Rowley PT. Inherited susceptibility to colorectal cancer. Annu Rev Med 2005;56:539-54. [PMID: 15660526 DOI: 10.1146/annurev.med.56.061704.135235] [Cited by in Crossref: 61] [Cited by in F6Publishing: 66] [Article Influence: 3.4] [Reference Citation Analysis]
|
| 544 |
Castellví-bel S, Castells A. Técnicas de genética y biología molecular para el análisis del cáncer colorrectal hereditario. Gastroenterología y Hepatología 2005;28:354-60. [DOI: 10.1157/13076354] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.1] [Reference Citation Analysis]
|
| 545 |
Olschwang S, Eisinger F. Prédisposition héréditaire au cancer colorectal et inactivation de la fonction de réparation des mésappariements de l'ADN. EMC - Hépato-Gastroenterologie 2005;2:214-22. [DOI: 10.1016/j.emchg.2005.03.002] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
|
| 546 |
Young Y, Terdiman JP. Endoscopic management of familial colonic neoplasia. Gastrointest Endosc Clin N Am 2005;15:549-80, ix-x. [PMID: 15990057 DOI: 10.1016/j.giec.2005.03.007] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 0.2] [Reference Citation Analysis]
|
| 547 |
Domingo E, Niessen RC, Oliveira C, Alhopuro P, Moutinho C, Espín E, Armengol M, Sijmons RH, Kleibeuker JH, Seruca R, Aaltonen LA, Imai K, Yamamoto H, Schwartz S Jr, Hofstra RM. BRAF-V600E is not involved in the colorectal tumorigenesis of HNPCC in patients with functional MLH1 and MSH2 genes. Oncogene 2005;24:3995-8. [PMID: 15782118 DOI: 10.1038/sj.onc.1208569] [Cited by in Crossref: 116] [Cited by in F6Publishing: 125] [Article Influence: 6.4] [Reference Citation Analysis]
|
| 548 |
Macrae F, Harris M. Re: Revised Bethesda Guidelines for Hereditary Nonpolyposis Colorectal Cancer (Lynch Syndrome) and Microsatellite Instability. JNCI: Journal of the National Cancer Institute 2005;97:936-7. [DOI: 10.1093/jnci/dji157] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 0.3] [Reference Citation Analysis]
|
| 549 |
Merg A, Lynch HT, Lynch JF, Howe JR. Hereditary colorectal cancer-part II. Curr Probl Surg 2005;42:267-333. [PMID: 15900295 DOI: 10.1067/j.cpsurg.2005.02.003] [Cited by in Crossref: 26] [Cited by in F6Publishing: 28] [Article Influence: 1.4] [Reference Citation Analysis]
|
| 550 |
Buckowitz A, Knaebel HP, Benner A, Bläker H, Gebert J, Kienle P, von Knebel Doeberitz M, Kloor M. Microsatellite instability in colorectal cancer is associated with local lymphocyte infiltration and low frequency of distant metastases. Br J Cancer. 2005;92:1746-1753. [PMID: 15856045 DOI: 10.1038/sj.bjc.6602534] [Cited by in Crossref: 177] [Cited by in F6Publishing: 192] [Article Influence: 9.8] [Reference Citation Analysis]
|
| 551 |
Fidder HH, Figer A, Geva R, Flex D, Schayek H, Avidan B, Meir SB, Friedman E. Genetic analyses in consecutive israeli jewish colorectal cancer patients. Am J Gastroenterol 2005;100:1376-80. [PMID: 15929773 DOI: 10.1111/j.1572-0241.2005.41580.x] [Cited by in Crossref: 13] [Cited by in F6Publishing: 13] [Article Influence: 0.7] [Reference Citation Analysis]
|
| 552 |
Coura RDS, Ashton-prolla P, Prolla JC. Hereditary non-polipomatous colorectal cancer: hereditary predisposition, diagnosis and prevention. Arq Gastroenterol 2005;42:99-106. [DOI: 10.1590/s0004-28032005000200007] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.1] [Reference Citation Analysis]
|
| 553 |
Bonaïti-pellié C, Eisinger F, Feingold J, Frébourg T, Grandjouan S, Lasset C, Laurent-puig P, Lecuru F, Millat B, Sobol H, Thomas G, Olschwang S. Prédispositions héréditaires au cancer colorectal. Gastroentérologie Clinique et Biologique 2005;29:701-10. [DOI: 10.1016/s0399-8320(05)82159-1] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 0.2] [Reference Citation Analysis]
|
| 554 |
Guimbaud R. Indications et intérêts de la consultation d’oncogénétique. Gastroentérologie Clinique et Biologique 2005;29:711-714. [DOI: 10.1016/s0399-8320(05)82160-8] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 0.2] [Reference Citation Analysis]
|
| 555 |
Woerner SM, Kloor M, Mueller A, Rueschoff J, Friedrichs N, Buettner R, Buzello M, Kienle P, Knaebel HP, Kunstmann E. Microsatellite instability of selective target genes in HNPCC-associated colon adenomas. Oncogene. 2005;24:2525-2535. [PMID: 15735733 DOI: 10.1038/sj.onc.1208456] [Cited by in Crossref: 67] [Cited by in F6Publishing: 71] [Article Influence: 3.7] [Reference Citation Analysis]
|
| 556 |
Rowley PT. Screening for an inherited susceptibility to colorectal cancer. Genet Test 2004;8:421-30. [PMID: 15684875 DOI: 10.1089/gte.2004.8.421] [Cited by in Crossref: 9] [Cited by in F6Publishing: 10] [Article Influence: 0.5] [Reference Citation Analysis]
|
| 557 |
Domingo E, Laiho P, Ollikainen M, Pinto M, Wang L, French AJ, Westra J, Frebourg T, Espín E, Armengol M. BRAF screening as a low-cost effective strategy for simplifying HNPCC genetic testing. J Med Genet. 2004;41:664-668. [PMID: 15342696 DOI: 10.1136/jmg.2004.020651] [Cited by in Crossref: 250] [Cited by in F6Publishing: 268] [Article Influence: 13.9] [Reference Citation Analysis]
|
| 558 |
Burt R, Neklason DW. Genetic testing for inherited colon cancer. Gastroenterology 2005;128:1696-716. [PMID: 15887160 DOI: 10.1053/j.gastro.2005.03.036] [Cited by in Crossref: 107] [Cited by in F6Publishing: 123] [Article Influence: 5.9] [Reference Citation Analysis]
|
| 559 |
Velayos FS, Allen BA, Conrad PG, Gum J Jr, Kakar S, Chung DC, Truta B, Sleisenger MH, Kim YS, Terdiman JP. Low rate of microsatellite instability in young patients with adenomas: reassessing the Bethesda guidelines. Am J Gastroenterol 2005;100:1143-9. [PMID: 15842591 DOI: 10.1111/j.1572-0241.2005.40862.x] [Cited by in Crossref: 39] [Cited by in F6Publishing: 33] [Article Influence: 2.2] [Reference Citation Analysis]
|
| 560 |
Stoffel EM, Syngal S. Adenomas in young patients: what is the optimal evaluation? Am J Gastroenterol 2005;100:1150-3. [PMID: 15842592 DOI: 10.1111/j.1572-0241.2005.41967.x] [Cited by in Crossref: 19] [Cited by in F6Publishing: 18] [Article Influence: 1.1] [Reference Citation Analysis]
|
| 561 |
Worthley DL, Walsh MD, Barker M, Ruszkiewicz A, Bennett G, Phillips K, Suthers G. Familial mutations in PMS2 can cause autosomal dominant hereditary nonpolyposis colorectal cancer. Gastroenterology 2005;128:1431-6. [PMID: 15887124 DOI: 10.1053/j.gastro.2005.04.008] [Cited by in Crossref: 51] [Cited by in F6Publishing: 56] [Article Influence: 2.8] [Reference Citation Analysis]
|
| 562 |
Müller A, Giuffre G, Edmonston TB, Mathiak M, Roggendorf B, Heinmöller E, Brodegger T, Tuccari G, Mangold E, Buettner R, Rüschoff J; German HNPCC Consortium German Cancer Aid (Deutsche Krebshilfe). Challenges and pitfalls in HNPCC screening by microsatellite analysis and immunohistochemistry. J Mol Diagn 2004;6:308-15. [PMID: 15507669 DOI: 10.1016/S1525-1578(10)60526-0] [Cited by in Crossref: 44] [Cited by in F6Publishing: 46] [Article Influence: 2.4] [Reference Citation Analysis]
|
| 563 |
Schneider KA, Branda KJ, Chittenden AB, Shannon KM. Cancer genetics. Encyclopedia of Genetics, Genomics, Proteomics and Bioinformatics 2005. [DOI: 10.1002/047001153x.g106420] [Reference Citation Analysis]
|
| 564 |
Soliman PT, Oh JC, Schmeler KM, Sun CC, Slomovitz BM, Gershenson DM, Burke TW, Lu KH. Risk factors for young premenopausal women with endometrial cancer. Obstet Gynecol. 2005;105:575-580. [PMID: 15738027 DOI: 10.1097/01.aog.0000154151.14516.f7] [Cited by in Crossref: 216] [Cited by in F6Publishing: 225] [Article Influence: 12.0] [Reference Citation Analysis]
|
| 565 |
Terdiman JP. Colorectal cancer at a young age. Gastroenterology 2005;128:1067-76. [PMID: 15825087 DOI: 10.1053/j.gastro.2005.02.055] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 0.3] [Reference Citation Analysis]
|
| 566 |
Guerrero D, Balen E, Martínez-peñuela JM, García-foncillas J, Larrinaga B, Cristina Caballero M, Herrera J, Miguel Lera J. Asociación entre la inestabilidad de microsatélites y las características clínicas y anatomopatológicas en pacientes con cáncer de colon esporádico. Medicina Clínica 2005;124:441-6. [DOI: 10.1157/13073216] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.1] [Reference Citation Analysis]
|
| 567 |
Strate LL, Syngal S. Hereditary colorectal cancer syndromes. Cancer Causes Control 2005;16:201-13. [DOI: 10.1007/s10552-004-3488-4] [Cited by in Crossref: 78] [Cited by in F6Publishing: 66] [Article Influence: 4.3] [Reference Citation Analysis]
|
| 568 |
Apessos A, Mihalatos M, Danielidis I, Kallimanis G, Agnantis NJ, Triantafillidis JK, Fountzilas G, Kosmidis PA, Razis E, Georgoulias VA. hMSH2 is the most commonly mutated MMR gene in a cohort of Greek HNPCC patients. Br J Cancer. 2005;92:396-404. [PMID: 15655560 DOI: 10.1038/sj.bjc.6602260] [Cited by in Crossref: 13] [Cited by in F6Publishing: 13] [Article Influence: 0.7] [Reference Citation Analysis]
|
| 569 |
Abdel-Rahman WM, Ollikainen M, Kariola R, Järvinen HJ, Mecklin JP, Nyström-Lahti M, Knuutila S, Peltomäki P. Comprehensive characterization of HNPCC-related colorectal cancers reveals striking molecular features in families with no germline mismatch repair gene mutations. Oncogene. 2005;24:1542-1551. [PMID: 15674332 DOI: 10.1038/sj.onc.1208387] [Cited by in Crossref: 61] [Cited by in F6Publishing: 71] [Article Influence: 3.4] [Reference Citation Analysis]
|
| 570 |
Jo WS, Chung DC. Genetics of hereditary colorectal cancer. Semin Oncol 2005;32:11-23. [PMID: 15726502 DOI: 10.1053/j.seminoncol.2004.09.034] [Cited by in Crossref: 38] [Cited by in F6Publishing: 41] [Article Influence: 2.1] [Reference Citation Analysis]
|
| 571 |
Castells A, Marzo M, Bellas B, Amador FJ, Lanas A, Mascort JJ, Ferrándiz J, Alonso P, Piñol V, Fernández M, Bonfill X, Piqué JM. [Clinical guidelines for the prevention of colorectal cancer]. Gastroenterol Hepatol 2004;27:573-634. [PMID: 15574281 DOI: 10.1016/s0210-5705(03)70535-4] [Cited by in Crossref: 1] [Cited by in F6Publishing: 4] [Article Influence: 0.1] [Reference Citation Analysis]
|
| 572 |
Schulmann K, Brasch FE, Kunstmann E, Engel C, Pagenstecher C, Vogelsang H, Krüger S, Vogel T, Knaebel HP, Rüschoff J, Hahn SA, Knebel-Doeberitz MV, Moeslein G, Meltzer SJ, Schackert HK, Tympner C, Mangold E, Schmiegel W; German HNPCC Consortium. HNPCC-associated small bowel cancer: clinical and molecular characteristics. Gastroenterology 2005;128:590-9. [PMID: 15765394 DOI: 10.1053/j.gastro.2004.12.051] [Cited by in Crossref: 142] [Cited by in F6Publishing: 145] [Article Influence: 7.9] [Reference Citation Analysis]
|
| 573 |
Schroy PC 3rd, Glick JT, Geller AC, Jackson A, Heeren T, Prout M. A novel educational strategy to enhance internal medicine residents' familial colorectal cancer knowledge and risk assessment skills. Am J Gastroenterol 2005;100:677-84. [PMID: 15743368 DOI: 10.1111/j.1572-0241.2005.41336.x] [Cited by in Crossref: 21] [Cited by in F6Publishing: 26] [Article Influence: 1.2] [Reference Citation Analysis]
|
| 574 |
Zhou X, Iversen ES Jr, Parmigiani G. Classification of Missense Mutations of Disease Genes. J Am Stat Assoc 2005;100:51-60. [PMID: 18418466 DOI: 10.1198/016214504000001817] [Cited by in Crossref: 14] [Cited by in F6Publishing: 15] [Article Influence: 0.8] [Reference Citation Analysis]
|
| 575 |
Lynch HT, Cristofaro G, Rozen P, Vasen H, Lynch P, Mecklin J, John JS. History of the International Collaborative Group on Hereditary NonPolyposis Colorectal Cancer. Familial Cancer 2005;4:3-5. [DOI: 10.1007/s10689-005-4149-9] [Reference Citation Analysis]
|
| 576 |
Velayos FS, Lee SH, Qiu H, Dykes S, Yiu R, Terdiman JP, Garcia-Aguilar J. The mechanism of microsatellite instability is different in synchronous and metachronous colorectal cancer. J Gastrointest Surg 2005;9:329-35. [PMID: 15749592 DOI: 10.1016/j.gassur.2004.05.007] [Cited by in Crossref: 18] [Cited by in F6Publishing: 21] [Article Influence: 1.0] [Reference Citation Analysis]
|
| 577 |
Guillem JG, Moore HG, Palmer C, Glogowski E, Finch R, Nafa K, Markowitz AJ, Offit K, Ellis NA. A636P testing in Ashkenazi Jews. Fam Cancer 2004;3:223-7. [PMID: 15516845 DOI: 10.1007/s10689-004-0899-z] [Cited by in Crossref: 5] [Cited by in F6Publishing: 6] [Article Influence: 0.3] [Reference Citation Analysis]
|
| 578 |
Shia J, Klimstra DS, Nafa K, Offit K, Guillem JG, Markowitz AJ, Gerald WL, Ellis NA. Value of immunohistochemical detection of DNA mismatch repair proteins in predicting germline mutation in hereditary colorectal neoplasms. Am J Surg Pathol. 2005;29:96-104. [PMID: 15613860 DOI: 10.1097/01.pas.0000146009.85309.3b] [Cited by in Crossref: 110] [Cited by in F6Publishing: 114] [Article Influence: 6.1] [Reference Citation Analysis]
|
| 579 |
Olschwang S, Bonaïti C, Feingold J, Frébourg T, Grandjouan S, Lasset C, Laurent-puig P, Lecuru F, Millat B, Sobol H, Thomas G, Eisinger F. Le syndrome HNPCC (hereditary non polyposis colon cancer) : identification et prise en charge. La Revue de Médecine Interne 2005;26:109-18. [DOI: 10.1016/j.revmed.2004.06.004] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.2] [Reference Citation Analysis]
|
| 580 |
Garber JE, Offit K. Hereditary cancer predisposition syndromes. J Clin Oncol. 2005;23:276-292. [PMID: 15637391 DOI: 10.1200/jco.2005.10.042] [Cited by in Crossref: 375] [Cited by in F6Publishing: 402] [Article Influence: 20.8] [Reference Citation Analysis]
|
| 581 |
Kouraklis G, Misiakos EP. Hereditary nonpolyposis colorectal cancer (Lynch syndrome): criteria for identification and management. Dig Dis Sci 2005;50:336-44. [PMID: 15745097 DOI: 10.1007/s10620-005-1607-z] [Cited by in Crossref: 14] [Cited by in F6Publishing: 16] [Article Influence: 0.8] [Reference Citation Analysis]
|
| 582 |
Huang D, Chen C, Sun W, Strom CM, Bender RA. High-throughput gene sequencing assay development for hereditary nonpolyposis colon cancer. Clin Colorectal Cancer. 2004;4:275-279. [PMID: 15555211 DOI: 10.3816/ccc.2004.n.027] [Cited by in Crossref: 9] [Cited by in F6Publishing: 10] [Article Influence: 0.5] [Reference Citation Analysis]
|
| 583 |
Lipton LR, Johnson V, Cummings C, Fisher S, Risby P, Eftekhar Sadat AT, Cranston T, Izatt L, Sasieni P, Hodgson SV, Thomas HJ, Tomlinson IP. Refining the Amsterdam Criteria and Bethesda Guidelines: testing algorithms for the prediction of mismatch repair mutation status in the familial cancer clinic. J Clin Oncol 2004;22:4934-43. [PMID: 15611508 DOI: 10.1200/JCO.2004.11.084] [Cited by in Crossref: 73] [Cited by in F6Publishing: 80] [Article Influence: 4.1] [Reference Citation Analysis]
|
| 584 |
Church JM. MOLECULAR GENETICS OF COLORECTAL CANCER. Current Therapy in Colon and Rectal Surgery 2005. [DOI: 10.1016/b978-1-55664-480-1.50064-2] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
|
| 585 |
Somoano B, Niendorf KB, Tsao H. Hereditary cancer syndromes of the skin. Clinics in Dermatology 2005;23:85-106. [DOI: 10.1016/j.clindermatol.2004.09.012] [Cited by in Crossref: 13] [Cited by in F6Publishing: 7] [Article Influence: 0.7] [Reference Citation Analysis]
|
| 586 |
Syngal S, Bandipalliam P, Boland CR. Surveillance of patients at high risk for colorectal cancer. Med Clin North Am 2005;89:61-84, vii-viii. [PMID: 15527809 DOI: 10.1016/j.mcna.2004.08.013] [Cited by in Crossref: 7] [Cited by in F6Publishing: 8] [Article Influence: 0.4] [Reference Citation Analysis]
|
| 587 |
Mangold E, Pagenstecher C, Friedl W, Mathiak M, Buettner R, Engel C, Loeffler M, Holinski-feder E, Müller-koch Y, Keller G, Schackert HK, Krüger S, Goecke T, Moeslein G, Kloor M, Gebert J, Kunstmann E, Schulmann K, Rüschoff J, Propping P; the German HNPCC Consortium. Spectrum and frequencies of mutations inMSH2 andMLH1 identified in 1,721 German families suspected of hereditary nonpolyposis colorectal cancer. Int J Cancer 2005;116:692-702. [DOI: 10.1002/ijc.20863] [Cited by in Crossref: 95] [Cited by in F6Publishing: 96] [Article Influence: 5.3] [Reference Citation Analysis]
|
| 588 |
Mckenzie S, Pierce H, Hanna N. Hereditary Nonpolyposis Colorectal Cancer (HNPCC) Syndrome. Encyclopedia of Medical Genomics and Proteomics 2004. [DOI: 10.3109/9780203997352.125] [Reference Citation Analysis]
|
| 589 |
Miquel C, Sabourin J, Elias D, Grandjouan S, Viguier J, Ducreux M, Duvillard P, Praz F. An appendix carcinoid tumor in a patient with hereditary nonpolyposis colorectal cancer. Human Pathology 2004;35:1564-7. [DOI: 10.1016/j.humpath.2004.09.017] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 0.4] [Reference Citation Analysis]
|
| 590 |
McGivern A, Wynter CV, Whitehall VL, Kambara T, Spring KJ, Walsh MD, Barker MA, Arnold S, Simms LA, Leggett BA. Promoter hypermethylation frequency and BRAF mutations distinguish hereditary non-polyposis colon cancer from sporadic MSI-H colon cancer. Fam Cancer. 2004;3:101-107. [PMID: 15340260 DOI: 10.1023/b:fame.0000039861.30651.c8] [Cited by in Crossref: 150] [Cited by in F6Publishing: 157] [Article Influence: 7.9] [Reference Citation Analysis]
|
| 591 |
Palmirotta R, Matera S, Curia MC, Aceto G, el Zhobi B, Verginelli F, Guadagni F, Casale V, Stigliano V, Messerini L, Mariani-Costantini R, Battista P, Cama A. Correlations between phenotype and microsatellite instability in HNPCC: implications for genetic testing. Fam Cancer 2004;3:117-21. [PMID: 15340262 DOI: 10.1023/B:FAME.0000039864.19083.3a] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 0.4] [Reference Citation Analysis]
|
| 592 |
Baudi F, Fersini G, Lavecchia A, Terracciano R, Leone F, Quaresima B, Faniello MC, De Paola L, Doldo P, Cuda G, Costanzo F, Venuta S. A novel missense germline mutation in exon 2 of the hMSH2 gene in a HNPCC family from Southern Italy. Cancer Lett 2005;223:285-91. [PMID: 15896463 DOI: 10.1016/j.canlet.2004.09.051] [Cited by in Crossref: 7] [Cited by in F6Publishing: 9] [Article Influence: 0.4] [Reference Citation Analysis]
|
| 593 |
Pigatto F, Bateman A, Bunyan D, Strike P, Wilkins E, Curtis C, Duncan P, May D, Nugent K, Eccles D. Economic and Practical Factors in Diagnosing HNPCC Using Clinical Criteria, Immunohistochemistry and Microsatellite Instability Analysis. Hered Cancer Clin Pract 2004;2:175-84. [PMID: 20233461 DOI: 10.1186/1897-4287-2-4-175] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 0.3] [Reference Citation Analysis]
|
| 594 |
Kruse R, Ruzicka T. DNA mismatch repair and the significance of a sebaceous skin tumor for visceral cancer prevention. Trends Mol Med 2004;10:136-41. [PMID: 15102357 DOI: 10.1016/j.molmed.2004.01.006] [Cited by in Crossref: 36] [Cited by in F6Publishing: 38] [Article Influence: 1.9] [Reference Citation Analysis]
|
| 595 |
Plaschke J, Engel C, Krüger S, Holinski-Feder E, Pagenstecher C, Mangold E, Moeslein G, Schulmann K, Gebert J, von Knebel Doeberitz M, Rüschoff J, Loeffler M, Schackert HK. Lower incidence of colorectal cancer and later age of disease onset in 27 families with pathogenic MSH6 germline mutations compared with families with MLH1 or MSH2 mutations: the German Hereditary Nonpolyposis Colorectal Cancer Consortium. J Clin Oncol 2004;22:4486-94. [PMID: 15483016 DOI: 10.1200/JCO.2004.02.033] [Cited by in Crossref: 178] [Cited by in F6Publishing: 190] [Article Influence: 9.4] [Reference Citation Analysis]
|
| 596 |
Rothenberger DA, Dalberg DL, Leininger A. Minnesota Colorectal Cancer Initiative: successful development and implementation of a community-based colorectal cancer registry. Dis Colon Rectum 2004;47:1571-7. [PMID: 15540283 DOI: 10.1007/s10350-004-0649-1] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 0.3] [Reference Citation Analysis]
|
| 597 |
Murff HJ, Byrne D, Syngal S. Cancer risk assessment: quality and impact of the family history interview. Am J Prev Med 2004;27:239-45. [PMID: 15450637 DOI: 10.1016/j.amepre.2004.05.003] [Cited by in Crossref: 7] [Cited by in F6Publishing: 42] [Article Influence: 0.4] [Reference Citation Analysis]
|
| 598 |
Lynch HT, Shaw TG, Lynch JF. Inherited predisposition to cancer: a historical overview. Am J Med Genet C Semin Med Genet 2004;129C:5-22. [PMID: 15264268 DOI: 10.1002/ajmg.c.30026] [Cited by in Crossref: 36] [Cited by in F6Publishing: 41] [Article Influence: 1.9] [Reference Citation Analysis]
|
| 599 |
Bliss CM Jr, Schroy PC 3rd. Endoscopic diagnosis and management of hereditary nonpolyposis colorectal cancer. Curr Opin Gastroenterol 2004;20:468-73. [PMID: 15689681 DOI: 10.1097/00001574-200409000-00009] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.2] [Reference Citation Analysis]
|
| 600 |
Grover S, Stoffel EM, Bussone L, Tschoegl E, Syngal S. Physician assessment of family cancer history and referral for genetic evaluation in colorectal cancer patients. Clin Gastroenterol Hepatol 2004;2:813-9. [PMID: 15354282 DOI: 10.1016/s1542-3565(04)00352-0] [Cited by in Crossref: 112] [Cited by in F6Publishing: 120] [Article Influence: 5.9] [Reference Citation Analysis]
|
| 601 |
Locker GY, Lynch HT. Genetic factors and colorectal cancer in Ashkenazi Jews. Familial Cancer 2004;3:215-21. [DOI: 10.1007/s10689-004-9547-x] [Cited by in Crossref: 17] [Cited by in F6Publishing: 17] [Article Influence: 0.9] [Reference Citation Analysis]
|
| 602 |
Suthers G. Genetic testing: a round table conversation. Intern Med J 2004;34:444-5; author reply 446-7. [PMID: 15271186 DOI: 10.1111/j.1444-0903.2004.00642.x] [Reference Citation Analysis]
|
| 603 |
Oliveira Ferreira F, Napoli Ferreira CC, Rossi BM, Toshihiko Nakagawa W, Aguilar S Jr, Monteiro Santos EM, Vierira Costa ML, Lopes A. Frequency of extra-colonic tumors in hereditary nonpolyposis colorectal cancer (HNPCC) and familial colorectal cancer (FCC) Brazilian families: An analysis by a Brazilian Hereditary Colorectal Cancer Institutional Registry. Fam Cancer 2004;3:41-7. [PMID: 15131405 DOI: 10.1023/B:FAME.0000026810.99776.e9] [Cited by in Crossref: 30] [Cited by in F6Publishing: 32] [Article Influence: 1.6] [Reference Citation Analysis]
|
| 604 |
Hendriks YM, Wagner A, Morreau H, Menko F, Stormorken A, Quehenberger F, Sandkuijl L, Møller P, Genuardi M, Van Houwelingen H, Tops C, Van Puijenbroek M, Verkuijlen P, Kenter G, Van Mil A, Meijers-Heijboer H, Tan GB, Breuning MH, Fodde R, Wijnen JT, Bröcker-Vriends AH, Vasen H. Cancer risk in hereditary nonpolyposis colorectal cancer due to MSH6 mutations: impact on counseling and surveillance. Gastroenterology 2004;127:17-25. [PMID: 15236168 DOI: 10.1053/j.gastro.2004.03.068] [Cited by in Crossref: 305] [Cited by in F6Publishing: 319] [Article Influence: 16.1] [Reference Citation Analysis]
|
| 605 |
Ruszkiewicz AR, Jass JR. Microsatellite Instability in Colorectal Cancer: What, How, When, and Why? Pathology Case Reviews 2004;9:163-72. [DOI: 10.1097/01.pcr.0000132991.85133.ef] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
|
| 606 |
Rüschoff J, Roggendorf B, Brasch F, Mathiak M, Aust DE, Plaschke J, Mueller W, Poremba C, Kloor M, Keller G, Muders M, Blasenbreu-Vogt S, Rümmele P, Müller A, Büttner R; Collaborative German Study Group on hereditary colorectal cancer funded by the German Cancer Aid (Deutsche Krebshilfe)]. [Molecular pathology in hereditary colorectal cancer. Recommendations of the Collaborative German Study Group on hereditary colorectal cancer funded by the German Cancer Aid (Deutsche Krebshilfe)]. Pathologe 2004;25:178-92. [PMID: 15138699 DOI: 10.1007/s00292-003-0641-x] [Cited by in Crossref: 8] [Cited by in F6Publishing: 9] [Article Influence: 0.4] [Reference Citation Analysis]
|
| 607 |
Lucci-Cordisco E, Zito I, Gensini F, Genuardi M. Hereditary nonpolyposis colorectal cancer and related conditions. Am J Med Genet A. 2003;122A:325-334. [PMID: 14518071 DOI: 10.1002/ajmg.a.20475] [Cited by in Crossref: 65] [Cited by in F6Publishing: 66] [Article Influence: 3.4] [Reference Citation Analysis]
|
| 608 |
Rajkumar T, Soumittra N, Pandey D, Nancy KN, Mahajan V, Majhi U. Mutation Analysis of hMSH2 and hMLH1 in Colorectal Cancer Patients in India. Genetic Testing 2004;8:157-62. [DOI: 10.1089/gte.2004.8.157] [Cited by in Crossref: 13] [Cited by in F6Publishing: 15] [Article Influence: 0.7] [Reference Citation Analysis]
|
| 609 |
Ramsey SD, Burke W, Clarke L. An economic viewpoint on alternative strategies for identifying persons with hereditary nonpolyposis colorectal cancer. Genet Med 2003;5:353-63. [PMID: 14501830 DOI: 10.1097/01.GIM.0000086626.03082.B5] [Cited by in Crossref: 35] [Cited by in F6Publishing: 39] [Article Influence: 1.8] [Reference Citation Analysis]
|
| 610 |
Sotsky Kent T, Yuan Z, Miller A, Weber TK. Deleted in oral cancer-1 expression upregulates proapoptosis elements in microsatellite-unstable human colorectal cancer. Ann Surg Oncol 2004;11:192-6. [PMID: 14761923 DOI: 10.1245/aso.2004.03.056] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 0.4] [Reference Citation Analysis]
|
| 611 |
Chan TL, Chan YW, Ho JW, Chan C, Chan AS, Chan E, Lam PW, Tse CW, Lee KC, Lau CW, Gwi E, Leung SY, Yuen ST. MSH2 c.1452-1455delAATG is a founder mutation and an important cause of hereditary nonpolyposis colorectal cancer in the southern Chinese population. Am J Hum Genet 2004;74:1035-42. [PMID: 15042510 DOI: 10.1086/383591] [Cited by in Crossref: 30] [Cited by in F6Publishing: 32] [Article Influence: 1.6] [Reference Citation Analysis]
|
| 612 |
Bermejo JL, Büchner F, Hemminki K. Familial risk of endometrial cancer after exclusion of families that fulfilled Amsterdam, Japanese or Bethesda criteria for HNPCC. Annals of Oncology 2004;15:598-604. [DOI: 10.1093/annonc/mdh135] [Cited by in Crossref: 12] [Cited by in F6Publishing: 12] [Article Influence: 0.6] [Reference Citation Analysis]
|
| 613 |
Filippini S, Jankilevich G, Barugel M, Santapá O, Valente S, Roca E, Di Lonardo A. Microsatellite instability detection in hereditary colorectal cancer: is it possible in a public hospital? International Congress Series 2004;1261:505-507. [DOI: 10.1016/s0531-5131(03)01702-3] [Reference Citation Analysis]
|
| 614 |
Fernandez E, Gallus S, La Vecchia C, Talamini R, Negri E, Franceschi S. Family History and Environmental Risk Factors for Colon Cancer. Cancer Epidemiology, Biomarkers & Prevention 2004;13:658-661. [DOI: 10.1158/1055-9965.658.13.4] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 0.2] [Reference Citation Analysis]
|
| 615 |
Umar A, Boland CR, Terdiman JP, Syngal S, de la Chapelle A, Rüschoff J, Fishel R, Lindor NM, Burgart LJ, Hamelin R. Revised Bethesda Guidelines for hereditary nonpolyposis colorectal cancer (Lynch syndrome) and microsatellite instability. J Natl Cancer Inst. 2004;96:261-268. [PMID: 14970275 DOI: 10.1093/jnci/djh034] [Cited by in Crossref: 2154] [Cited by in F6Publishing: 2308] [Article Influence: 113.4] [Reference Citation Analysis]
|
| 616 |
Hampel H, Sweet K, Westman JA, Offit K, Eng C. Referral for cancer genetics consultation: a review and compilation of risk assessment criteria. J Med Genet. 2004;41:81-91. [PMID: 14757853 DOI: 10.1136/jmg.2003.010918] [Cited by in Crossref: 102] [Cited by in F6Publishing: 123] [Article Influence: 5.4] [Reference Citation Analysis]
|
| 617 |
Kievit W, De Bruin J, Adang E, Ligtenberg M, Nagengast F, Van Krieken J, Hoogerbrugge N. Current clinical selection strategies for identification of hereditary non-polyposis colorectal cancer families are inadequate: a meta-analysis: Identification of HNPCC. Clinical Genetics 2004;65:308-16. [DOI: 10.1111/j.1399-0004.2004.00220.x] [Cited by in Crossref: 53] [Cited by in F6Publishing: 55] [Article Influence: 2.8] [Reference Citation Analysis]
|
| 618 |
Umar A, Risinger JI, Hawk ET, Barrett JC. Testing guidelines for hereditary non-polyposis colorectal cancer. Nat Rev Cancer 2004;4:153-8. [PMID: 14964310 DOI: 10.1038/nrc1278] [Cited by in Crossref: 121] [Cited by in F6Publishing: 129] [Article Influence: 6.4] [Reference Citation Analysis]
|
| 619 |
Miyakura Y, Sugano K, Akasu T, Yoshida T, Maekawa M, Saitoh S, Sasaki H, Nomizu T, Konishi F, Fujita S, Moriya Y, Nagai H. Extensive but hemiallelic methylation of the hMLH1 promoter region in early-onset sporadic colon cancers with microsatellite instability. Clin Gastroenterol Hepatol 2004;2:147-56. [PMID: 15017620 DOI: 10.1016/s1542-3565(03)00314-8] [Cited by in Crossref: 74] [Cited by in F6Publishing: 86] [Article Influence: 3.9] [Reference Citation Analysis]
|
| 620 |
Lynch HT, Riley BD, Weissman SM, Coronel SM, Kinarsky Y, Lynch JF, Shaw TG, Rubinstein WS. Hereditary nonpolyposis colorectal carcinoma (HNPCC) and HNPCC-like families: Problems in diagnosis, surveillance, and management. Cancer. 2004;100:53-64. [PMID: 14692024 DOI: 10.1002/cncr.11912] [Cited by in Crossref: 61] [Cited by in F6Publishing: 63] [Article Influence: 3.2] [Reference Citation Analysis]
|
| 621 |
Lynch HT, Cristofaro G, Rozen P, Vasen H, Lynch P, Mecklin JP, St John J. History of the International Collaborative Group on Hereditary Non Polyposis Colorectal Cancer. Fam Cancer 2003;2:3-5. [PMID: 14574154 DOI: 10.1023/a:1025001714023] [Cited by in Crossref: 15] [Cited by in F6Publishing: 16] [Article Influence: 0.8] [Reference Citation Analysis]
|
| 622 |
Yelland JM. Genetic Counseling for Inherited Cancer Syndromes. Inherited Cancer Syndromes 2004. [DOI: 10.1007/0-387-21596-4_2] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
|
| 623 |
Acton RT, Nabell LM. Assessing Genetic Risk of Cancer. Inherited Cancer Syndromes 2004. [DOI: 10.1007/0-387-21596-4_1] [Cited by in Crossref: 1] [Article Influence: 0.1] [Reference Citation Analysis]
|
| 624 |
Bennett M, Clune Y, Shanahan F, O’sullivan G, Collins J. Synbiotics and colon cancer. Functional Foods, Ageing and Degenerative Disease 2004. [DOI: 10.1533/9781855739017.4.524] [Reference Citation Analysis]
|
| 625 |
Tischkowitz M, Hodgson S. Screening Those at High Risk for Colorectal Cancer. Radiology and Imaging of the Colon 2004. [DOI: 10.1007/978-3-642-18834-3_2] [Reference Citation Analysis]
|
| 626 |
Church J, Casey G. The Inherited Syndromes: Familial Adenomatous Polyposis, Hereditary Nonpolyposis Colorectal Cancer, and the Hamartomatous Polyposes. Molecular Genetics of Colorectal Neoplasia 2004. [DOI: 10.1007/978-1-4419-9310-6_9] [Reference Citation Analysis]
|
| 627 |
Piñol V, Andreu M, Castells A, Payá A, Bessa X, Rodrigo J; Gastrointestinal Oncology Group of the Spanish Gastroenterological Association. Frequency of hereditary non-polyposis colorectal cancer and other colorectal cancer familial forms in Spain: a multicentre, prospective, nationwide study. Eur J Gastroenterol Hepatol 2004;16:39-45. [PMID: 15095851 DOI: 10.1097/00042737-200401000-00007] [Cited by in Crossref: 58] [Cited by in F6Publishing: 60] [Article Influence: 3.1] [Reference Citation Analysis]
|
| 628 |
Capellá G, Peinado MA. Genomic Instability, DNA Repair Pathways, and Cancer. Principles of Molecular Oncology 2004. [DOI: 10.1007/978-1-59259-664-5_15] [Reference Citation Analysis]
|
| 629 |
Cullinane CA, Ellenhorn JD, Weitzel JN. Microsatellite instability is a rare finding in tumors of patients with both primary renal and rectal neoplasms. Cancer Genetics and Cytogenetics 2004;148:163-5. [DOI: 10.1016/s0165-4608(03)00275-9] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 0.1] [Reference Citation Analysis]
|
| 630 |
Seldon JL, Ganz PA. Genetic Counseling for Hereditary Cancer Predisposition Testing. Cancer Diagnostics 2004. [DOI: 10.1007/978-1-59259-791-8_21] [Reference Citation Analysis]
|
| 631 |
Boyd J. Hereditary Gynecologic Cancer Syndromes. Gynecologic Cancer 2004. [DOI: 10.1016/b978-0-443-07142-3.50066-x] [Reference Citation Analysis]
|
| 632 |
Müller H, Plasilova M, Russell AM, Heinimann K. Genetic predisposition as a basis for chemoprevention, surgical and other interventions in colorectal cancer. Recent Results Cancer Res 2003;163:235-47; discussion 264-6. [PMID: 12903858 DOI: 10.1007/978-3-642-55647-0_21] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.1] [Reference Citation Analysis]
|
| 633 |
Müller W, Burgart LJ, Krause-Paulus R, Thibodeau SN, Almeida M, Edmonston TB, Boland CR, Sutter C, Jass JR, Lindblom A, Lubinski J, MacDermot K, Sanders DS, Morreau H, Müller A, Oliani C, Orntoft T, Ponz De Leon M, Rosty C, Rodriguez-Bigas M, Rüschoff J, Ruszkiewicz A, Sabourin J, Salovaara R, Möslein G; ICG-HNPCC (International Collaborative Group). The reliability of immunohistochemistry as a prescreening method for the diagnosis of hereditary nonpolyposis colorectal cancer (HNPCC)--results of an international collaborative study. Fam Cancer 2001;1:87-92. [PMID: 14574003 DOI: 10.1023/a:1013840907881] [Cited by in Crossref: 72] [Cited by in F6Publishing: 77] [Article Influence: 3.6] [Reference Citation Analysis]
|
| 634 |
Levene S, Scott G, Price P, Sanderson J, Evans H, Taylor C, Bass S, Lewis C, Hodgson S. Does the occurrence of certain rare cancers indicate an inherited cancer susceptibility? Fam Cancer 2003;2:15-25. [PMID: 14574163 DOI: 10.1023/a:1023265919884] [Cited by in Crossref: 5] [Cited by in F6Publishing: 6] [Article Influence: 0.3] [Reference Citation Analysis]
|
| 635 |
Jover R, Payá A. [Microsatellite instability in colorectal cancer: concept, detection methods and clinical utility]. Gastroenterol Hepatol 2003;26:656-63. [PMID: 14670241 DOI: 10.1016/s0210-5705(03)70427-0] [Reference Citation Analysis]
|
| 636 |
Berends MJ, Wu Y, Sijmons RH, van der Sluis T, Ek WB, Ligtenberg MJ, Arts NJ, ten Hoor KA, Kleibeuker JH, de Vries EG, Mourits MJ, Hollema H, Buys CH, Hofstra RM, van der Zee AG. Toward New Strategies to Select Young Endometrial Cancer Patients for Mismatch Repair Gene Mutation Analysis. JCO 2003;21:4364-70. [DOI: 10.1200/jco.2003.04.094] [Cited by in Crossref: 100] [Cited by in F6Publishing: 108] [Article Influence: 5.0] [Reference Citation Analysis]
|
| 637 |
Cui L, Jin HY, Cheng HY, Yan YD, Meng RG, Yu DH. Clinicopathologic characteristics of Chinese hereditary non-polyposis colorectal cancer. Chinese Journal of Digestive Diseases 2003;4:186-189. [DOI: 10.1046/j.1443-9573.2003.t01-5-.x] [Reference Citation Analysis]
|
| 638 |
Ahmed FE. Colon Cancer: Prevalence, Screening, Gene Expression and Mutation, and Risk Factors and Assessment. Journal of Environmental Science and Health, Part C 2003;21:65-131. [DOI: 10.1081/gnc-120026233] [Cited by in Crossref: 38] [Cited by in F6Publishing: 38] [Article Influence: 1.9] [Reference Citation Analysis]
|
| 639 |
Annie Yu HJ, Lin KM, Ota DM, Lynch HT. Hereditary nonpolyposis colorectal cancer: preventive management. Cancer Treat Rev. 2003;29:461-470. [PMID: 14585257 DOI: 10.1016/s0305-7372(03)00084-7] [Cited by in Crossref: 39] [Cited by in F6Publishing: 42] [Article Influence: 2.0] [Reference Citation Analysis]
|
| 640 |
Shia J, Ellis NA, Paty PB, Nash GM, Qin J, Offit K, Zhang XM, Markowitz AJ, Nafa K, Guillem JG, Wong WD, Gerald WL, Klimstra DS. Value of histopathology in predicting microsatellite instability in hereditary nonpolyposis colorectal cancer and sporadic colorectal cancer. Am J Surg Pathol 2003;27:1407-17. [PMID: 14576473 DOI: 10.1097/00000478-200311000-00002] [Cited by in Crossref: 169] [Cited by in F6Publishing: 175] [Article Influence: 8.5] [Reference Citation Analysis]
|
| 641 |
Liengswangwong U, Nitta T, Kashiwagi H, Kikukawa H, Kawamoto T, Todoroki T, Uchida K, Khuhaprema T, Karalak A, Srivatanakul P. Infrequent microsatellite instability in liver fluke infection-associated intrahepatic cholangiocarcinomas from Thailand. Int J Cancer. 2003;107:375-380. [PMID: 14506736 DOI: 10.1002/ijc.11380] [Cited by in Crossref: 13] [Cited by in F6Publishing: 15] [Article Influence: 0.7] [Reference Citation Analysis]
|
| 642 |
Yuan Z, Sotsky Kent T, Weber TK. Differential expression of DOC-1 in microsatellite-unstable human colorectal cancer. Oncogene 2003;22:6304-10. [PMID: 13679870 DOI: 10.1038/sj.onc.1206609] [Cited by in Crossref: 27] [Cited by in F6Publishing: 29] [Article Influence: 1.4] [Reference Citation Analysis]
|
| 643 |
Renkonen E, Zhang Y, Lohi H, Salovaara R, Abdel-Rahman WM, Nilbert M, Aittomaki K, Jarvinen HJ, Mecklin JP, Lindblom A. Altered expression of MLH1, MSH2, and MSH6 in predisposition to hereditary nonpolyposis colorectal cancer. J Clin Oncol. 2003;21:3629-3637. [PMID: 14512394 DOI: 10.1200/JCO.2003.03.181] [Cited by in Crossref: 67] [Cited by in F6Publishing: 75] [Article Influence: 3.4] [Reference Citation Analysis]
|
| 644 |
Schulmann K, Hahn SA, Brasch F, Schmiegel W. Microsatellite instability and expression of MLH1 and MSH2 in carcinomas of the small intestine. Cancer 2003;98:1774-1775. [DOI: 10.1002/cncr.11706] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
|
| 645 |
Stone W, Krishnan K, Papas A. Oxidants and Antioxidants in the Pathology of Colon Cancer. Oxidative Stress and Disease 2003. [DOI: 10.1201/9780203912874.ch22] [Reference Citation Analysis]
|
| 646 |
DeFrancisco J, Grady WM. Diagnosis and management of hereditary non-polyposis colon cancer. Gastrointest Endosc 2003;58:390-408. [PMID: 14528214 DOI: 10.1067/s0016-5107(03)00014-2] [Cited by in Crossref: 18] [Cited by in F6Publishing: 16] [Article Influence: 0.9] [Reference Citation Analysis]
|
| 647 |
Scaife CL, Rodriguez-Bigas MA. Lynch syndrome: implications for the surgeon. Clin Colorectal Cancer 2003;3:92-8. [PMID: 12952564 DOI: 10.3816/CCC.2003.n.015] [Cited by in Crossref: 16] [Cited by in F6Publishing: 15] [Article Influence: 0.8] [Reference Citation Analysis]
|
| 648 |
Dykes SL, Qui H, Rothenberger DA, García-Aguilar J. Evidence of a preferred molecular pathway in patients with synchronous colorectal cancer. Cancer 2003;98:48-54. [PMID: 12833454 DOI: 10.1002/cncr.11445] [Cited by in Crossref: 23] [Cited by in F6Publishing: 26] [Article Influence: 1.2] [Reference Citation Analysis]
|
| 649 |
Perry W. History and Physical Examination. Handbook of Colorectal Surgery, Second Edition 2003. [DOI: 10.1201/b14821-4] [Reference Citation Analysis]
|
| 650 |
Drake AC, Campbell H, Porteous ME, Dunlop MG. The contribution of DNA mismatch repair gene defects to the burden of gynecological cancer. Int J Gynecol Cancer 2003;13:262-77. [PMID: 12801255 DOI: 10.1046/j.1525-1438.2003.13194.x] [Cited by in Crossref: 17] [Cited by in F6Publishing: 17] [Article Influence: 0.9] [Reference Citation Analysis]
|
| 651 |
Grady WM. Genetic testing for high-risk colon cancer patients. Gastroenterology 2003;124:1574-94. [PMID: 12761718 DOI: 10.1016/s0016-5085(03)00376-7] [Cited by in Crossref: 137] [Cited by in F6Publishing: 143] [Article Influence: 6.9] [Reference Citation Analysis]
|
| 652 |
Maruyama A, Saito T, Hachitanda Y, Tsukamoto N. Cancer history and loss of MSH2 and MLH1 protein expression in patients with endometrial hyperplasia. Int J Gynecol Cancer 2003;13:352-60. [PMID: 12801268 DOI: 10.1046/j.1525-1438.2003.13190.x] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
|
| 653 |
Helm J, Choi J, Sutphen R, Barthel JS, Albrecht TL, Chirikos TN. Current and evolving strategies for colorectal cancer screening. Cancer Control 2003;10:193-204. [PMID: 12794617 DOI: 10.1177/107327480301000302] [Cited by in Crossref: 29] [Cited by in F6Publishing: 29] [Article Influence: 1.5] [Reference Citation Analysis]
|
| 654 |
Wagner A, Barrows A, Wijnen JT, van der Klift H, Franken PF, Verkuijlen P, Nakagawa H, Geugien M, Jaghmohan-Changur S, Breukel C, Meijers-Heijboer H, Morreau H, van Puijenbroek M, Burn J, Coronel S, Kinarski Y, Okimoto R, Watson P, Lynch JF, de la Chapelle A, Lynch HT, Fodde R. Molecular analysis of hereditary nonpolyposis colorectal cancer in the United States: high mutation detection rate among clinically selected families and characterization of an American founder genomic deletion of the MSH2 gene. Am J Hum Genet 2003;72:1088-100. [PMID: 12658575 DOI: 10.1086/373963] [Cited by in Crossref: 148] [Cited by in F6Publishing: 160] [Article Influence: 7.4] [Reference Citation Analysis]
|
| 655 |
Allen BA, Terdiman JP. Hereditary polyposis syndromes and hereditary non-polyposis colorectal cancer. Best Pract Res Clin Gastroenterol 2003;17:237-58. [PMID: 12676117 DOI: 10.1016/s1521-6918(02)00149-x] [Cited by in Crossref: 40] [Cited by in F6Publishing: 41] [Article Influence: 2.0] [Reference Citation Analysis]
|
| 656 |
Cruz-correa M, Giardiello FM. Diagnosis and management of hereditary colon cancer. Hematology/Oncology Clinics of North America 2003;17:539-551. [DOI: 10.1016/s0889-8588(03)00009-1] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 0.3] [Reference Citation Analysis]
|
| 657 |
Loren DE, Lewis J, Kochman ML. Colon cancer: detection and prevention. Hematology/Oncology Clinics of North America 2003;17:553-574. [DOI: 10.1016/s0889-8588(03)00022-4] [Reference Citation Analysis]
|
| 658 |
Plaschke J, Schwanebeck U, Pistorius S, Saeger HD, Schackert HK. Methylenetetrahydrofolate reductase polymorphisms and risk of sporadic and hereditary colorectal cancer with or without microsatellite instability. Cancer Lett 2003;191:179-85. [PMID: 12618331 DOI: 10.1016/s0304-3835(02)00633-x] [Cited by in Crossref: 34] [Cited by in F6Publishing: 36] [Article Influence: 1.7] [Reference Citation Analysis]
|
| 659 |
Kullmann F. [Carcinogenesis and hereditart colon cancers]. Internist (Berl) 2003;44:254-5, 258-67. [PMID: 12731412 DOI: 10.1007/s00108-002-0807-2] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.2] [Reference Citation Analysis]
|
| 660 |
Hartmann A, Dietmaier W, Hofstädter F, Burgart LJ, Cheville JC, Blaszyk H. Urothelial carcinoma of the upper urinary tract: inverted growth pattern is predictive of microsatellite instability. Hum Pathol 2003;34:222-7. [PMID: 12673555 DOI: 10.1053/hupa.2003.22] [Cited by in Crossref: 52] [Cited by in F6Publishing: 50] [Article Influence: 2.6] [Reference Citation Analysis]
|
| 661 |
Wang Y, Friedl W, Lamberti C, Jungck M, Mathiak M, Pagenstecher C, Propping P, Mangold E. Hereditary nonpolyposis colorectal cancer: frequent occurrence of large genomic deletions in MSH2 and MLH1 genes. Int J Cancer 2003;103:636-41. [PMID: 12494471 DOI: 10.1002/ijc.10869] [Cited by in Crossref: 74] [Cited by in F6Publishing: 82] [Article Influence: 3.7] [Reference Citation Analysis]
|
| 662 |
Cai SJ, Xu Y, Cai GX, Lian P, Guan ZQ, Mo SJ, Sun MH, Cai Q, Shi DR. Clinical characteristics and diagnosis of patients with hereditary nonpolyposis colorectal cancer. World J Gastroenterol 2003; 9(2): 284-287 [PMID: 12532449 DOI: 10.3748/wjg.v9.i2.284] [Cited by in CrossRef: 29] [Cited by in F6Publishing: 34] [Article Influence: 1.5] [Reference Citation Analysis]
|
| 663 |
Liang JT, Huang KC, Cheng AL, Jeng YM, Wu MS, Wang SM. Clinicopathological and molecular biological features of colorectal cancer in patients less than 40 years of age. Br J Surg 2003;90:205-14. [PMID: 12555297 DOI: 10.1002/bjs.4015] [Cited by in Crossref: 125] [Cited by in F6Publishing: 132] [Article Influence: 6.3] [Reference Citation Analysis]
|
| 664 |
Hendriks Y, Franken P, Dierssen JW, De Leeuw W, Wijnen J, Dreef E, Tops C, Breuning M, Bröcker-Vriends A, Vasen H, Fodde R, Morreau H. Conventional and tissue microarray immunohistochemical expression analysis of mismatch repair in hereditary colorectal tumors. Am J Pathol 2003;162:469-77. [PMID: 12547705 DOI: 10.1016/S0002-9440(10)63841-2] [Cited by in Crossref: 122] [Cited by in F6Publishing: 130] [Article Influence: 6.1] [Reference Citation Analysis]
|
| 665 |
Guillem JG, Rapaport BS, Kirchhoff T, Kolachana P, Nafa K, Glogowski E, Finch R, Huang H, Foulkes WD, Markowitz A, Ellis NA, Offit K. A636P is associated with early-onset colon cancer in Ashkenazi Jews. J Am Coll Surg 2003;196:222-5. [PMID: 12595050 DOI: 10.1016/S1072-7515(02)01808-2] [Cited by in Crossref: 21] [Cited by in F6Publishing: 21] [Article Influence: 1.1] [Reference Citation Analysis]
|
| 666 |
Stein E. Tumors and Tumor-like Lesions of the Colon, Rectum, Anus, and Perianal Region. Anorectal and Colon Diseases 2003. [DOI: 10.1007/978-3-642-18977-7_6] [Reference Citation Analysis]
|
| 667 |
Stein E. Tumoren und tumorartige Läsionen des Dickdarms, Anorektums und Perianalbereichs. Proktologie 2003. [DOI: 10.1007/978-3-642-55594-7_6] [Reference Citation Analysis]
|
| 668 |
Jagadeesh D, Syngal S. Genetic testing for hereditary nonpolyposis colorectal cancer. Curr Opin Gastroenterol 2003;19:57-63. [PMID: 15699895 DOI: 10.1097/00001574-200301000-00010] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 0.2] [Reference Citation Analysis]
|
| 669 |
Boardman LA. Heritable colorectal cancer syndromes: recognition and preventive management. Gastroenterol Clin North Am 2002;31:1107-31. [PMID: 12489281 DOI: 10.1016/s0889-8553(02)00049-3] [Cited by in Crossref: 78] [Cited by in F6Publishing: 79] [Article Influence: 3.7] [Reference Citation Analysis]
|
| 670 |
Zawacki KL. Hereditary cancer syndromes of the gastrointestinal system. AACN Clin Issues 2002;13:523-39. [PMID: 12473915 DOI: 10.1097/00044067-200211000-00006] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.1] [Reference Citation Analysis]
|
| 671 |
Trimbath JD, Giardiello FM. Review article: genetic testing and counselling for hereditary colorectal cancer. Aliment Pharmacol Ther 2002;16:1843-57. [PMID: 12390093 DOI: 10.1046/j.1365-2036.2002.01357.x] [Cited by in Crossref: 39] [Cited by in F6Publishing: 37] [Article Influence: 1.9] [Reference Citation Analysis]
|
| 672 |
Reyes CM, Allen BA, Terdiman JP, Wilson LS. Comparison of selection strategies for genetic testing of patients with hereditary nonpolyposis colorectal carcinoma: effectiveness and cost-effectiveness. Cancer 2002;95:1848-56. [PMID: 12404277 DOI: 10.1002/cncr.10910] [Cited by in Crossref: 49] [Cited by in F6Publishing: 54] [Article Influence: 2.3] [Reference Citation Analysis]
|
| 673 |
Lawes DA, SenGupta SB, Boulos PB. Pathogenesis and clinical management of hereditary non-polyposis colorectal cancer. Br J Surg 2002;89:1357-69. [PMID: 12390374 DOI: 10.1046/j.1365-2168.2002.02290.x] [Cited by in Crossref: 23] [Cited by in F6Publishing: 24] [Article Influence: 1.1] [Reference Citation Analysis]
|
| 674 |
Robbins DH, Itzkowitz SH. The molecular and genetic basis of colon cancer. Med Clin North Am 2002;86:1467-95. [PMID: 12510461 DOI: 10.1016/s0025-7125(02)00084-6] [Cited by in Crossref: 59] [Cited by in F6Publishing: 59] [Article Influence: 2.8] [Reference Citation Analysis]
|
| 675 |
Yuen ST, Chan TL, Ho JW, Chan AS, Chung LP, Lam PW, Tse CW, Wyllie AH, Leung SY. Germline, somatic and epigenetic events underlying mismatch repair deficiency in colorectal and HNPCC-related cancers. Oncogene 2002;21:7585-92. [PMID: 12386821 DOI: 10.1038/sj.onc.1205968] [Cited by in Crossref: 57] [Cited by in F6Publishing: 62] [Article Influence: 2.7] [Reference Citation Analysis]
|
| 676 |
Gille JJ, Hogervorst FB, Pals G, Wijnen JT, van Schooten RJ, Dommering CJ, Meijer GA, Craanen ME, Nederlof PM, de Jong D, McElgunn CJ, Schouten JP, Menko FH. Genomic deletions of MSH2 and MLH1 in colorectal cancer families detected by a novel mutation detection approach. Br J Cancer 2002;87:892-7. [PMID: 12373605 DOI: 10.1038/sj.bjc.6600565] [Cited by in Crossref: 115] [Cited by in F6Publishing: 129] [Article Influence: 5.5] [Reference Citation Analysis]
|
| 677 |
Dunlop MG; British Society for Gastroenterology, Association of Coloproctology for Great Britain and Ireland. Guidance on gastrointestinal surveillance for hereditary non-polyposis colorectal cancer, familial adenomatous polypolis, juvenile polyposis, and Peutz-Jeghers syndrome. Gut 2002;51 Suppl 5:V21-7. [PMID: 12221036 DOI: 10.1136/gut.51.suppl_5.v21] [Cited by in Crossref: 155] [Cited by in F6Publishing: 173] [Article Influence: 7.4] [Reference Citation Analysis]
|
| 678 |
Trowbridge B, Burt RW. Colorectal cancer screening. Surg Clin North Am 2002;82:943-57. [PMID: 12507201 DOI: 10.1016/s0039-6109(02)00045-2] [Cited by in Crossref: 15] [Cited by in F6Publishing: 18] [Article Influence: 0.7] [Reference Citation Analysis]
|
| 679 |
Al-Taie OH, Seufert J, Mörk H, Treis H, Mentrup B, Thalheimer A, Starostik P, Abel J, Scheurlen M, Köhrle J, Jakob F. A complex DNA-repeat structure within the Selenoprotein P promoter contains a functionally relevant polymorphism and is genetically unstable under conditions of mismatch repair deficiency. Eur J Hum Genet 2002;10:499-504. [PMID: 12173025 DOI: 10.1038/sj.ejhg.5200811] [Cited by in Crossref: 36] [Cited by in F6Publishing: 36] [Article Influence: 1.7] [Reference Citation Analysis]
|
| 680 |
Machin P, Catasus L, Pons C, Muñoz J, Conde-Zurita JM, Balmaña J, Barnadas M, Martí RM, Prat J, Matias-Guiu X. Microsatellite instability and immunostaining for MSH-2 and MLH-1 in cutaneous and internal tumors from patients with the Muir-Torre syndrome. J Cutan Pathol 2002;29:415-20. [PMID: 12139636 DOI: 10.1034/j.1600-0560.2002.290705.x] [Cited by in Crossref: 58] [Cited by in F6Publishing: 60] [Article Influence: 2.8] [Reference Citation Analysis]
|
| 681 |
Peterson KA, DiSario JA. Secondary prevention: screening and surveillance of persons at average and high risk for colorectal cancer. Hematol Oncol Clin North Am 2002;16:841-65. [PMID: 12418051 DOI: 10.1016/s0889-8588(02)00031-x] [Cited by in Crossref: 5] [Cited by in F6Publishing: 6] [Article Influence: 0.2] [Reference Citation Analysis]
|
| 682 |
Rossi BM, Lopes A, Oliveira Ferreira F, Nakagawa WT, Napoli Ferreira CC, Casali Da Rocha JC, Simpson CC, Simpson AJ. hMLH1 and hMSH2 gene mutation in Brazilian families with suspected hereditary nonpolyposis colorectal cancer. Ann Surg Oncol 2002;9:555-61. [PMID: 12095971 DOI: 10.1007/BF02573891] [Cited by in F6Publishing: 15] [Reference Citation Analysis]
|
| 683 |
Cruz-Correa M, Giardiello FM. Diagnosis and management of hereditary colon cancer. Gastroenterol Clin North Am 2002;31:537-49, x. [PMID: 12134617 DOI: 10.1016/s0889-8553(02)00009-2] [Cited by in Crossref: 32] [Cited by in F6Publishing: 35] [Article Influence: 1.5] [Reference Citation Analysis]
|
| 684 |
Loren DE, Lewis J, Kochman ML. Colon cancer: detection and prevention. Gastroenterol Clin North Am 2002;31:565-86. [PMID: 12134619 DOI: 10.1016/s0889-8553(02)00015-8] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 0.4] [Reference Citation Analysis]
|
| 685 |
Caldes T, Godino J, de la Hoya M, Garcia Carbonero I, Perez Segura P, Eng C, Benito M, Diaz-Rubio E. Prevalence of germline mutations of MLH1 and MSH2 in hereditary nonpolyposis colorectal cancer families from Spain. Int J Cancer 2002;98:774-9. [PMID: 11920650 DOI: 10.1002/ijc.10240] [Cited by in Crossref: 33] [Cited by in F6Publishing: 35] [Article Influence: 1.6] [Reference Citation Analysis]
|
| 686 |
Terdiman JP, Levin TR, Allen BA, Gum JR Jr, Fishbach A, Conrad PG, Miller GA, Weinberg V, Bachman R, Bergoffen J, Stembridge A, Toribara NW, Sleisenger MH, Kim YS. Hereditary nonpolyposis colorectal cancer in young colorectal cancer patients: high-risk clinic versus population-based registry. Gastroenterology 2002;122:940-7. [PMID: 11910346 DOI: 10.1053/gast.2002.32537] [Cited by in Crossref: 26] [Cited by in F6Publishing: 28] [Article Influence: 1.2] [Reference Citation Analysis]
|
| 687 |
Müller A, Fishel R. Mismatch repair and the hereditary non-polyposis colorectal cancer syndrome (HNPCC). Cancer Invest 2002;20:102-9. [PMID: 11852992 DOI: 10.1081/cnv-120000371] [Cited by in Crossref: 86] [Cited by in F6Publishing: 97] [Article Influence: 4.1] [Reference Citation Analysis]
|
| 688 |
Scartozzi M, Bianchi F, Rosati S, Galizia E, Antolini A, Loretelli C, Piga A, Bearzi I, Cellerino R, Porfiri E. Mutations of hMLH1 and hMSH2 in patients with suspected hereditary nonpolyposis colorectal cancer: correlation with microsatellite instability and abnormalities of mismatch repair protein expression. J Clin Oncol 2002;20:1203-8. [PMID: 11870161 DOI: 10.1200/JCO.2002.20.5.1203] [Cited by in Crossref: 28] [Cited by in F6Publishing: 41] [Article Influence: 1.3] [Reference Citation Analysis]
|
| 689 |
Ikenaga M, Tomita N, Sekimoto M, Ohue M, Yamamoto H, Miyake Y, Mishima H, Nishisho I, Kikkawa N, Monden M. Use of microsatellite analysis in young patients with colorectal cancer to identify those with hereditary nonpolyposis colorectal cancer. J Surg Oncol 2002;79:157-65. [PMID: 11870666 DOI: 10.1002/jso.10064] [Cited by in Crossref: 12] [Cited by in F6Publishing: 17] [Article Influence: 0.6] [Reference Citation Analysis]
|
| 690 |
Palazzo JP, Edmonston TB, Chaille-Arnold LM, Burkholder S. Invasive papillary adenocarcinoma of the colon. Hum Pathol 2002;33:372-5. [PMID: 11979380 DOI: 10.1053/hupa.2002.32228] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 0.3] [Reference Citation Analysis]
|
| 691 |
Furukawa T, Konishi F, Shitoh K, Kojima M, Nagai H, Tsukamoto T. Evaluation of screening strategy for detecting hereditary nonpolyposis colorectal carcinoma. Cancer 2002;94:911-20. [DOI: 10.1002/cncr.10332] [Cited by in Crossref: 26] [Cited by in F6Publishing: 27] [Article Influence: 1.2] [Reference Citation Analysis]
|
| 692 |
Plaschke J, Krüger S, Pistorius S, Theissig F, Saeger HD, Schackert HK. Involvement of hMSH6 in the development of hereditary and sporadic colorectal cancer revealed by immunostaining is based on germline mutations, but rarely on somatic inactivation. Int J Cancer 2002;97:643-8. [PMID: 11807791 DOI: 10.1002/ijc.10097] [Cited by in Crossref: 56] [Cited by in F6Publishing: 60] [Article Influence: 2.7] [Reference Citation Analysis]
|
| 693 |
Couturier D. Notions récentes sur la cancérogenèse intestinale, leurs implications dans le dépistage du risque génétique et l’action préventive des anti-inflammatoires non stéroïdiens. Bulletin de l'Académie Nationale de Médecine 2002;186:421-445. [DOI: 10.1016/s0001-4079(19)34348-1] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.0] [Reference Citation Analysis]
|
| 694 |
Schulmann K, Reiser M, Schmiegel W. Colonic cancer and polyps. Best Pract Res Clin Gastroenterol 2002;16:91-114. [PMID: 11977931 DOI: 10.1053/bega.2002.0268] [Cited by in Crossref: 36] [Cited by in F6Publishing: 37] [Article Influence: 1.7] [Reference Citation Analysis]
|
| 695 |
Sweet KM, Bradley TL, Westman JA. Identification and referral of families at high risk for cancer susceptibility. J Clin Oncol 2002;20:528-37. [PMID: 11786583 DOI: 10.1200/JCO.2002.20.2.528] [Cited by in Crossref: 67] [Cited by in F6Publishing: 95] [Article Influence: 3.2] [Reference Citation Analysis]
|
| 696 |
Müller A, Shim KS, Fishel R. Hereditary Colon Cancer and DNA Mismatch Repair. Encyclopedia of Cancer 2002. [DOI: 10.1016/b0-12-227555-1/00152-0] [Reference Citation Analysis]
|
| 697 |
Ponz de Leon M. Hereditary Non-polyposis Colorectal Cancer (Lynch Syndrome). Colorectal Cancer 2002. [DOI: 10.1007/978-3-642-56008-8_10] [Reference Citation Analysis]
|
| 698 |
Ponz de Leon M. The Causes of Colorectal Cancer. Colorectal Cancer 2002. [DOI: 10.1007/978-3-642-56008-8_1] [Reference Citation Analysis]
|
| 699 |
Schneider K, Shannon K, Chittenden A, Hiller E, Kieffer S. Cancer Genetic Counseling. The Molecular Basis of Human Cancer 2002. [DOI: 10.1007/978-1-59259-125-1_21] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.0] [Reference Citation Analysis]
|
| 700 |
van Stolk RU. Familial and inherited colorectal cancer: endoscopic screening and surveillance. Gastrointest Endosc Clin N Am 2002;12:111-33. [PMID: 11916155 DOI: 10.1016/s1052-5157(03)00062-x] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 0.2] [Reference Citation Analysis]
|
| 701 |
Boman BM, Melchert L, Fields JZ. Hereditary Cancer. The Molecular Basis of Human Cancer 2002. [DOI: 10.1007/978-1-59259-125-1_8] [Reference Citation Analysis]
|
| 702 |
Katballe N, Christensen M, Wikman FP, Ørntoft TF, Laurberg S. Frequency of hereditary non-polyposis colorectal cancer in Danish colorectal cancer patients. Gut 2002;50:43-51. [PMID: 11772966 DOI: 10.1136/gut.50.1.43] [Cited by in Crossref: 52] [Cited by in F6Publishing: 59] [Article Influence: 2.5] [Reference Citation Analysis]
|
| 703 |
Young J, Simms LA, Biden KG, Wynter C, Whitehall V, Karamatic R, George J, Goldblatt J, Walpole I, Robin SA, Borten MM, Stitz R, Searle J, McKeone D, Fraser L, Purdie DR, Podger K, Price R, Buttenshaw R, Walsh MD, Barker M, Leggett BA, Jass JR. Features of colorectal cancers with high-level microsatellite instability occurring in familial and sporadic settings: parallel pathways of tumorigenesis. Am J Pathol 2001;159:2107-16. [PMID: 11733361 DOI: 10.1016/S0002-9440(10)63062-3] [Cited by in Crossref: 270] [Cited by in F6Publishing: 284] [Article Influence: 12.3] [Reference Citation Analysis]
|
| 704 |
Hemminki K, Li X. Familial colorectal adenocarcinoma from the Swedish Family-Cancer Database. Int J Cancer 2001;94:743-8. [PMID: 11745471 DOI: 10.1002/ijc.1533] [Cited by in Crossref: 32] [Cited by in F6Publishing: 35] [Article Influence: 1.5] [Reference Citation Analysis]
|
| 705 |
Bacon AL, Dunlop MG, Farrington SM. Hypermutability at a poly(A/T) tract in the human germline. Nucleic Acids Res 2001;29:4405-13. [PMID: 11691928 DOI: 10.1093/nar/29.21.4405] [Cited by in Crossref: 19] [Cited by in F6Publishing: 20] [Article Influence: 0.9] [Reference Citation Analysis]
|
| 706 |
Church J, Lowry A, Simmang C; Standards Task Force, American Society of Colon and Rectal Surgeons. Practice parameters for the identification and testing of patients at risk for dominantly inherited colorectal cancer--supporting documentation. Dis Colon Rectum 2001;44:1404-12. [PMID: 11598466 DOI: 10.1007/BF02234589] [Cited by in Crossref: 13] [Cited by in F6Publishing: 16] [Article Influence: 0.6] [Reference Citation Analysis]
|
| 707 |
Clarke LA, Rebelo CS, Gonçalves J, Boavida MG, Jordan P. PCR amplification introduces errors into mononucleotide and dinucleotide repeat sequences. Mol Pathol 2001;54:351-3. [PMID: 11577179 DOI: 10.1136/mp.54.5.351] [Cited by in Crossref: 103] [Cited by in F6Publishing: 105] [Article Influence: 4.7] [Reference Citation Analysis]
|
| 708 |
Terdiman JP. HNPCC: an uncommon but important diagnosis. Gastroenterology 2001;121:1005-8. [PMID: 11606514 DOI: 10.1053/gast.2001.28634] [Cited by in Crossref: 11] [Cited by in F6Publishing: 13] [Article Influence: 0.5] [Reference Citation Analysis]
|
| 709 |
Cunningham JM, Kim CY, Christensen ER, Tester DJ, Parc Y, Burgart LJ, Halling KC, McDonnell SK, Schaid DJ, Walsh Vockley C, Kubly V, Nelson H, Michels VV, Thibodeau SN. The frequency of hereditary defective mismatch repair in a prospective series of unselected colorectal carcinomas. Am J Hum Genet 2001;69:780-90. [PMID: 11524701 DOI: 10.1086/323658] [Cited by in Crossref: 240] [Cited by in F6Publishing: 261] [Article Influence: 10.9] [Reference Citation Analysis]
|
| 710 |
Wüllenweber HP, Sutter C, Autschbach F, Willeke F, Kienle P, Benner A, Bähring J, Kadmon M, Herfarth C, von Knebel Doeberitz M, Gebert J. Evaluation of Bethesda guidelines in relation to microsatellite instability. Dis Colon Rectum 2001;44:1281-9. [PMID: 11584201 DOI: 10.1007/BF02234785] [Cited by in Crossref: 16] [Cited by in F6Publishing: 18] [Article Influence: 0.7] [Reference Citation Analysis]
|
| 711 |
Paraf F, Gilquin M, Longy M, Gilbert B, Gorry P, Petit B, Labrousse F. MLH1 and MSH2 protein immunohistochemistry is useful for detection of hereditary non-polyposis colorectal cancer in young patients. Histopathology 2001;39:250-8. [PMID: 11532035 DOI: 10.1046/j.1365-2559.2001.01203.x] [Cited by in Crossref: 25] [Cited by in F6Publishing: 25] [Article Influence: 1.1] [Reference Citation Analysis]
|
| 712 |
Emery J, Lucassen A, Murphy M. Common hereditary cancers and implications for primary care. Lancet 2001;358:56-63. [PMID: 11454400 DOI: 10.1016/S0140-6736(00)05257-0] [Cited by in Crossref: 46] [Cited by in F6Publishing: 51] [Article Influence: 2.1] [Reference Citation Analysis]
|
| 713 |
Maruyama A, Miyamoto S, Saito T, Kondo H, Baba H, Tsukamoto N. Clinicopathologic and familial characteristics of endometrial carcinoma with multiple primary carcinomas in relation to the loss of protein expression of MSH2 and MLH1. Cancer 2001;91:2056-64. [PMID: 11391585 DOI: 10.1002/1097-0142(20010601)91:11<2056::aid-cncr1232>3.0.co;2-s] [Cited by in Crossref: 7] [Cited by in F6Publishing: 8] [Article Influence: 0.3] [Reference Citation Analysis]
|
| 714 |
Kim HS, Cho NB, Yoo JH, Shin KH, Park JG, Kim YI, Kim WH. Microsatellite instability in double primary cancers of the colorectum and stomach. Mod Pathol 2001;14:543-8. [PMID: 11406654 DOI: 10.1038/modpathol.3880347] [Cited by in Crossref: 7] [Cited by in F6Publishing: 9] [Article Influence: 0.3] [Reference Citation Analysis]
|
| 715 |
Karran P. Human Mismatch Repair: Defects and Predisposition to Cancer. eLS 2001. [DOI: 10.1038/npg.els.0000572] [Reference Citation Analysis]
|
| 716 |
Wiesner GL, Platzer P, Buxbaum S, Lewis S, MacMillen M, Olechnowicz J, Willis J, Chakravarti A, Elston RC, Markowitz SD. Testing for colon neoplasia susceptibility variants at the human COX2 locus. J Natl Cancer Inst 2001;93:635-9. [PMID: 11309440 DOI: 10.1093/jnci/93.8.635] [Cited by in Crossref: 10] [Cited by in F6Publishing: 12] [Article Influence: 0.5] [Reference Citation Analysis]
|
| 717 |
Buller RE, Shahin MS, Holmes RW, Hatterman M, Kirby PA, Sood AK. p53 Mutations and microsatellite instability in ovarian cancer: Yin and yang. Am J Obstet Gynecol 2001;184:891-902; discussion 902-3. [PMID: 11303196 DOI: 10.1067/mob.2001.113856] [Cited by in Crossref: 15] [Cited by in F6Publishing: 15] [Article Influence: 0.7] [Reference Citation Analysis]
|
| 718 |
Bittorf B, Kessler H, Merkel S, Brückl W, Wein A, Ballhausen W, Hohenberger W, Günther K. Multiple primary malignancies: An epidemiological and pedigree analysis of 57 patients with at least three tumours. European Journal of Surgical Oncology (EJSO) 2001;27:302-13. [DOI: 10.1053/ejso.2001.1112] [Cited by in Crossref: 31] [Cited by in F6Publishing: 39] [Article Influence: 1.4] [Reference Citation Analysis]
|
| 719 |
Rex DK, Bond JH, Feld AD. Medical-legal risks of incident cancers after clearing colonoscopy. Am J Gastroenterol 2001;96:952-7. [PMID: 11316211 DOI: 10.1111/j.1572-0241.2001.03677.x] [Cited by in Crossref: 68] [Cited by in F6Publishing: 74] [Article Influence: 3.1] [Reference Citation Analysis]
|
| 720 |
Saletti P, Edwin ID, Pack K, Cavalli F, Atkin WS. Microsatellite instability: application in hereditary non-polyposis colorectal cancer. Ann Oncol 2001;12:151-60. [PMID: 11300317 DOI: 10.1023/a:1008342420825] [Cited by in Crossref: 7] [Cited by in F6Publishing: 9] [Article Influence: 0.3] [Reference Citation Analysis]
|
| 721 |
Alexander J, Watanabe T, Wu TT, Rashid A, Li S, Hamilton SR. Histopathological identification of colon cancer with microsatellite instability. Am J Pathol 2001;158:527-35. [PMID: 11159189 DOI: 10.1016/S0002-9440(10)63994-6] [Cited by in Crossref: 369] [Cited by in F6Publishing: 395] [Article Influence: 16.8] [Reference Citation Analysis]
|
| 722 |
Puig-la Calle J, Guillem JG. Genetics, Screening and Chemoprevention. Modern Management of Cancer of the Rectum 2001. [DOI: 10.1007/978-1-4471-0331-8_3] [Reference Citation Analysis]
|
| 723 |
Terdiman JP, Gum JR Jr, Conrad PG, Miller GA, Weinberg V, Crawley SC, Levin TR, Reeves C, Schmitt A, Hepburn M, Sleisenger MH, Kim YS. Efficient detection of hereditary nonpolyposis colorectal cancer gene carriers by screening for tumor microsatellite instability before germline genetic testing. Gastroenterology 2001;120:21-30. [PMID: 11208710 DOI: 10.1053/gast.2001.20874] [Cited by in Crossref: 104] [Cited by in F6Publishing: 109] [Article Influence: 4.7] [Reference Citation Analysis]
|
| 724 |
Ruo L, Cellini C, La-Calle JP Jr, Murray M, Thaler HT, Quan SH, Guillem JG. Limitations of family cancer history assessment at initial surgical consultation. Dis Colon Rectum 2001;44:98-103; discussion 103-4. [PMID: 11805570 DOI: 10.1007/BF02234829] [Cited by in Crossref: 25] [Cited by in F6Publishing: 27] [Article Influence: 1.1] [Reference Citation Analysis]
|
| 725 |
Gafa R, Maestri I, Matteuzzi M, Santini A, Ferretti S, Cavazzini L, Lanza G. Sporadic colorectal adenocarcinomas with high-frequency microsatellite instability. Cancer. 2000;89:2025-2037. [PMID: 11066042 DOI: 10.1002/1097-0142(20001115)89:10%3C2025::AID-CNCR1%3E3.0.CO;2-S] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
|
| 726 |
Gaf� R, Maestri I, Matteuzzi M, Santini A, Ferretti S, Cavazzini L, Lanza G. Sporadic colorectal adenocarcinomas with high-frequency microsatellite instability: Pathobiologic features, hMLH1 and hMSH2 expression, and clinical outcome. Cancer 2000;89:2025-37. [DOI: 10.1002/1097-0142(20001115)89:10<2025::aid-cncr1>3.0.co;2-s] [Cited by in Crossref: 149] [Cited by in F6Publishing: 148] [Article Influence: 6.5] [Reference Citation Analysis]
|
| 727 |
Church J, McGannon E. Family history of colorectal cancer: how often and how accurately is it recorded? Dis Colon Rectum 2000;43:1540-4. [PMID: 11089589 DOI: 10.1007/BF02236735] [Cited by in Crossref: 44] [Cited by in F6Publishing: 47] [Article Influence: 1.9] [Reference Citation Analysis]
|
| 728 |
Anwar S, Hall C, White J, Deakin M, Farrell W, Elder JB. Hereditary non-polyposis colorectal cancer: an updated review. Eur J Surg Oncol 2000;26:635-45. [PMID: 11078609 DOI: 10.1053/ejso.2000.0974] [Cited by in Crossref: 12] [Cited by in F6Publishing: 14] [Article Influence: 0.5] [Reference Citation Analysis]
|
| 729 |
Starostik P, Greiner A, Schwarz S, Patzner J, Schultz A, Müller-Hermelink HK. The role of microsatellite instability in gastric low- and high-grade lymphoma development. Am J Pathol 2000;157:1129-36. [PMID: 11021817 DOI: 10.1016/S0002-9440(10)64628-7] [Cited by in Crossref: 28] [Cited by in F6Publishing: 29] [Article Influence: 1.2] [Reference Citation Analysis]
|
| 730 |
Takagi S, Kinouchi Y, Hiwatashi N, Nagashima F, Chida M, Takahashi S, Negoro K, Shimosegawa T, Toyota T. Relationship between microsatellite instability and telomere shortening in colorectal cancer. Dis Colon Rectum 2000;43:S12-7. [PMID: 11052472 DOI: 10.1007/BF02237220] [Cited by in Crossref: 19] [Cited by in F6Publishing: 21] [Article Influence: 0.8] [Reference Citation Analysis]
|
| 731 |
Thorson AG, Faria J. Familial Adenomatous Polyposis, Hereditary Nonpolyposis Colon Cancer, and Familial Risk. Surgical Oncology Clinics of North America 2000;9:683-97. [DOI: 10.1016/s1055-3207(18)30104-2] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 0.2] [Reference Citation Analysis]
|
| 732 |
Schoen RE. Families at risk for colorectal cancer: risk assessment and genetic testing. J Clin Gastroenterol 2000;31:114-20. [PMID: 10993425 DOI: 10.1097/00004836-200009000-00005] [Cited by in Crossref: 18] [Cited by in F6Publishing: 18] [Article Influence: 0.8] [Reference Citation Analysis]
|
| 733 |
Burt RW. Colon cancer screening. Gastroenterology 2000;119:837-53. [PMID: 10982778 DOI: 10.1053/gast.2000.16508] [Cited by in Crossref: 248] [Cited by in F6Publishing: 255] [Article Influence: 10.8] [Reference Citation Analysis]
|
| 734 |
Syngal S, Fox EA, Eng C, Kolodner RD, Garber JE. Sensitivity and specificity of clinical criteria for hereditary non-polyposis colorectal cancer associated mutations in MSH2 and MLH1. J Med Genet 2000;37:641-5. [PMID: 10978352 DOI: 10.1136/jmg.37.9.641] [Cited by in Crossref: 191] [Cited by in F6Publishing: 208] [Article Influence: 8.3] [Reference Citation Analysis]
|
| 735 |
Kim HC, Wheeler JM, Kim JC, Ilyas M, Beck NE, Kim BS, Park KC, Bodmer WF. The E-cadherin gene (CDH1) variants T340A and L599V in gastric and colorectal cancer patients in Korea. Gut 2000;47:262-7. [PMID: 10896919 DOI: 10.1136/gut.47.2.262] [Cited by in Crossref: 45] [Cited by in F6Publishing: 47] [Article Influence: 2.0] [Reference Citation Analysis]
|
| 736 |
Hampel H, Peltomaki P. Hereditary colorectal cancer: risk assessment and management. Clin Genet 2000;58:89-97. [PMID: 11005140 DOI: 10.1034/j.1399-0004.2000.580201.x] [Cited by in Crossref: 58] [Cited by in F6Publishing: 60] [Article Influence: 2.5] [Reference Citation Analysis]
|
| 737 |
Ho JW, Yuen ST, Chung LP, Kwan KY, Chan TL, Leung SY, Chan AS, Tse Cw, Lam PW, Luk IS. Distinct clinical features associated with microsatellite instability in colorectal cancers of young patients. Int J Cancer 2000;89:356-60. [PMID: 10956410 DOI: 10.1002/1097-0215(20000720)89:4<356::aid-ijc7>3.0.co;2-j] [Cited by in Crossref: 19] [Cited by in F6Publishing: 21] [Article Influence: 0.8] [Reference Citation Analysis]
|
| 738 |
Syngal S, Clarke G, Bandipalliam P. Potential roles of genetic biomarkers in colorectal cancer chemoprevention. J Cell Biochem Suppl 2000;34:28-34. [PMID: 10762012 DOI: 10.1002/(sici)1097-4644(2000)77:34+<28::aid-jcb7>3.0.co;2-r] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 0.4] [Reference Citation Analysis]
|
| 739 |
Balmaña J, Brunet J, Pericay C, Capellà G, Peinado MÁ, Blanco I, López JJL, Marcuello E. What is the hereditary non-polyposis colorectal cancer syndrome? Rev Oncología 2000;2:191-201. [DOI: 10.1007/bf02979554] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.0] [Reference Citation Analysis]
|
| 740 |
Wheeler JM, Bodmer WF, Mortensen NJ. DNA mismatch repair genes and colorectal cancer. Gut 2000;47:148-53. [PMID: 10861278 DOI: 10.1136/gut.47.1.148] [Cited by in Crossref: 119] [Cited by in F6Publishing: 131] [Article Influence: 5.2] [Reference Citation Analysis]
|
| 741 |
Ponz de Leon M, Roncucci L. The cause of colorectal cancer. Dig Liver Dis 2000;32:426-39. [PMID: 11030190 DOI: 10.1016/s1590-8658(00)80265-0] [Cited by in Crossref: 22] [Cited by in F6Publishing: 24] [Article Influence: 1.0] [Reference Citation Analysis]
|
| 742 |
Tsao H. Update on familial cancer syndromes and the skin. Journal of the American Academy of Dermatology 2000;42:939-69. [DOI: 10.1067/mjd.2000.104681] [Cited by in Crossref: 45] [Cited by in F6Publishing: 45] [Article Influence: 2.0] [Reference Citation Analysis]
|
| 743 |
Lynch HT, Lynch JF. Hereditary nonpolyposis colorectal cancer. Semin Surg Oncol 2000;18:305-13. [PMID: 10805952 DOI: 10.1002/(sici)1098-2388(200006)18:4<305::aid-ssu5>3.0.co;2-a] [Cited by in Crossref: 45] [Cited by in F6Publishing: 55] [Article Influence: 2.0] [Reference Citation Analysis]
|
| 744 |
Syngal S. Hereditary nonpolyposis colorectal cancer: a call for attention. J Clin Oncol 2000;18:2189-92. [PMID: 10829037 DOI: 10.1200/JCO.2000.18.11.2189] [Cited by in Crossref: 7] [Cited by in F6Publishing: 8] [Article Influence: 0.3] [Reference Citation Analysis]
|
| 745 |
Westman J, Hampel H, Bradley T. Efficacy of a touchscreen computer based family cancer history questionnaire and subsequent cancer risk assessment. J Med Genet 2000;37:354-60. [PMID: 10807694 DOI: 10.1136/jmg.37.5.354] [Cited by in Crossref: 43] [Cited by in F6Publishing: 51] [Article Influence: 1.9] [Reference Citation Analysis]
|
| 746 |
Wilentz RE, Goggins M, Redston M, Marcus VA, Adsay NV, Sohn TA, Kadkol SS, Yeo CJ, Choti M, Zahurak M, Johnson K, Tascilar M, Offerhaus GJ, Hruban RH, Kern SE. Genetic, immunohistochemical, and clinical features of medullary carcinoma of the pancreas: A newly described and characterized entity. Am J Pathol 2000;156:1641-51. [PMID: 10793075 DOI: 10.1016/S0002-9440(10)65035-3] [Cited by in Crossref: 199] [Cited by in F6Publishing: 222] [Article Influence: 8.7] [Reference Citation Analysis]
|
| 747 |
Peters JA, Rubinstein WS. Genetics and the Multidisciplinary Breast Center. Surgical Oncology Clinics of North America 2000;9:367-396. [DOI: 10.1016/s1055-3207(18)30159-5] [Cited by in Crossref: 1] [Article Influence: 0.0] [Reference Citation Analysis]
|
| 748 |
Cohn DE, Babb S, Whelan AJ, Mutch DG, Herzog TJ, Rader JS, Elbendary A, Goodfellow PJ. Atypical clustering of gynecologic malignancies: A family study including molecular analysis of candidate genes. Gynecol Oncol 2000;77:18-25. [PMID: 10739686 DOI: 10.1006/gyno.1999.5709] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 0.3] [Reference Citation Analysis]
|
| 749 |
Plaschke J, Kruppa C, Tischler R, Bocker T, Pistorius S, Dralle H, Rüschoff J, Saeger HD, Fishel R, Schackert HK. Sequence analysis of the mismatch repair gene hMSH6 in the germline of patients with familial and sporadic colorectal cancer. Int J Cancer 2000;85:606-13. [PMID: 10699937 DOI: 10.1002/(sici)1097-0215(20000301)85:5<606::aid-ijc2>3.0.co;2-b] [Cited by in Crossref: 34] [Cited by in F6Publishing: 42] [Article Influence: 1.5] [Reference Citation Analysis]
|
| 750 |
Sasaki M, Dahiya R, Fujimoto S, Ishikawa M, Oshimura M. The expansion of the CAG repeat in exon 1 of the human androgen receptor gene is associated with uterine endometrial carcinoma. Mol Carcinog 2000;27:237-44. [DOI: 10.1002/(sici)1098-2744(200003)27:3<237::aid-mc11>3.0.co;2-0] [Cited by in Crossref: 26] [Cited by in F6Publishing: 27] [Article Influence: 1.1] [Reference Citation Analysis]
|
| 751 |
Siah SP, Quinn DM, Bennett GD, Casey G, Flower RL, Suthers G, Rudzki Z. Microsatellite instability markers in breast cancer: a review and study showing MSI was not detected at 'BAT 25' and 'BAT 26' microsatellite markers in early-onset breast cancer. Breast Cancer Res Treat 2000;60:135-42. [PMID: 10845276 DOI: 10.1023/a:1006315315060] [Cited by in Crossref: 36] [Cited by in F6Publishing: 39] [Article Influence: 1.6] [Reference Citation Analysis]
|
| 752 |
Starostik P, Greiner A, Schultz A, Zettl A, Peters K, Rosenwald A, Kolve M, Müller-hermelink HK. Genetic aberrations common in gastric high-grade large B-cell lymphoma. Blood 2000;95:1180-7. [DOI: 10.1182/blood.v95.4.1180.004k14_1180_1187] [Cited by in Crossref: 59] [Cited by in F6Publishing: 59] [Article Influence: 2.6] [Reference Citation Analysis]
|
| 753 |
Berg KD, Glaser CL, Thompson RE, Hamilton SR, Griffin CA, Eshleman JR. Detection of microsatellite instability by fluorescence multiplex polymerase chain reaction. J Mol Diagn 2000;2:20-8. [PMID: 11272898 DOI: 10.1016/S1525-1578(10)60611-3] [Cited by in Crossref: 114] [Cited by in F6Publishing: 119] [Article Influence: 5.0] [Reference Citation Analysis |
